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The dorsal striatum and the medial prefrontal cortex are part of a 
neurocircuitry that is affected by acute and chronic drug use. In the present 
studies, we sought to characterize the pharmacological effects of ethanol on 
extracellular catecholamine concentrations in the dorsal striatum and medial 
prefrontal cortex. To this end, we utilized two different routes of administration to 
quantify ethanol’s actions. We performed in vivo microdialysis in adult, male Long 
Evans rats as they received single or repeated intravenous infusions of ethanol. 
Following infusion of a 1-g/kg dose of ethanol, we observed no significant effects 
on extracellular dopamine in either the dorsomedial or dorsolateral striatum, but 
in a separate group of animals, we observed significant stimulation of 
extracellular norepinephrine in the medial prefrontal cortex. However, following a 
cumulative intravenous dosing protocol, we observed a gradual ramping up of 
tonic dopamine activity in the dorsal striatal subregions, which was more robust 
 viii 
in the dorsomedial striatum. Subsequently, we performed in vivo microdialysis in 
separate groups of rats during an operant self-administration session to quantify 
the time course of extracellular dopamine and norepinephrine in the medial 
prefrontal cortex. In the seven operant sessions prior to the microdialysis test 
session, each group of rats had been assigned to a separate treatment group: 
one that received a sweetened ethanol solution, one that received a sucrose 
solution, and a handling control group that did not receive any drinking solutions. 
In the ethanol-experienced animals, we report a reduction in basal dopamine and 
norepinephrine in the medial prefrontal cortex, relative to control groups. 
However, there were no significant differences in the temporal profile of 
extracellular norepinephrine across the three treatment groups. These studies 
demonstrate that limited voluntary ethanol consumption appears to be sufficient 
to alter tonic catecholamine signaling in the medial prefrontal cortex. Additionally, 
we conclude that central catecholamine signaling pathways are a target for 
ethanol. 
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ALCOHOL USE DISORDERS 
Definition and global impact 
The National Institute on Alcohol Abuse and Alcoholism (NIAAA) defines 
alcohol use disorders (AUDs) as a condition in which “a patient’s drinking causes 
distress or harm” (NIAAA, 2016). The most recent version of the Data and 
Statistics Manual of Mental Disorders V (DSM-5; American Psychiatric 
Association, 2013) utilizes AUD in lieu of two previously distinct conditions – 
alcohol abuse and alcohol dependence. Similar to other substance use 
disorders, core symptoms of AUDs include the compulsive drug seeking and 
consummatory behaviors even in the face of negative consequences, loss of 
control over alcohol use, and the development of a negative affective state when 
alcohol use is discontinued (Koob & Volkow, 2016).  
In 2014, 88% of adults (18 years or older) in the U.S. reported that they 
had used alcohol in their lifetime, and 57% reported using alcohol in the past 
month, a criterion commonly used to identify regular use (NIAAA, 2016). While 
many individuals will engage in problematic drinking behaviors, such as binge 
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and heavy drinking, few go on to develop severe alcohol use disorders, or 
alcoholism (NIAAA, 2016). In 2014, about 7% of adults in the U.S. had an AUD, 
with rates twice as high for men as women.  
The global economic and societal burdens of alcohol abuse are 
disproportionately staggering relative to other conditions that have greater 
prevalence. In the U.S. alone, the costs associated with alcohol misuse in 2010 
we $249.0 billion (NIAAA, 2016). According to the World Health Organization 
Global Status Report on Alcohol and Health (2014), 5.1% of the global burden of 
disease and injury was due to alcohol consumption. 
These statistics highlight the need for research into the development and 
expression of alcohol use disorders. Understanding the biological, psychological, 
and neurological components of this condition will be critical to the development 
of preventative and early intervention measures, improvement of the current 
standard of care and treatment, and to influencing public policy and awareness. 
 
Proposed neurobiology 
A dramatic shift occurs in the motivation to seek and use drugs, including 
alcohol that precedes the development of maladaptive and pathological 
substance use. Initially, drug-seeking behavior is goal-directed and may be 
impulsive, mediated by the positive reinforcing effects of the drug (Koob & 
Volkow, 2016; Mangieri, Cofresí, & Gonzales, 2012). With alcohol, such positive 
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hedonic features may include anxiolysis, euphoria, and increased sociability. 
Following repeated cycles of intoxication, withdrawal, and craving, drug-seeking 
behaviors become more automated and habitual. As the motivation to seek drugs 
becomes an attempt to resolve the negative affective state induced by 
withdrawal, substance use behaviors become compulsive, driven by an urge to 
resist tension or anxiety (Volkow, Koob, & McLellan, 2016). 
 Currently, the proposed neurobiological mechanisms underlying the 
progression from impulsive to compulsive drug use exists within a conceptual 
framework of drug dependence as established by Dr. George Koob and 
colleagues. This framework consists of three primary domains: binge/intoxication, 
withdrawal/negative affect, and preoccupation/anticipation. Each of these 
domains is associated with adaptations in specific circuits. For example, a 
common feature of all abused drugs is their ability to acutely stimulate the 
mesocorticolimbic dopamine system, which contributes to the positive reinforcing 
effects of drugs and alcohol. This central circuit consists of dopamine neurons 
originating in the ventral tegmental area (VTA) and projecting to the prefrontal 
cortex, nucleus accumbens, dorsomedial striatum, ventral pallidum, and other 
regions (Everitt & Robbins, 2005; Koob & Volkow, 2010). Repeated stimulation of 
this circuit by exogenous rewards facilitates the learning of stimuli that are 
associated with the reward (Schultz, 1997). Over time neuroadaptations within 
this circuit may promote enhanced motivation for drug-related stimuli over natural 
reinforcers. 
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 Following a binge/intoxication experience, an individual may experience 
unpleasant and potentially stressful effects that occur when the drug is eliminated 
from the body. The emergence of withdrawal symptoms, such as dysphoria, pain, 
and malaise, is one of the criteria listed in the DSM-5 for diagnosing substance 
use disorders (American Psychiatric Association, 2013). The withdrawal/negative 
affect domain is characterized by increases in reward thresholds, an escalation in 
drug consumption, and activation of stress and anxiety circuits within the 
extended amygdala, habenula, ventral tegmental area, and the nucleus 
accumbens (Koob & Volkow, 2016). The aversive and negative affective state 
induced by acute or protracted abstinence can be alleviated by consumption of 
the drug, which contributes to the development of craving and appetitive 
behaviors, and eventually may progress to habitual and compulsive drug seeking 
behavior (Koob & Volkow, 2016). 
 Chronic drug use is associated with deficits in executive functions, which 
are primarily governed by the prefrontal cortex. Impairments in decision-making, 
inhibitory control, working memory, and behavioral flexibility are believed to be 
the result of neuroplastic changes in dopamine and glutamatergic signaling 
observed in the frontal cortex of humans and animals following long-term chronic 
drug use (Koob & Volkow, 2016; Volkow et al., 2016). Neuroadaptations within 
the frontal cortex may also contribute to the development of incentive salience 
and the incubation of craving by drug-associated stimuli, which are 
characteristics of the preoccupation/anticipation domain. The ability of drug-
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associated cues to activate reward and emotional/motivational circuitry is a 
critical factor in the development of habitual and compulsive drug seeking 
behaviors. 
 
THE DORSAL STRIATUM 
Anatomy 
 The dorsal striatum, or the caudate-putamen in primates, is the largest 
component of the basal ganglia (Gerfen & Surmeier, 2011). The basal ganglia 
connect essentially all cortical areas involved in the planning and executive 
control of actions with regions that modulate behavior (Gerfen, 2004; Gerfen & 
Surmeier, 2011). The major inputs to the basal ganglia are glutamatergic 
neurons of the neocortex and midbrain dopamine neurons, which target the 
dorsal striatum. 
The dorsal striatum integrates sensorimotor, motivational and emotional 
information to direct an appropriate behavioral response. GABAergic medium 
spiny neurons originating in the dorsal striatum are the major output neurons of 
the basal ganglia and can be divided into two distinct populations based on their 
projections. One population directly innervates the GABAergic neurons in the 
medial globus pallidus and SN pars reticulata, which target thalamic nuclei that 
coordinate movement generation (Gerfen, 2004). This “direct” projection system 
is characterized by the presence of D1 dopamine receptors and appears to 
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generally excite downstream neural systems that affect behavior (Gerfen, 2004; 
Gerfen & Surmeier, 2011; Yin & Knowlton, 2006). In contrast, the “indirect” 
projection system innervates an intermediate nucleus, the lateral globus pallidus, 
which together with the subthalamic nucleus, targets behavior output systems 
within the thalamus (Gerfen, 2004; Gerfen & Surmeier, 2011). This indirect 
pathway is characterized by the presence of D2 dopamine receptors on medium 
spiny neurons and appears to generally inhibit circuits regulating behavioral 
output and motor activity. Therefore, striatal output is critically modulated by 
dopamine activity. Dopamine neurons projecting to the dorsal striatum originate 
in ventral tegmental area and substantia nigra pars compacta, and are highly 
sensitive to action outcomes.  
 
Habitual behavior definition 
 As discussed above, drugs of abuse, including alcohol, activate the 
mesocorticolimbic dopamine pathway, which is associated with the stimulating 
and reinforcing aspects of the drug itself (Di Chiara & Imperato, 1988; Yin, 
Ostlund, & Balleine, 2008). This may contribute to the motivation to voluntarily 
seek and consume drugs. Such behavior is considered goal-directed because it 
is sensitive to the value of the outcome, and may be modified based on the 
perceived changes in the value of the outcome. With extended training and 
experience, the behavior becomes automated or habitual, and is not altered in 
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response to reward devaluation (Corbit, Nie, & Janak, 2012; Faure, Haberland, 
Condé, & El Massioui, 2005; Jonkman, Pelloux, & Everitt, 2012; Yin, Knowlton, & 
Balleine, 2004). Rather than performing an action to attain a specific outcome, a 
conditioned stimulus automatically elicits a response, and this may be the 
precursor to compulsive behavior. As evidenced by animal models of drug use, 
with prolonged training drug-associated sensory cues acquire incentive salience 
and as conditioned reinforcers, they can drive drug-seeking behavior on their 
own (Dickinson, Wood, & Smith, 2002). In humans, a stimulus may be a context 
in which drug use has previously occurred, an internal emotional state (i.e. 
stress/anxiety), a specific object that is associated with the drug, or the drug 
itself. 
 
The dorsal striatum, dopamine, and habit formation 
 The current literature suggests that the shift in drug-seeking behavior from 
voluntary to habitual, observed after chronic and prolonged use of a drug, may 
be due to a transition in the neuroanatomical substrates controlling behavior, 
possibly via a dopamine-dependent mechanism (Corbit et al., 2012; Everitt & 
Robbins, 2013; Volkow, Wang, Fowler, Tomasi, & Telang, 2011; Yin & Knowlton, 
2006). Acute drug administration is associated with increased dopamine activity 
in the ventral striatum, a region necessary for the acquisition of goal-directed 
behavior and instrumental conditioning (learning the association between an 
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action and the presentation of a reward) (Everitt & Robbins, 2013). However, if 
drug seeking and consumption behavior is maintained over an extended period 
of time, there appears to be recruitment of the dorsal striatal dopaminergic circuit, 
as indicated by human and animal studies (Balleine, Delgado, & Hikosaka, 2007; 
Volkow et al., 2011; Willuhn, Burgeno, Everitt, & Phillips, 2012). Actions that 
produce positive hedonic outcomes stimulate dopamine release into the striatum, 
which is critical for synaptic plasticity and reinforcement learning. This may 
enable drug-associated stimuli to assume a greater influence in predicting the 
expression of appetitive behaviors (Everitt & Robbins, 2013). 
The dorsal striatum has functionally distinct lateral and medial subregions 
that display differential neuronal firing patterns in response to ethanol and 
ethanol-associated cues (Fanelli, Klein, Reese, & Robinson, 2013). These 
subregions appear to have different roles in the regulation of behavior, with the 
dorsomedial striatum (DMS) regulating goal-directed behavior and the 
dorsolateral striatum (DLS) regulating automated stimulus-response behaviors 
(Balleine et al., 2007; Everitt & Robbins, 2013; Faure et al., 2005; O’Doherty et 
al., 2004; Yin & Knowlton, 2006; Yin et al., 2004, 2008). Corbit et al. (2012) 
demonstrated the dichotomous roles of the DMS and DLS using an operant 
model of alcohol self-administration in rats. Following limited alcohol experience 
(after 2 weeks of operant self-administration), responding for alcohol is sensitive 
to devaluation, an effect that is blocked by inactivating the DMS with GABA 
agonists. After prolonged alcohol exposure (after 8 weeks of operant self-
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administration), responding for alcohol is insensitive to reward devaluation, 
indicating that control over behavior has shifted to a habit-based mechanism. 
Inactivating the DLS reversed this effect. Other manipulations of the dorsal 
striatal subregions, including lesion studies and studies testing other drugs of 
abuse, support these findings (Yin et al., 2004; Yin, Ostlund, Knowlton, & 
Balleine, 2005). 
It is generally supported that dopamine signaling in the dorsal striatum is 
critical for the reinforcement learning that underlies the development of habitual 
drug seeking behavior (Belin & Everitt, 2008; Centonze, Picconi, Gubellini, 
Bernardi, & Calabresi, 2001; Faure et al., 2005; Ito, Dalley, Robbins, & Everitt, 
2002; Kreitzer & Malenka, 2005; Lovinger, 2010). Furthermore, ethanol has been 
shown to enhance plasticity among D1-containing medium spiny neurons (Wang 
et al., 2015). However, few studies have looked at the direct pharmacological 
effects of ethanol on dopamine in the dorsal striatum. Quantitating these effects, 
particularly within each of the dorsal striatal subregions, is necessary for 




THE PREFRONTAL CORTEX 
Anatomy 
The prefrontal cortex (PFC) is a large heterogeneous region located at the 
anterior pole of the frontal cortex (Abernathy et al, 2010). The PFC is extensively 
connected with sensory systems, cortical and subcortical motor coordination 
systems, autonomic systems, and limbic and midbrain regions involved with 
motivation, reward, emotion, and memory (Miller & Cohen, 2001; Ongür & Price, 
2000). Therefore, the PFC is well-situated to exert top-down control over 
behavior. It consists of 3 interconnected subregions: lateral PFC, medial PFC, 
and orbital PFC. Because the studies described herein analyzed the effects of 
ethanol on neurochemistry within the medial PFC (mPFC) in rodents, discussion 
of all PFC subregions is beyond the scope of this manuscript. 
Within the mPFC, about 80-90% of the neuronal population is excitatory 
pyramidal cells, while the remaining 10-20% is GABAergic interneurons (Riga, 
Matos, et al., 2014). The mPFC in rodents can be subdivided into the prelimbic 
mPFC (functionally analogous to the dorsolateral PFC in humans and primates) 
and the infralimbic mPFC (functionally analogous to the ventromedial PFC in 
humans and primates), which are reciprocally connected (Abernathy, Chandler, 
& Woodward, 2010; Riga, Matos, et al., 2014; Vertes, 2006). The mPFC strongly 
projects to cortical and subcortical structures involved in motor coordination 
(Abernathy et al., 2010; Miller & Cohen, 2001). The prelimbic region provides 
 11 
glutamatergic projections to the nucleus accumbens core and the dorsomedial 
striatum, while the infralimbic region densely innervates the nucleus accumbens 
shell (Abernathy et al., 2010; Ongür & Price, 2000; Voorn, Vanderschuren, 
Groenewegen, Robbins, & Pennartz, 2004). These circuits are likely involved in 
reward-guided choice behaviors. Also implicated in reward (and aversion) 
processing are the reciprocal projections between the mPFC and the ventral 
tegmental area, which is also innervated by noradrenergic neurons originating in 
the locus coeruleus. Cortical processing of internal affective states and memory 
appears to occur via reciprocal projections between the mPFC and the 
hippocampus and between the mPFC and the amygdala (Abernathy et al, 2010; 
Ongür & Price, 2000).  
 
mPFC functional roles 
 With the evolution of more complex organisms, it became necessary for 
the development of a brain region to mediate higher-order executive functions 
such as reasoning, attention, planning, working memory, and decision making 
(Abernathy et al, 2010; Riga et al, 2014). To ensure survival, consistent 
monitoring of internal goals and external environmental patterns became 
necessary, as well as the ability to flexibly orchestrate complex behavioral 
responses. The current literature indicates that these roles appear to be 
dependent on the mPFC (Miller & Cohen, 2001). To accomplish this, the mPFC 
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must attend to relevant stimuli, suppress responding to irrelevant stimuli, plan 
behavioral sequences based on environmental stimuli and past experiences, and 
select appropriate motor behaviors in response to environmental stimuli and 
internal states (Miller & Cohen, 2001; Abernathy et al, 2010). 
 
Attention and behavioral flexibility 
Recent work implicates the mPFC in specific aspects of attention, 
learning, and behavioral flexibility. For example, inactivation or lesions of the 
mPFC do not impair acquisition of visual cue discrimination learning or response 
discrimination learning, nor do such manipulations impair reversal learning, but 
they do impair extradimensional set-shifting behaviors (Birrell & Brown, 2000; 
Floresco, Block, & Tse, 2008; Killcross & Coutureau, 2003). Extradimensional 
set-shifting behaviors require an organism to reorient attention to a different set 
of sensory features of complex stimuli, while discrimination or reversal learning 
does not require shifting attention to previously irrelevant stimuli (Birrell & Brown, 
2000; Dalley, Cardinal, & Robbins, 2004). Another task for assaying directed and 
sustained attention, is the 5-choice serial reaction time task (5-CSRTT). Damage 
to the mPFC produces substantial deficits in accuracy on this task, and is 
associated with premature and perseverative responding (Chudasama et al., 
2003; Robbins, 2002). These studies and others support a general role for the 
mPFC as a supervisory attentional and behavioral control center (Perry et al., 
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2011). Supporting these preclinical findings is a study in humans with surgical 
lesions of the dorsolateral PFC. While some of these patients performed 
successfully on a visual discrimination reversal task, those that showed impaired 
performance reported deficits in attentional control (Hornak et al., 2004). In 
summary, these studies support the role of the mPFC in monitoring and flexibly 
attending to motivational and contextual stimuli to guide decision-making and 
adaptive behaviors. 
 
Regulation of appetitive instrumental behavior 
The ability to detect and respond to contextual stimuli predicting risk or 
reward is critical for survival. The PFC is central to reward-based decision-
making, but it is functionally heterogeneous in processing specific aspects of 
reward seeking and acquisition (Tzschentke, 2000). The medial PFC appears 
particularly important in orienting attention and arousal towards reward-predicting 
stimuli to drive appetitive behaviors. Additionally, evidence suggests that the 
mPFC may be necessary for the reinforcing effects of some drugs of abuse. For 
example, mPFC lesions prevent the acquisition of conditioned place preference 
(a behavioral assessment of the subjective rewarding aspects of reinforcers) for 
morphine and cocaine (Hao et al., 2008; Tzschentke, 2000). Animals will also 
self-administer cocaine into the mPFC (Goeders & Smith, 1983). 
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Because the mPFC regulates working memory, it is central in tracking 
temporal and discriminative information related to reward-associated rules and 
cues. In reinforcement learning, action selection is partly determined by the 
outcomes of previous choices. Indeed, work has shown that neural signaling in 
the mPFC increases during the onset of a chosen action (Matsumoto, Suzuki, & 
Tanaka, 2003), and remains elevated until its outcome (Sul, Kim, Huh, Lee, & 
Jung, 2010). Upon receipt of a rewarding outcome, neural signaling was further 
enhanced (Sul et al., 2010). Persistent neural activity observed in the mPFC (or 
dlPFC of primates) during a delay period, either between the behavioral 
response and the outcome delivery or between trials, is believed to be a correlate 
of temporary active maintenance of information relating an action choice on a 
given trial to the outcome of the trial (Bouret & Sara, 2004; Funahashi, 2006; 
Matsumoto et al, 2003; Sul et al., 2010). Interestingly, this pattern of sustained 
neural activity is only observed when the behavioral sequence is performed in 
the appropriate context (Mulder, Nordquist, Örgüt, & Pennartz, 2003). Therefore, 
the mPFC appears to regulate goal-directed responding triggered by stimuli that 
predict an anticipated outcome. 
Consistent with this hypothesis, the mPFC has been implicated in cue-
induced reward seeking behavior. Drug-related contextual cues and cue-induced 
drug seeking are associated with neuronal activation in the mPFC of rats (Ball & 
Slane, 2012; Bossert et al., 2012; Koya et al., 2009). For example, tetrodotoxin 
injections into the mPFC attenuated the ability of a cocaine-paired context to 
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reinstate extinguished cocaine seeking behavior (Fuchs et al., 2005). In humans, 
increased glucose metabolism has been observed in the dorsolateral PFC in 
cocaine abusers upon presentation of drug-related stimuli (Grant et al., 1996). 
Mechanistic studies have implicated prefrontal cortical glutamateric and 
dopaminergic signaling in conditioned appetitive behaviors (Baldwin, Sadeghian, 
& Kelley, 2002), though it is likely that other systems are involved. For example, 
downregulation of glutamatergic transmission in the mPFC is associated with 
cue-induced heroin reinstatement in rats (Van den Oever et al., 2008; Van den 
Oever, Spijker, Smit, & De Vries, 2010).  
Other work has attempted to delineate specific roles of the prelimbic and 
infralimbic subregions in appetitive behaviors. Inactivation of the dorsal mPFC 
(prelimbic PFC) inhibited cue-induced sucrose seeking behavior. In contrast, 
inactivation of the ventral mPFC (infralimbic PFC) appeared to increase 
responding to unrewarded cues, an indication of reduced inhibitory control 
(Ishikawa, Ambroggi, Nicola, & Fields, 2008). In rats that had undergone 
extensive extinction training for cocaine self-administration, inactivation of the 
infralimbic PFC induced reinstatement of cocaine seeking, while activation of the 
infralimbic PFC suppressed cocaine-induced reinstatement (Peters, LaLumiere, 
& Kalivas, 2008). Together, these data suggest a specific role of the infralimbic 
cortex in inhibitory control over conditioned behavior. However, other work has 
yielded inconsistent results. For example, rats with prelimbic PFC lesions 
showed increased premature responding and shortened response latencies in a 
 16 
cue-triggered reaction time task (Narayanan, Horst, & Laubach, 2006). Another 
study demonstrated abolishment of context-potentiated food consumption in 
sated rats with lesions of the infralimbic cortex relative to sham-lesioned controls 
(Petrovich, Ross, Holland, & Gallagher, 2007). The use of different behavioral 
tasks may explain the inconsistent results from these lesion/inactivation studies, 
but further investigation is necessary to determine the precise functional roles of 
the prelimbic and infralimbic cortices in inhibitory control. Nevertheless, the 
studies discussed above implicate the mPFC in the regulation of reward-seeking 
behaviors in response to environmental stimuli. 
 
Role of catecholamines in mPFC functions 
 The catecholamines dopamine and norepinephrine are critical 
neuromodulators in various mPFC-mediated functions, including working 
memory, arousal and attention, behavioral flexibility, and stress- and reward-
related behaviors (Dalley et al., 2004; Jett & Morilak, 2013; Lapiz & Morilak, 
2006; Riga, Matos, et al., 2014; Zvani L Rossetti & Carboni, 2005). However, it 
has been difficult to accurately delineate the specific roles of cortical dopamine 
and norepinephrine in behavior (Feenstra, 2000). One observation that has been 
consistently reported is that catecholamines can exert a biphasic effect on 
cognitive and executive functions, following an inverted-U shape concentration-
response curve (Arnsten, 1997; Cools & D’Esposito, 2011; Dalley et al., 2004).  
 17 
Because basal catecholamine concentrations in the mPFC are relatively 
low, small fluctuations in extracellular concentrations can have significant effects 
on mPFC-mediated functions. Tonic catecholamine levels are typically low in 
fatigued/low arousal states, and increase in response to stress or in cases of 
heightened vigilance (Aston-Jones, Rajkowski, & Cohen, 1999; Jett & Morilak, 
2013; Nakane, Shimizu, & Hori, 1994). Reduced extracellular catecholamine 
signaling can result in increased distractibility and poor impulse control, which will 
hinder appropriate responding in cognitively taxing situations (Arnsten & Pliszka, 
2011; Carli, Robbins, Evenden, & Everitt, 1983; Cole & Robbins, 1992). 
Moderately elevated catecholamine levels (such as in an alert, nonstressed 
state) can improve behavioral flexibility, attention to salient stimuli, and working 
memory, which are necessary in the face of environmental challenges. This 
engagement of the mPFC appears to be mediated via dopamine D1 receptors 
and high-affinity α2 adrenergic receptors, as determined by pharmacological 
studies (Arnsten & Pliszka, 2011; Riga et al., 2014; Robbins, 2002; Spencer, 
Devilbiss, & Berridge, 2015; Wang et al., 2007). In contrast, excessive activation 
of dopamine D1 receptors (Arnsten, 1997; Rios Valentim, Gontijo, Peres, 
Rodrigues, & Nakamura-Palacios, 2009; Robbins, 2002; Vijayraghavan, Wang, 
Birnbaum, Williams, & Arnsten, 2007) and α1 adrenergic receptors (Lapiz & 
Morilak, 2006; Ramos & Arnsten, 2007) will impair mPFC functioning, as is the 
case following exposure to stress or high doses of stimulant drugs. Chronic 
stimulation of these receptors can result in an inability to distinguish between 
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relevant and irrelevant stimuli and impair response accuracy in attentional tasks 
(Blaine, Milivojevic, Fox, & Sinha, 2016). 
It has been difficult to characterize precise roles for dopamine and 
norepinephrine in the mPFC for several reasons, a few being: (1) extracellular 
concentrations of dopamine and norepinephrine are regulated by overlapping 
mechanisms (Morón, Brockington, Wise, Rocha, & Hope, 2002; Pan, Yang, & 
Lin, 2004; Tanda, Pontieri, Frau, & Di Chiara, 1997), (2) the mPFC is especially 
sensitive to small changes in neurochemical activity (Arnsten & Pliszka, 2011; 
Ramos & Arnsten, 2007), (3) cortical dopamine and norepinephrine activity 
increases in response to salient stimuli, regardless of valence (Feenstra, 2000; 
Popescu, Zhou, & Poo, 2016), and (4) recent work has provided evidence of the 
co-release of dopamine and norepinephrine from noradrenergic terminals 
(Devoto, Flore, Pani, & Gessa, 2001; Devoto, Flore, Pira, Diana, & Gessa, 2002; 
Devoto, Flore, Saba, Fà, & Gessa, 2005). In spite of these confounds, however, 
some work has suggested differential roles of cortical dopamine and 
norepinephrine in specific aspects of behavior. During performance on a T-maze 
task of spatial working memory, Rossetti and Carboni (2005) observed increases 
in extracellular concentrations of both catecholamines during the task. 
Interestingly, they observed significantly greater increases in noradrenergic 
activity in rats trained to alternate entrances into the left and right arms on the 
maze with each trial, as compared to untrained animals. This finding suggests 
specific recruitment of mPFC noradrenergic activity in more cognitively 
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demanding situations, possibly because such situations require heightened 
arousal and selective orientation of attention (Rossetti & Carboni, 2005; Robbins, 
2002).  
The same study also reported increased dopamine, but not 
norepinephrine concentrations during the waiting/anticipatory period prior to the 
start of the task, which concluded with the animal obtaining food reinforcement. 
This is consistent with the role of mesocortical dopamine in reward prediction 
error and reward expectancy (Jo & Mizumori, 2016; Merali, McIntosh, & 
Anisman, 2004; Parker, Alberico, Miller, & Narayanan, 2013; Rossetti & Carboni, 
2005). An additional role of cortical dopamine appears to be in enhancing the 
signal to noise ratio of relevant stimuli by reducing mPFC responsiveness to 
irrelevant stimuli (Arnsten & Pliszka, 2011; Berridge & Devilbiss, 2011). Together, 
these studies indicate that while dopamine and norepinephrine dually modulate 
many mPFC functions, these systems may differentially modulate precise 
aspects of cognitive behaviors, but this hypothesis requires further investigation. 
 
Appetitive behaviors 
 The role of mesocortical dopamine in appetitive behaviors has been the 
subject of much research, but the role of norepinephrine has received 
considerably less attention. Significant elevations in extracellular dopamine in the 
medial PFC of rats have been observed in response to sensory cues associated 
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with food and upon the initiation of food consumption (Ahn & Phillips, 1999; 
Bassareo & Di Chiara, 1997). Additionally, acute administration of various 
commonly abused drugs, such as cocaine, amphetamine, alcohol, and THC, has 
been shown to stimulate extracellular dopamine in the mPFC (Jianping, Paredes, 
Lowinson, & Gardner, 1990; Moghaddam, Roth, & Bunney, 1990; Sorg & 
Kalivas, 1993a). Because dopamine signaling facilitates the plasticity underlying 
reinforcement learning, it is believed that mPFC dopamine mediates some of the 
reinforcing properties of food and abused drugs. This is supported by studies 
using conditioned place preference, a behavioral assay of a substance’s 
motivational and reinforcing properties. For example, microinjections of a D1-
dopamine receptor antagonists into the medial PFC block cocaine-induced 
conditioned place preference (Sanchez, Bailie, Wu, Li, & Sorg, 2003). However, 
a complementary role of mPFC norepinephrine in reward-seeking and 
consummatory behaviors has not yet been confirmed. 
 Numerous studies have implicated cortical norepinephrine in mediating 
attention and arousal, cognitive functions that are involved in appetitive and 
seeking behaviors. Early in vivo electrophysiological recordings from locus 
coeruleus neurons in awake monkeys demonstrated an ability of sensory cues, 
such as the presentation of a juice drink or a food odor, to stimulate neuronal 
firing (though the projection targets of these neurons were not determined) 
(Foote, Aston-Jones, & Bloom, 1980). Additionally, some potential mechanisms 
to facilitate functional crosstalk between noradrenergic and dopaminergic 
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signaling within the mPFC have been identified. For example, co-localization of 
D2-dopamine and β1-adrenergic receptors has been observed on prefrontal 
cortical neurons (Xing, Li, & Gao, 2016). Therefore, it is reasonable to 
hypothesize that mPFC norepinephrine may play a role in responding to 
appetitive conditioned stimuli, and some supportive evidence exists. Upon 
presentation of a conditioned stimulus and a food reward, significant stimulation 
of extracellular norepinephrine (and dopamine) is observed in the mPFC. 
Presentation of the conditioned stimulus alone was also sufficient to stimulate 
extracellular norepinephrine, though this response was much less robust than 
when food was simultaneously presented (Mingote et al, 2004). In another study, 
selective lesions of mPFC noradrenergic afferents abolished morphine 
conditioned place preference in rodents. However, this behavioral effect may 
have been due to indirect effects on accumbal dopamine signaling, as the same 
lesions also abolished the morphine-induced dopamine response in the nucleus 
accumbens (Ventura, Alcaro, & Puglisi-Allegra, 2005). Together, this work 
indicates a potential role of cortical norepinephrine signaling in appetitive 
behaviors, which may serve to complement dopamine’s role in reward prediction.   
 
mPFC function and alcohol 
 Some of the cognitive-behavioral functions of the mPFC in which 
catecholamines have been implicated are affected by acute and chronic alcohol 
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experience. The effects of acute systemic ethanol on cognitive-behavioral tasks 
appear to be dose-dependent. Higher doses (1 g/kg and higher) produce 
impairments in working memory and response inhibition in rodents, while low 
doses facilitate or have no effect on these measures (Popke, Allen, & Paule, 
2000; Rossetti et al., 2002). In humans, while acute ethanol significantly impairs 
response inhibition, assessing it’s effects on working memory has yielded mixed 
results (Abernathy et al, 2010; Gan et al., 2014; Hendershot et al., 2015). Due to 
the correlational nature of these acute studies, however, caution must be taken in 
interpreting these observations as resulting from ethanol’s direct actions on 
mPFC function. A limited amount of work has been done to quantifying the 
actions of acute ethanol on mPFC neurochemistry and physiology. 
 In contrast, numerous studies have compared mPFC functioning in 
detoxified alcoholics and healthy controls. In general, alcoholics typically display 
hypofunction of the mPFC, which likely contributes to the loss of behavioral 
control and deficits in executive functions reported in these subjects (Goldstein & 
Volkow, 2011; Noël et al., 2005; Wang et al., 2016). Relative to controls, human 
alcoholics show impairments in manipulating working memory, flexibility in 
planning and problem solving, attentional shifting, ignoring distractions and 
irrelevant stimuli, and in response inhibition (Noël et al., 2001; Noël et al., 2005; 
Wang et al., 2016). Additionally, alcoholics show greater activation of the dlPFC 
and mPFC induced by alcohol-related cues, which is correlated with self-reported 
craving (Goldstein & Volkow, 2011; Grüsser et al., 2004).  
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While these studies demonstrate impaired PFC function in human 
alcoholics, it is often unclear if such deficits are pre-existing or induced by 
chronic alcohol use. Furthermore, if such deficits are due to ethanol-induced 
effects on PFC function, it is necessary to determine the mechanisms and time 
course by which these developments occur. Animal studies have found that 
synaptic alterations occur in the mPFC with chronic ethanol exposure, 
particularly among glutamatergic, dopaminergic, and GABAergic signaling, which 
may contribute to the impairments in mPFC function observed in human and 
animal models of alcohol dependency (Abernathy et al., 2010; Kroener et al., 
2012). For example, following chronic intermittent exposure to ethanol vapor, 
mice show altered LTP in the mPFC, which was hypothesized to be a result of 
increased synaptic expression of NR1 and NR2B NMDA receptor subunits 
(Kroener et al., 2012). Furthermore, these mice displayed deficits in behavioral 
flexibility, consistent with impaired mPFC activity. However, it is unclear if such 
synaptic and behavioral changes are apparent following a limited period of 
voluntary ethanol self-administration, or if these changes are the result of 
repeated cycles of intoxication and withdrawal. 
 Additionally, a few studies have demonstrated a functional role of the 
mPFC in alcohol self-administration. For example, a reduction in responding for 
ethanol has been reported following microinjections of muscimol, quinpirole or 
raclopride into the mPFC (Hodge, Chappelle, & Samson, 1996; Samson & 
Chappell, 2001). Similarly, inactivation/damage to the mPFC impaired extinction 
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of ethanol conditioned place preference in mice (Groblewski & Cunningham, 
2012). Another recent study identified a neuronal ensemble within the infralimbic 
cortex that appears to regulate cue-induced alcohol seeking behaviors, such that 
ablation of this ensemble produces persistent alcohol seeking in rats that is not 
observed following general inactivation of the infralimbic cortex (Pfarr et al., 
2015; Willcocks & McNally, 2013). However, the neurochemical correlates of 
alcohol seeking and consummatory behaviors remain unclear. 
METHODS OVERVIEW 
Modeling aspects of alcohol use disorders in animals 
 While animal models do not accurately represent clinical substance use 
disorders in their entirety, they can be used to examine specific elements of the 
condition. With regards to the study of alcohol use disorders, animal models are 
useful for examining the pharmacological, behavioral, neurological, and 
physiological effects of acute and chronic alcohol experience (Lynch, Nicholson, 
Dance, Morgan, & Foley, 2010; Tabakoff & Hoffman, 2000). In this dissertation, 
two different paradigms were employed to examine the effects of ethanol on 
neurochemistry and the role of catecholamines in ethanol seeking and 
consummatory behaviors in rats. 
  
1. Passive ethanol administration paradigm 
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This paradigm is primarily used as a pharmacological assay, as it 
minimizes the influences of behavior, motivation, and expectancy 
on neurochemistry. Ethanol may be administered intravenously, 
intraperitoneally, or intragastrically. Intravenous ethanol 
administration was employed in the subsequent studies to quantify 
the acute effects of ethanol on extracellular catecholamines in 
multiple brain regions. 
2. Ethanol self-administration paradigm 
Self-administration paradigms, particularly operant conditioning 
models, have greater face validity for human alcohol use than 
passive drug administration paradigms. To facilitate consumption of 
intoxicating doses of ethanol, outbred strains of rats, including the 
Long Evans strain used in the subsequent experiments, typically 
require the use of a sweetened ethanol solution. 
 
Microdialysis 
Microdialysis is an analyte collection technique that, when applied to 
neuroscience, enables the sampling and quantification of neurotransmitters, 
peptides, hormones, and other molecules from the extracellular space (Chefer, 
Thompson, Zapata, & Shippenberg, 2009).  The central component is the 
microdialysis probe, which can vary in its construction to optimize recovery of the 
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analyte of interest. The probes used in the discussed studies were manually 
constructed per the procedures described by Pettit and Justice (1991). In 
general, the microdialysis probes consist two pieces of fused silica, an “inlet” and 
an “outlet” through which analyte-free artificial cerebrospinal fluid (ACSF) is 
continuously perfused at a low flow rate. At one end, both strands of fused silica 
are enclosed in a porous cellulose membrane that is semi-permeable on the 
basis of molecular weight. Once the probe is implanted into the tissue and 
perfusion begins, analytes diffuse from the extracellular space across the 
membrane along their concentration gradient (Chefer et al., 2009). Analytes are 
then picked up by the perfusate and carried through the outlet silica into 
collection vials. Sample collection times vary depending on the analyte of interest 
and the sensitivity of the analytical equipment, usually between 1-30 minutes.  
In the preceding studies, we have applied in vivo conventional 
microdialysis to measure the relative extracellular concentrations of ethanol, 
dopamine, and norepinephrine in awake, freely behaving animals. With 
conventional microdialysis, the concentration of analyte recovered in the sample 
vials represents a fraction of the total extracellular concentration. For more 
details regarding the basic principles of microdialysis, see Chapter 2. 
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SPECIFIC AIMS AND HYPOTHESES 
Overall Rationale 
 Catecholamine signaling within the dorsal striatum and medial prefrontal 
cortex mPFC) is critical to the planning and execution of motivated behaviors, 
including alcohol seeking and consummatory behaviors. Acute and chronic 
alcohol use have been shown to alter the function and neuronal activity within the 
dorsal striatum and the mPFC. The direct pharmacological effects of alcohol on 
catecholaminergic signaling within these regions has not been thoroughly 
characterized so it is unclear when and by which mechanism ethanol may be 
inducing alterations. Our objective with the subsequent studies is to quantify 
neurochemical activity in animal models of initial alcohol exposure in an attempt 
to understand how ethanol’s early pharmacological actions influence or underlie 
the neuroadaptations observed in animal models of habitual and compulsive 
alcohol use. 
 Within the dorsal striatum, dopamine signaling is a critical mediator in the 
neuroplasticity underlying goal-directed and habitual behaviors, but it is unclear 
when ethanol-induced plasticity occurs. Furthermore, evidence suggests that 
differential mechanisms may regulate dopamine signaling within the medial and 
lateral subregions of the dorsal striatum, which are known to be functionally 
distinct. Prior to characterizing ethanol-induced alterations in the functions of the 
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dorsomedial and dorsolateral striata, it is critical to quantify ethanol’s acute 
pharmacological effects on extracellular dopamine within each of these 
subregions. This may also contribute to our understanding of ethanol’s 
mechanism of action. 
 The dorsal striatal subregions are a downstream target of mPFC 
glutamatergic afferents involved in the planning and coordination of motivated 
behaviors. The activity of glutamatergic neurons within the mPFC has been 
shown to be modulated by both norepinephrine and dopamine (Goldwater et al., 
2009; Sekio & Seki, 2014). Therefore, any observed functional and neuronal 
alterations in the dorsal striatum may be preceded by altered catecholamine 
activity within the mPFC. Additionally, it is necessary to understand in which 
aspects of alcohol seeking and consummatory behaviors that catecholaminergic 
activity is specifically activated.  
 
Specific aims 
Specific aim 1: Quantify and compare the acute pharmacological effects of 
ethanol on dopamine activity in the dorsomedial and dorsolateral striata 
 While previous studies have measured dorsal striatal dopamine following 
an acute administration of ethanol, none have specifically explored subregional 
differences. Given the functional and anatomical distinctions of the dorsomedial 
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and dorsolateral striatum, we predict that ethanol would have differential effects 
on extracellular dopamine in these subregions. 
 
Specific aim 2: Validate the emergence of a hypodopaminergia in the mPFC with 
limited, voluntary ethanol self-administration experience. 
 Following about one week of sweetened ethanol self-administration, rats 
showed reduced basal dopamine concentrations in the mPFC compared to 
control rats that received sucrose or no reinforcer. Although this observation is 
consistent with previous work associating a hypodopaminergic state with high 
alcohol consumption and animal models alcohol of dependence (S. R. George et 
al., 1995; Karkhanis, Rose, Huggins, Konstantopoulos, & Jones, 2015; Siciliano 
et al., 2016), such a state has not been observed following only one week of 
ethanol experience in non-dependent animal models. Therefore, replicating our 
findings is necessary. 
 
Specific aim 3: Quantify extracellular norepinephrine activity in the mPFC 
following acute, intravenous ethanol and during an operant self-administration 
session 
 While ethanol’s interactions with the mesocortical dopamine system have 
been thoroughly explored, the cortical noradrenergic system has received 
considerable less attention. Given norepinephrine’s role in regulating arousal, 
and that initial exposure to ethanol can be acutely arousing, we expect to 
 30 
observe an increase in extracellular norepinephrine concentrations following 
acute, intravenous ethanol administration. Additionally, within the mPFC, 
extracellular concentrations of dopamine and norepinephrine are similarly 
regulated, and they appear to work in concert to modulate executive functions 
and motivated behaviors. Therefore, we will quantify the temporal activity of 
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ABSTRACT 
In vivo monitoring of dopamine via microdialysis has demonstrated that acute, 
systemic ethanol increases extracellular dopamine in regions innervated by 
dopaminergic neurons originating in the ventral tegmental area and substantia 
nigra. Simultaneous measurement of dialysate dopamine and ethanol allows 
comparison of the time courses of their extracellular concentrations. Early studies 
demonstrated dissociations between the time courses of brain ethanol 
concentrations and dopaminergic responses in the nucleus accumbens (NAc) 
elicited by acute ethanol administration. While both brain ethanol and 
extracellular dopamine levels peak during the first 5 minutes following systemic 
ethanol administration, the dopamine response returns to baseline while brain 
ethanol concentrations remain elevated. Post hoc analyses examined ratios of 
the dopamine response (represented as a percent above baseline) to tissue 
 32 
concentrations of ethanol at different time points within the first 25-30 minutes in 
the prefrontal cortex, NAc core and shell, and dorsomedial striatum following a 
single intravenous infusion of ethanol (1 g/kg). The temporal patterns of these 
“response ratios” differed across brain regions, possibly due to regional 
differences in the mechanisms underlying the decline of the dopamine signal 
associated with acute intravenous ethanol administration and/or to the differential 
effects of acute ethanol on the properties of subpopulations of midbrain 
dopamine neurons. This review draws on neurochemical, physiological, and 
molecular studies to summarize the effects of acute ethanol administration on 
dopamine activity in the prefrontal cortex and striatal regions, to explore the 
potential reasons for the regional differences observed in the decline of ethanol-
induced dopamine signals, and to suggest directions for future research. 
 
INTRODUCTION 
Alcoholism represents the end stage in the transition from voluntary to 
uncontrolled alcohol consumption. These behavioral transitions are the result of 
ethanol-induced alterations in the fundamental molecular and cellular processes 
that regulate cognition, motivation, and reward seeking behaviors. Therefore, 
characterizing the acute neurochemical effects of ethanol is critical to 
understanding the development and progression of alcohol use disorders.  
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Ethanol is believed to exert its reinforcing effects on behavior, at least in part, via 
activation of the mesolimbic dopamine circuit. This circuit consists of dopamine 
neurons originating in the ventral tegmental area (VTA) and terminating in the 
nucleus accumbens (NAc), and is implicated in motivated and goal-directed 
behaviors (Gonzales, Job, & Doyon, 2004). Ethanol has been shown to acutely 
enhance the firing rate of VTA dopamine neurons in vitro and increase 
extracellular dopamine in the NAc in awake, freely moving animals (Brodie, 
Pesold, & Appel, 1999; Brodie, Shefner, & Dunwiddie, 1990) (for reviews see 
(Gonzales et al., 2004; Morikawa & Morrisett, 2010)). Additional pharmacological, 
lesion, and genetic studies have further implicated the mesolimbic dopamine 
circuit as a target for ethanol (Gonzales et al., 2004; Koob & Volkow, 2010; 
Morikawa & Morrisett, 2010; Westerink, Enrico, Feimann, & De Vries, 1998). 
 Additionally, ethanol has been shown to effect mesocortical and 
nigrostriatal dopamine activity. Mesocortical dopamine neurons originate in the 
VTA and terminate in the prefrontal cortex (PFC), and contribute to the regulation 
of cognition and executive control of goal-directed behaviors (Westerink et al., 
1998). Nigrostriatal dopamine neurons originate in the substantia nigra and 
innervate the dorsal striatum. These neurons coordinate motor responses 
relevant to goal-directed and habitual behaviors (Koob & Volkow, 2010; Santiago 
& Westerink, 1992; Yin & Knowlton, 2006). Neurochemical studies demonstrate 
that acute ethanol administration results in increased extracellular dopamine 
levels in the prefrontal cortex (Z.-M. Ding et al., 2011; Schier, Dilly, & Gonzales, 
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2013). In contrast, the nigrostriatal dopamine circuit may be less sensitive to 
acute ethanol administration (Di Chiara & Imperato, 1988; Melendez, Rodd-
Henricks, McBride, & Murphy, 2003), but may be gradually recruited with chronic 
ethanol self-administration (Budygin et al., 2003, 2007; Corbit, Nie, & Janak, 
2014; Koob & Volkow, 2010).  
This review summarizes recent in vivo microdialysis studies exploring the 
effects of acute, passive ethanol administration on dopamine activity in the 
medial PFC and striatal subregions. Additionally, we conducted post hoc 
analyses on these published and unpublished data to explore the decline of the 
ethanol-induced dopamine signal during the descending limb of the ethanol 
concentration time course in the medial PFC, NAc core and shell, and 
dorsomedial striatum (DMS). The results of our analyses revealed unexpected 
differences across these regions. In this review, we discuss the rationale and 
methodology for the post hoc analyses, propose explanations for the observed 
regional differences, and suggest directions for further research. 
 
DISSOCIATION OF THE TEMPORAL PROFILES OF DIALYSATE ETHANOL AND DOPAMINE 
In vivo microdialysis is frequently employed to monitor and quantify 
extracellular neurochemical changes in select brain regions induced by 
pharmacological, behavioral, or environmental manipulations in freely moving 
animals (Gonzales, Tang, & Robinson, 2002) Over the past few decades, 
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changes in extracellular dopamine activity in response to acute ethanol have 
been extensively investigated using in vivo molecular monitoring techniques, 
including microdialysis. While the temporal resolution of microdialysis is limited, 
this technique can detect relatively fast changes in extracellular concentrations of 
various analytes with sampling times as low as 1 minute (Newton & Justlce, 
1994).  
Our lab and others have extended its application to monitor the quantity 
and time course of brain concentrations of ethanol following systemic 
administration (Ferraro, Weyers, Carrozza, & Vogel, 1990; Howard, Schier, 
Wetzel, Duvauchelle, & Gonzales, 2008; Schier et al., 2013; Valenta et al., 2013; 
Yoshimoto & Komura, 1993). Concurrent analyses of both analytes from the 
same microdialysis sample enables characterization of dopaminergic activity 
relative to ascending and descending tissue concentrations of ethanol. Using this 
approach, it was discovered that the time course of the dopamine response in 
the NAc to acute ethanol did not overlap with the temporal profile of brain ethanol 
concentrations (Fig. 1) (Yim et al., 2000). Yim et al. reported that following an 
intraperitoneal (i.p.) injection of 1 or 2 g/kg ethanol in naïve rats, extracellular 
dopamine reaches peak concentrations to 140% of baseline levels within the first 
15-minute sample while ethanol also attains peak brain concentrations 15-30 
minutes following the injection, depending on the dose administered. The 
accumbal dopamine response returns to baseline 60-90 minutes post injection, 
while ethanol remains elevated in the dialysate. Dialysate ethanol concentrations 
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did not return to baseline during the 2-hour sampling period post-injection (Yim et 
al., 2000). 
 
Figure 1: Dialysate concentrations of dopamine in the nucleus accumbens and 
tissue concentrations of ethanol following acute ethanol 
administration (1 g/kg, i.p.). 
 
There is a dissociation in the time courses of dopamine and ethanol 
concentrations in which dopamine returns to baseline levels while ethanol 
remains elevated in the tissue. The ethanol injection occurred at 0-minute time 
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Interpreting the dissociation of the temporal profiles of dialysate ethanol 
and dopamine: relevance to acute tolerance 
Yim et al. hypothesized that the observed dissociation in the time courses 
of the dopamine response and dialysate ethanol concentrations following acute 
ethanol administration may be due to the development of acute tolerance (Yim et 
al., 2000). The dissociation between ethanol and dopamine occurs during the 
descending phase of the brain ethanol concentration curve, and this temporal 
pattern aligns with that observed in behavioral studies of acute tolerance in 
humans and rodents (Le & Mayer, 1995; LeBlanc, Kalant, & Gibbins, 1975). 
Following a single dose of ethanol in humans, behavioral stimulation is reported 
during the ascending limb of the blood ethanol curve, while sedation and reduced 
impairments in the activation of motor responses are reported during the 
descending limb of the blood ethanol curve (Fillmore, Marczinski, & Bowman, 
2005; Martin, Earleywine, Musty, Perrine, & Swift, 1993).  Acute tolerance to the 
stimulating and motor impairing effects of ethanol represents a physiological 
adaption occurring during a single ethanol exposure (Le & Mayer, 1995; LeBlanc 
et al., 1975), and may be relevant in predicting individual vulnerability to alcohol 
use disorders (Fillmore et al., 2005; Martin et al., 1993; Tampier, Quintanilla, & 
Mardones, 2000). For example, selectively bred alcohol-preferring rats develop 
acute tolerance to a single dose of ethanol more rapidly than non-preferring rats 
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(Tampier & Mardones, 1999; Waller, McBride, Lumeng, & Li, 1983). Consistent 
with this observation, rats displaying high acute tolerance tend to consume larger 
quantities of ethanol (Tampier et al., 2000). Together these findings suggest a 
relationship between the propensity to consume large quantities of ethanol 
(possibly due to a genetic vulnerability) and the tendency to exhibit rapid acute 
behavioral tolerance.  
In alcohol non-preferring rats, acute tolerance to the motor impairing 
effects of ethanol develops within 60-90 minutes following an i.p. injection of 2 or 
2.3 g/kg ethanol (Tampier & Mardones, 1999; Waller et al., 1983). This time 
course overlaps with that of the dissociation between ethanol and dopamine 
following an i.p. injection of a 1 g/kg dose of ethanol (Yim et al., 2000). While 
dopamine in the NAc likely is not responsible for the specific motor behaviors 
assessed in the studies by Tampier et al. (1999; 2000)  and Waller et al. (1983), 
dopaminergic mechanisms are hypothesized to contribute to the acute 
stimulating effects of low to moderate doses of ethanol during the ascending limb 
of the blood ethanol concentration curve (Imperato & Di Chiara, 1986; Wise & 
Bozarth, 1987). Early work showed that following i.p. administration of 0.25 and 
0.5 g/kg ethanol, peak behavioral stimulation (defined as rearing, ambulation, 
and grooming) correlated with peak extracellular dopamine activity in the NAc at 
20 minutes post-injection, and behavioral activity declined as dopamine levels 
returned to baseline (Imperato & Di Chiara, 1986). Additionally, dopamine 
antagonists have been shown to dose-dependently reduce the locomotor-
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stimulating effects of ethanol in FAST mice, a strain of mice that is highly 
sensitive to the stimulating effects of acute ethanol (Shen, Crabbe, & Phillips, 
1995). However, while dopaminergic mechanisms may contribute to the 
expression of acute tolerance, the exact cellular and molecular mechanisms 
underlying this phenomenon are unknown, and therefore one cannot rule out the 
possibility of additional contributory mechanisms outside of the mesolimbic 
dopamine system (Ludvig, George, Tang, Gonzales, & Bungay, 2001). 
 
Interpreting the dissociation of the temporal profiles of dialysate ethanol 
and dopamine: relevance to ethanol’s mechanism of action 
A temporal dissociation between extracellular dopamine and drug 
concentrations is not observed with psychostimulants but has been observed 
with morphine. These effects may be related to differences in the mechanisms of 
actions of ethanol, psychostimulants, and morphine. Following acute drug 
administration, psychostimulants demonstrate a direct relationship between brain 
concentrations of drug and the dopamine response in the striatum. Using in vivo 
microdialysis, Kuczenski et al. (1997) demonstrated that extracellular 
concentrations of striatal dopamine and amphetamine showed nearly identical 
temporal profiles following a single subcutaneous dose of amphetamine (Fig. 2a) 
(Kuczenski et al., 1997). A similar concentration-response relationship has been 
observed with cocaine. Following an i.p. injection of 30 mg/kg, cocaine attains a 
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maximum concentration of 10 micromolar within 20-30 minutes post injection 
(Fig. 2b) (Nicolaysen, Pan, & Justice, 1988). Extracellular dopamine 
concentrations in the striatum also peaked at 30 minutes post cocaine 
administration. As extracellular concentrations of cocaine and dopamine 
declined, there was a linear relationship between dialysate dopamine and drug 
concentrations (Nicolaysen et al., 1988). The effect of cocaine on extracellular 
dopamine has also been shown to occur within seconds of an intravenous 
infusion using fast scan cyclic voltammetry (Cheer et al., 2007; Mateo, Budygin, 
Morgan, Roberts, & Jones, 2004), but this method does not allow concurrent 
analysis of extracellular cocaine concentrations; therefore, the relationship 
between the drug response and the drug under these conditions is not 
completely clear. 
Interestingly, in contrast to psychostimulants, a dissociation in dialysate 
concentrations of morphine and extracellular dopamine in the striatum occurs 
following acute administration of morphine. However, the time course of this 
dissociation contrasts with that of ethanol in that the dissociation between 
extracellular concentrations of morphine and dopamine appears to occur 
primarily during ramping up of the dopamine response, rather than during the 
decline of the dopamine response. Gottas et al. recently demonstrated that 
following intravenous (i.v.) morphine administration, drug concentrations in the 
brain reached peak levels within 5-7 minutes (Fig. 2c) (Gottås, Boix, Øiestad, 
Vindenes, & Mørland, 2014). In contrast, extracellular dopamine in the striatum 
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gradually increased, reaching peak levels approximately 46 minutes following the 
i.v. morphine infusion. Thereafter, extracellular morphine and dopamine levels 
slowly declined towards baseline, but neither reached baseline during the 2 
hours following the infusion. During the decline of the dopamine signal, the 
dissociation with extracellular concentrations of morphine was less apparent 
(Gottås et al., 2014).  
The mechanisms by which psychostimulants and morphine enhance 
extracellular dopamine are well understood. Cocaine and amphetamine exert 
their primary effects on dopamine activity at the terminals of dopamine neurons. 
Cocaine inhibits the dopamine transporter, blocking a major mechanism of 
dopamine clearance from the synapse and thus, resulting in increased levels of 
extracellular dopamine (Church, Justice, & Byrd, 1987; Nicolaysen et al., 1988). 
Amphetamine also alters the function of the dopamine transporter in addition to 
interfering with the storage of dopamine into synaptic vesicles (Calipari & Ferris, 
2013). In contrast, the molecular and cellular mechanisms by which ethanol 
enhances dopaminergic activity are not clearly understood. The lack of a direct 
relationship between extracellular ethanol and dopamine is consistent with 
experimental evidence that ethanol does not directly impair dopamine reuptake 
(Budygin, Phillips, Wightman, & Jones, 2001; Yim & Gonzales, 2000). Using no 
net flux in vivo microdialysis, it was demonstrated that a 1-g/kg (i.p.) dose of 
ethanol increases the equilibrium point where no net flux is observed for 
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dopamine in the NAc, but it does not alter the slope of the no net flux plot (Yim & 
Gonzales, 2000). 
Alternative possibilities include an indirect effect of ethanol on the 
stimulation of dopamine release or a rapid desensitization of the mechanism(s) 
by which ethanol acts to facilitate increased dopaminergic activity. A mechanism 
by which morphine increases mesocorticolimbic dopamine activity is through 
binding to mu opioid receptors (MORs) on specific GABAergic terminals that 
synapse onto VTA dopamine neurons. Activation of these MORs hyperpolarizes 
the GABA neuron, removing the tonic inhibition of VTA dopamine neurons (Di 
Chiara & North, 1992; Johnson & North, 1992; Volman et al., 2013). The 
possibility of a disinhibitory mechanism of ethanol action on VTA dopamine 
neurons has been suggested based on evidence demonstrating a reduction in 
the activity of VTA GABAergic neurons following ethanol administration 
(Gallegos, Lee, Criado, Henriksen, & Steffensen, 1999; Stobbs et al., 2004; Xiao, 
Zhang, Krnjević, & Ye, 2007). However, it is not entirely clear if this effect 
underlies the stimulation of mesocorticolimbic dopamine activity observed in vivo 
following acute ethanol administration (for review see (Morikawa & Morrisett, 
2010)). Furthermore, other groups have reported conflicting results regarding the 
effect of ethanol on GABAergic transmission in the VTA. For example, ethanol 
has been shown to potentiate GABA release onto VTA dopamine neurons in vitro 
(Theile, Morikawa, Gonzales, & Morrisett, 2008, 2009). Additionally, a recent 
microdialysis study showed no significant effect of systemic ethanol 
 43 
administration on GABA concentrations in the VTA of alcohol-preferring and 
alcohol non-preferring rat lines (Kemppainen, Raivio, Nurmi, & Kiianmaa, 2010). 
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Figure 2: Temporal profiles of extracellular concentrations of amphetamine, 
cocaine, or morphine and dopamine following acute systemic 
administration.   
 
A) Extracellular concentrations of dopamine (top left panel) and amphetamine 
(bottom left panel) in the dorsal striatum demonstrate nearly identical temporal 
profiles following acute administration of amphetamine (8 mg/kg, s.c.). Symbols 
represent mean. Reproduced with permission from Kuczenski et al. (1997). B) 
Extracellular concentrations of cocaine (filled diamonds) and dopamine (open 
diamonds) in the striatum demonstrate similar temporal profiles following cocaine 
administration (30 mg/kg, i.p.). Symbols represent mean. Reproduced with 
permission from Nicolaysen et al. (1988). C) A temporal dissociation in dialysate 
concentrations of morphine (filled triangles) and extracellular dopamine (open 
triangles) in the striatum occurs within the first 40 minutes following acute 
administration of morphine (1 mg, i.v.). After 40 minutes, a temporal dissociation 
is no longer apparent between extracellular levels of morphine and dopamine. 




























































































 The original study by Yim et al. directly compared the time courses of the 
dopamine response and dialysate ethanol concentrations, focusing on an 
extended time period encompassing the 15-120 minutes following the 
intraperitoneal (i.p.) injection (Yim et al., 2000). This allowed comparison with 
ethanol-induced behaviors that had similar time courses, as discussed above.  
More recent work has now allowed higher resolution sampling during the 
microdialysis experiment so that times within the first 30 minutes of ethanol 
administration can be analyzed.   
A potential confound in the study by Yim et al. is that ethanol 
administration via i.p. injections may be aversive to naïve rats and as a result, 
such studies may include effects of stress on dopamine activity (Abercrombie, 
Keefe, DiFrischia, & Zigmond, 1989; Ciccocioppo et al., 1999; Cloutier & 
Newberry, 2008; Kalivas & Duffy, 1995; Sorg & Kalivas, 1993b). Intravenous 
ethanol administration minimizes stress in naïve animals because no animal 
handling is required. Using this route of administration, Howard et al. found a 
similar dissociation in the decline of the dopamine response relative to 
descending concentrations of ethanol (Howard et al., 2008). 
To explore the dissociation in the temporal profiles of extracellular 
dopamine and brain ethanol concentrations across brain regions, we performed 
post hoc analyses on our existing body of data.  Similar to Yim et al. we 
computed ratios (referred to as “response ratios”) of the dopamine response 
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(represented as a percent over baseline) to tissue concentrations of ethanol (Yim 
et al., 2000). We hypothesized that within the first 25-30 minutes following acute 
ethanol administration, the “response ratios” within each brain region would 
decline in a similar manner. Contrary to our expectations, we observed regional 
differences in the temporal profiles of the “response ratios”, suggesting distinct 
mechanisms may underlie the decline of the dopamine signal during the 
descending limb of the ethanol concentration curve. Here we describe the 
methods by which we determined the “response ratios” for each brain region, our 
results, and a limited interpretation of our results. 
 We analyzed data collected from in vivo microdialysis experiments in the 
nucleus accumbens core (NAc core) and shell (NAc shell) regions, medial 
prefrontal cortex (mPFC), and dorsomedial striatum (DMS) following acute i.v. 
ethanol administration (1 g/kg). In the subsequent sections, we first review the 
methodological details of our microdialysis experiments and discuss the 
adjustments made to our calculations to correct for procedural differences across 
experiments. Due to the lower concentration of endogenous dopamine in the 
mPFC, methodological modifications, such as an increase to probe lengths and a 
decrease in the perfusate flow rate, were made to enhance dopamine recovery in 
this region. 
 The probes used in our studies are constructed in our laboratory 
according the procedures described by Pettit and Justice (Doyon et al., 2003a; 
Howard et al., 2008; Pettit & Justice, 1991a; Schier et al., 2013; Valenta et al., 
 47 
2013). The probe active area is 1.5 millimeters for striatal regions and 2.75-3.25 
millimeters for the mPFC (Howard et al., 2008; Schier et al., 2013; Valenta et al., 
2013). Probes are continuously perfused with artificial cerebrospinal fluid (ACSF) 
at a flow rate of 2 microliters/minute for striatal samples and 1 microliter/minute 
for prefrontal cortical samples (Howard et al., 2008; Schier et al., 2013; Valenta 
et al., 2013). In every experiment, 2-4 samples are collected prior to any 
infusions to determine basal dopamine levels for each animal. Relative standard 
deviations are calculated to assess the stability of basal dopamine activity for 
each animal. Only those animals demonstrating relative standard deviation 
values <0.25 were included in the microdialysis experiments. In striatal 
experiments, samples are collected in 5-minute intervals, but the collection time 
is increased to 10 minutes for mPFC samples to account for the decreased flow 
rate. To control for any effects of an i.v. infusion on extracellular dopamine 
activity, a saline infusion is given either to the same animal prior to the ethanol 
infusion (for within-subjects study designs) or to a separate group of animals (for 
between-subjects study designs) and dialysate samples are subsequently 
collected. The control saline infusions had no significant effects on extracellular 
dopamine in all of the experiments included in our analyses (Howard et al., 2008; 
Schier et al., 2013; Valenta et al., 2013). At the conclusion of experiments, the 
ACSF is replaced with calcium-free ACSF and perfused through the probe for 1-2 
hours and a final 2 samples are collected. These samples are necessary to 
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confirm calcium-dependent exocytotic dopamine release from neurons 
surrounding the probe membrane.  
 
In vivo extraction fraction for ethanol  
Dialysate ethanol concentrations are quantified via gas chromatography, 
but these concentrations are only a fraction of the tissue concentration of 
ethanol. To determine the in vivo recovery of ethanol for our probes in Long 
Evans rats, Howard et al. inhibited ethanol metabolism via intravenous 
administration of the alcohol dehydrogenase inhibitor 4-methylpyrazole (2 mg/kg) 
to produce a “pseudo-steady state”, and then systemically administered ethanol. 
A ratio of dialysate ethanol concentrations to blood ethanol concentrations was 
calculated and the in vivo extraction fraction for ethanol was determined to be 
0.14 (Howard et al., 2008). This value was used to determine the tissue 
concentrations of ethanol for each animal included in our analyses. 
 
Effect of methodological differences on in vivo ethanol recovery 
To account for the differences in microdialysis parameters across 
experiments, we made adjustments to our calculations of ethanol tissue 
concentrations. A linear relationship approximates the increase in ethanol 
recovery across a probe as a function of probe length in the range of 1-3 mm 
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(George, 2000). Therefore, the in vivo recovery constant for ethanol was 
adjusted accordingly for the mPFC data. For example, the extraction fraction for 
ethanol for a probe with a length of 3 millimeters would be doubled to 0.28. 
Additionally, the microdialysis experiments sampling from the mPFC used a 
lower perfusate flow rate than the striatal experiments. An inverse relationship 
exists between perfusate flow rate and analyte extraction fraction, where the 
percent of relative in vivo recovery declines exponentially as the flow rate is 
increased (Benveniste, 1989; Chefer, Thompson, Zapata, & Shippenberg, 2009; 
Jamal et al., 2003; Kendrick, 1989). As a result, the in vivo extraction fraction for 
ethanol was also increased by a factor of 1.56 for animals in the mPFC 
experiments. Therefore, with both adjustments accounting for the increased 
probe length and decreased flow rate, the final extraction fraction for ethanol for 
the mPFC dialysate samples was 0.364-0.437. 
 
Methods  
Using a similar method to that described by Yim et al. (2000), we 
calculated tissue concentrations of ethanol and “response ratios” for each animal 
within the first 25-30 minutes following the ethanol infusion (1 g/kg). It should be 
noted that because the studies were not conducted simultaneously, we are 
unable to directly compare the “response ratios” across the four brain regions. 
Given the variability in basal dopamine levels across the NAc core and shell, 
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mPFC, and DMS, we focused on the percent change in dopamine levels relative 
to baseline. However, we also conducted the same analyses on the raw 
dopamine values and obtained similar temporal patterns in the “response ratios” 
for each brain region (data not shown). The equations used to determine tissue 
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“Response ratios” for NAc core and shell 
 Following i.v. ethanol administration, the dopamine response in the NAc 
shell peaked to 40% over baseline within the first 5-minute sample and then 
declined faster than dialysate ethanol concentrations. For the “response ratio” 
analyses, 23 animals from 3 studies (Howard et al., 2008; Valenta et al., 2013)  
(the third study is unpublished) were included. It should be noted that a subset of 
these animals (n=5) received a hypotonic ethanol solution, though it is unlikely 
that this had any significant effects on extracellular dopamine in the NAc, as 
hypotonic and isotonic ethanol solutions produced no differential effects on 
extracellular dopamine in the mPFC (Schier et al., 2013). There were no 
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statistically significant changes in the “response ratios” the initial 25 minutes 
following the ethanol infusion for the NAc shell (Fig. 3; F(4, 88)=1.82, n.s.). Of the 
animals included in the analyses, there were 4 animals whose dopamine 
response returned to or dropped below baseline within the 25 minutes following 
the ethanol infusion. 
 For the NAc core, 6 animals from one study (Howard et al., 2008) were 
included in the “response ratio” analyses, and these animals also received a 
hypotonic ethanol solution. Within the first 25 minutes following the ethanol 
infusion, there were no significant changes in the “response ratios” in the core 
(Fig. 4; F(4, 20)=1.05, n.s.).  The ethanol-induced dopamine response returned 
to or dropped below baseline in 2 of the 6 animals within 25 minutes following the 
ethanol infusion. Three additional animals had extracellular dopamine levels 




Figure 3: “Response ratios” in the NAc shell region for the first 25 minutes 
following intravenous ethanol administration (1-g/kg). 
 
The ratios are the dopamine response (represented as a percent over baseline) 
relative to tissue concentrations of ethanol. Symbols represent mean ± S.E.M 
(n=23). 
 
Figure 4: “Response ratios” in the NAc core region for the first 25 minutes 
following intravenous ethanol administration (1-g/kg). 
 
The ratios are the dopamine response (represented as a percent over baseline) 
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“Response ratios” for mPFC 
 Nineteen animals from one study (Schier et al., 2013) were included in the 
“response ratio” analyses for the mPFC. The “response ratios” significantly 
declined at a relatively linear rate over the first 30 minutes following the ethanol 
infusion (Fig. 5; F(2, 36)=5.66, p=0.007).  In 3 of the 19 animals included in the 
analyses, the dopamine response returned or dropped below baseline within the 
30 minutes following the ethanol infusion. 
 
“Response ratios” for DMS 
 The DMS “response ratio” analyses included 9 animals from one study 
(unpublished data). There was no main effect of time in the overall ANOVA for 
the  “response ratios” in this region (Fig. 6; F(4, 32)=0.553, n.s.). There were 5 
animals whose dopamine responses returned to or dropped below baseline 
within the first 25 minutes following the ethanol infusion.  
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Figure 5: “Response ratios” in the PFC region for the first 30 minutes following 
intravenous ethanol administration (1-g/kg). 
 
The ratios are the dopamine response (represented as a percent over baseline) 
relative to tissue concentrations of ethanol. Symbols represent mean ± S.E.M 
(n=19). *Post hoc T-tests indicate significance when compared to the 10-minute 
time point following overall significance in the ANOVA; p<0.05. 
 
Figure 6: “Response ratios” in the DMS region for the first 30 minutes following 
intravenous ethanol administration. 
 
The ratios are the dopamine response (represented as a percent over baseline) 
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INTERPRETATION 
“Response ratios” were calculated for the first 25-30 minutes following 
acute i.v. ethanol and thus are likely not relevant to acute behavioral tolerance, 
as behavioral tolerance occurs on the time course of hours, as discussed above. 
However, within this short time frame, acute tolerance may be developing to the 
pharmacological mechanisms by which ethanol stimulates mesocorticolimbic 
dopamine activity. Our analyses of “response ratios” do not directly assess the 
mechanism by which ethanol stimulates extracellular dopamine concentrations. 
However, these analyses did reveal interesting regional differences in the decline 
of the dopamine signal during the descending limb of the blood ethanol 
concentration curve. Below, we speculate about possible reasons for the faster 
decline in the “response ratios” in the PFC versus striatal regions. 
 
Projection-specific subpopulations of midbrain dopamine neurons may be 
differentially affected by ethanol 
 Recent work has suggested that midbrain dopamine neurons are 
physiologically, molecularly and functionally distinct, and therefore may be 
differentially affected by commonly abused drugs. While there is not yet a 
consensus in the field regarding the specific differences among midbrain 
dopamine neurons, and species-specific differences are apparent, recent work 
has demonstrated that specific characteristics of midbrain dopamine neurons 
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vary depending on neuronal projection targets. Some of this recent work, as well 
as the general physiological and molecular characteristics of midbrain dopamine 
neurons have been reviewed previously (Lammel, Lim, & Malenka, 2014; 
Marinelli & McCutcheon, 2014; Morikawa & Morrisett, 2010; Ungless & Grace, 
2012; Volman et al., 2013; Yetnikoff, Lavezzi, Reichard, & Zahm, 2014) and thus 
will be only briefly summarized here. 
Specifically, VTA dopamine neurons projecting to the PFC, NAc core, NAc 
medial shell, and basolateral amygdala (BLA) do not universally display the 
characteristics historically used to identify dopamine neurons. For example, 
recordings from adult mouse brain slices demonstrate that in response to low 
current levels, these dopamine neurons fire action potentials at frequencies in the 
range of 10-15 Hz, which are significantly higher than the firing frequencies of 
those projecting to the NAc lateral shell and nigrostriatal dopamine neurons (3-6 
Hz) in vitro (Lammel et al., 2008, 2014; Roeper, 2013; Ungless & Grace, 2012). 
Furthermore, these fast-firing dopamine neurons are able to sustain these higher 
firing frequencies for several seconds (Lammel et al., 2008). Another key 
physiological difference is the lack of an Ih current in the fast-firing dopamine 
neurons in vitro, which contrasts the large Ih current observed in dopamine 
neurons projecting to the NAc lateral shell (Lammel et al., 2014; Ungless & 
Grace, 2012).  
Additionally, molecular differences exist among these distinct 
subpopulations of midbrain dopamine neurons, including the expression of 
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somatodendritic D2-like autoreceptors, which has historically been used as a 
criterion for identifying dopamine neurons. Using transgenic mice that lacked 
specifically D2-subtype autoreceptors on dopamine neurons, but expressed 
postsynaptic D2 receptors on non-dopaminergic neurons, Bello et al. recorded 
the activity of presumed midbrain dopamine neurons in horizontal brain slices 
(Bello et al., 2011). These neurons did not respond to bath application of 
quinpirole, while those from control mice demonstrated hyperpolarization. This 
work provides strong evidence that within the D2-like receptor family, D2-subtype 
receptors are the primary mediators of auto-inhibition at the level of the cell body 
in midbrain dopamine neurons (Bello et al., 2011). However, the projection 
targets of the recorded neurons were not identified, which is critical given the 
profound heterogeneity observed among midbrain dopamine neurons. 
Furthermore, the identification criteria for dopamine neurons used by Bello and 
colleagues may have prevented sampling from mesocortical neurons, which 
appear to lack somatodendritic autoreceptors altogether (Bannon, Michaud, & 
Roth, 1981; Bannon & Roth, 1983; Lammel et al., 2008; Ungless & Grace, 2012). 
Lammel and colleagues reported that in coronal midbrain slices of adult mice, 
bath application of 100 mM dopamine did not alter the firing frequencies of 
mesocortical dopamine neurons, while hyperpolarizing all other VTA dopamine 
neurons (Lammel et al., 2008). It should be stated, however, that species-specific 
variation may exist with regards to the expression of somatodendritic 
autoreceptors on mesocortical dopamine neurons. Margolis and colleagues 
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identified PFC-projecting tyrosine hydroxylase-positive neurons that were 
hyperpolarized by bath-application of quinpirole in horizontal brain slices from 
adolescent rats (Margolis, Mitchell, Ishikawa, Hjelmstad, & Fields, 2008). 
 When considering these molecular and physiological distinctions, it is not 
surprising that midbrain dopamine neurons also demonstrate significant 
pharmacological and functional heterogeneity that is also associated with their 
projection targets. In a series of studies, Westerink and colleagues (Santiago & 
Westerink, 1992; Westerink et al., 1998; Westerink, Kwint, & deVries, 1996) 
demonstrated significant differential responsiveness of mesocortical, mesolimbic, 
and nigrostriatal dopamine neurons to various pharmacological manipulations. 
For example, infusion of the GABAa receptor agonist muscimol into the VTA 
through a microdialysis probe significantly decreased extracellular dopamine in 
the PFC and NAc, but in contrast, muscimol infused into the SNc significantly 
elevated extracellular dopamine levels in the dorsal striatum (Westerink et al., 
1998; Westerink et al., 1996). Administration of NMDA and the GABAb receptor 
agonist baclofen into the VTA via a microdialysis probe also produced differential 
effects on the percent change in and the temporal pattern of extracellular 
dopamine in the PFC, NAc, and dorsal striatum (Westerink et al., 1998). 
Rewarding and aversive stimuli also have been shown to produce 
differential effects on extracellular dopamine in cortical and striatal regions. Acute 
exposure to rewarding or appetitive stimuli such as drugs of abuse significantly 
increase extracellular dopamine in the NAc and PFC, but the dorsal striatum 
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appears to be acutely less sensitive to such stimuli (Bassareo, Tanda, Petromilli, 
Giua, & Di Chiara, 1996; Cenci, Kalén, Mandel, & Björklund, 1992; Di Chiara & 
Imperato, 1988; Horvitz, 2000; Howard et al., 2008; Mark, Smith, Rada, & 
Hoebel, 1994; Schier et al., 2013; Valenta et al., 2013; Willuhn et al., 2012). 
Aversive and stressful stimuli have been shown to increase extracellular 
dopamine in the PFC to a much greater extent than in the NAc or dorsal striatum 
(Abercrombie et al., 1989; Bassareo et al., 1996; Cenci et al., 1992; Horvitz, 
2000; Kalivas & Duffy, 1995; Sorg & Kalivas, 1993b). Additionally, aversive 
stimuli increase the AMPAR/NMDAR ratio only in dopaminergic cells projecting 
to the PFC and lateral NAc shell, indicating modulation of excitatory synapses on 
these subpopulations of dopamine neurons (Lammel, Ion, Roeper, & Malenka, 
2011). In contrast, AMPAR/NMDAR ratios increased only in those dopamine 
neurons projecting to medial and lateral NAc in response to acute cocaine 
reward (Lammel et al., 2011, 2014). Similarly, rats exposed to a single high dose 
of toluene vapor demonstrated significant increases in AMPA/NMDA ratios in 
VTA dopamine neurons projecting to the NAc core and medial shell, but not in 
mesocortical dopamine neurons (Beckley, Evins, Fedarovich, Gilstrap, & 
Woodward, 2013). Therefore, subpopulations of midbrain dopamine neurons 
appear serve distinct roles in the response to salient events depending on the 
motivational valence of the event (for reviews see (Marinelli & McCutcheon, 
2014; Volman et al., 2013)), and this may have functional relevance to 
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stimulation of dopamine activity observed in specific target regions following 
acute ethanol administration  
While the cellular and molecular mechanisms by which ethanol stimulates 
mesocorticolimbic dopamine activity are not entirely understood, ethanol may 
potentially exert differential effects on midbrain dopamine neuron subpopulations. 
Therefore, the anatomical distribution and physiological, molecular, and 
functional heterogeneity of midbrain dopamine neurons may contribute to the 
regional differences observed in the “response ratio” analyses. Ethanol has been 
shown to directly stimulate VTA dopamine neurons (Brodie et al., 1999, 1990), 
but the projection targets of the recorded neurons were not identified. Differential 
effects of ethanol have been observed in the VTA with respect to the anterior and 
posterior regions. Rats will self-administer various doses of ethanol directly into 
the posterior VTA, but not the anterior VTA (Rodd-Henricks, McKinzie, Crile, 
Murphy, & McBride, 2000). Recently, ethanol has been shown to increase the 
firing rate of dopamine neurons located in the posterior VTA, but suppresses the 
firing rate of dopamine neurons originating in the anterior VTA (Guan et al., 
2012). These differential effects of ethanol on the anatomical divisions of the VTA 
may contribute to the differences seen in the “response ratios” in target regions. 
The dopamine neurons projecting to the PFC, NAc core and medial shell, and 
BLA form distinct populations within the medial posterior VTA (Lammel et al., 
2008, 2014). In contrast, dopamine neurons projecting to the lateral NAc shell 
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are found in the lateral posterior and anterior VTA, with a significant number of 
these neurons also located in the SNc (Lammel et al., 2008).  
Additionally, acute ethanol may selectively modulate excitatory (and/or 
inhibitory) synapses on VTA dopamine neurons, similar to the effect observed 
following acute cocaine or toluene administration (Beckley et al., 2013; Lammel 
et al., 2011). Acute systemic administration of ethanol has been shown to 
strengthen excitatory synapses on VTA dopamine neurons, as indicated by 
increased AMPAR/NMDAR ratios (Saal, Dong, Bonci, & Malenka, 2003), but 
because the projection targets of these neurons were not identified, it is unclear if 
this effect uniform across dopamine neurons. Ethanol may exert differential 
effects on midbrain dopamine neurons, such as selectively enhancing firing rates 
or excitatory/inhibitory synapses, which could alter dopamine activity in target 
regions and thus, potentially contribute to the regional differences in “response 
ratios”.  
 
Regional differences in dopamine clearance  
The observed regional differences in the temporal profiles of the 
“response ratios” may be due, at least in part, to regional differences in the 
mechanisms of dopamine clearance or variations in the sensitivity of the 
clearance mechanisms to ethanol. Early on it was demonstrated that regional 
differences exist in the dynamic regulation of extracellular dopamine. Garris and 
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Wightman determined ratios of dopamine release to uptake to quantify and 
compare the regulation of extracellular dopamine across the PFC and striatal 
regions (Garris & Wightman, 1994). In striatal regions, this ratio is low, indicating 
“uptake-dominant” regulation of extracellular dopamine concentrations. In 
contrast, this ratio is 5-10 times larger in the PFC, indicating “release-dominant” 
dynamics of interstitial dopamine. Furthermore, dopamine terminals in the PFC 
show a reduced density of dopamine transporters relative to striatal regions 
(Cass & Gerhardt, 1995; Javitch, Strittmatter, & Snyder, 1985).  
 Clearance of evoked dopamine in the PFC appears slower than that in the 
striatum and uptake by high affinity dopamine transporters (DAT) is not the 
primary mechanism of clearance (Cass & Gerhardt, 1995; Yavich, Forsberg, 
Karayiorgou, Gogos, & Männistö, 2007). Studies comparing the effect of DAT 
blockade across brain regions consistently demonstrate reduced efficacy of DAT 
inhibition on extracellular dopamine in the PFC relative to striatal regions 
(Budygin et al., 1999; Cass & Gerhardt, 1995; Käenmäki et al., 2010; Mazei, 
Pluto, Kirkbride, & Pehek, 2002; Wayment, Schenk, & Sorg, 2001). For example, 
the dopamine uptake inhibitor GBR-12909 increases the amplitude and time 
course of dopamine signals by 200% in the striatum, which contrasts with the 30-
40% increase in these parameters observed in the PFC (Cass & Gerhardt, 1995; 
Izenwasser, Werling, & Cox, 1990). 
Other work has focused on the predominant role of metabolism relative to 
catecholamine uptake mechanisms on dopamine clearance in the PFC. Using in 
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vitro voltammetry, Wayment et al. demonstrated a linear rate of clearance in the 
PFC, but pharmacological blockade of DAT/NET (norepinephrine transporter) 
and inhibition of monoamine oxidase (MAO) produced a biphasic dopamine 
clearance profile due to an additive effect of the drugs. Based on these findings, 
Wayment and colleagues concluded that dopamine clearance velocity in the PFC 
is 50-70% dependent on uptake mechanisms (DAT/NET) and 30-50% dependent 
on MAO (Wayment et al., 2001). However, this study did not address the role of 
metabolism by catechol-O-methyltransferase (COMT), which is particularly 
important for dopamine clearance in regions where DAT density is low and has 
been demonstrated to play a significant role in dopamine clearance in the PFC 
(Käenmäki et al., 2010; Schott et al., 2010; Tunbridge, Bannerman, Sharp, & 
Harrison, 2004; Yavich et al., 2007). COMT mRNA expression is significantly 
higher in the PFC than the striatum in human and rat brains (Matsumoto et al., 
2003). COMT metabolizes dopamine to 3-methoxytyramine (3-MT), which 
accounts for approximately 60% of the total dopamine turnover in the frontal 
cortex, but only 15% in the striatum (Karoum, Chrapusta, & Egan, 1994). 
Additionally, pharmacological inhibition of COMT by tolcapone in the PFC 
significantly increases evoked extracellular dopamine (Lapish et al., 2009; 
Tunbridge et al., 2004). In contrast, systemic administration of tolcapone does 
not alter extracellular dopamine in the striatum, except under the conditions of 
dopamine uptake inhibition (Budygin et al., 1999). In summary, dopamine 
clearance in the PFC relies heavily on metabolism, while in striatal regions 
 64 
dopamine clearance is driven by reuptake mechanisms. If the rate of decline of 
the dopamine signal is differentially regulated across brain regions, then this 
could be a potential explanation for the observed regional differences in the 
temporal profiles of the “response ratios”.  
 Examination of the interaction between ethanol and dopamine clearance 
mechanisms has predominantly focused on DAT. Acute ethanol administration 
has been shown to enhance (Mayfield, Maiya, Keller, & Zahniser, 2001; Y. 
Wang, Palmer, Cline, & Gerhardt, 1997), decrease (Robinson, Volz, Schenk, & 
Wightman, 2005), or not affect (Budygin et al., 2001; Yim & Gonzales, 2000) DAT 
uptake velocity in the striatum. Of note, however, is that despite the discrepant 
observations of ethanol’s effects on DAT activity, there appears to be agreement 
that ethanol does not alter the transporter’s affinity for dopamine (Mayfield et al., 
2001; Robinson et al., 2005). Genetic manipulations may provide a means of 
resolving the discrepant results. DAT-knockout (DAT-KO) mice show similar 
increases in extracellular dopamine in the dorsal striatum as wild type (WT) mice 
following acute systemic administration of ethanol, which is consistent with 
previous work demonstrating that direct inhibition or reduction in DAT activity by 
ethanol is not a primary mechanism underlying stimulation of striatal dopamine 
activity (Mathews, John, Lapa, Budygin, & Jones, 2006). Furthermore, fast-scan 
cyclic voltammetry in brain slices from DAT-KO and WT mice demonstrated no 
effect of 20 or 200 mM ethanol on the rate of dopamine clearance in the dorsal 
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striatum (Mathews et al., 2006). However, to date there are no published studies 
exploring the effect of acute ethanol on DAT in the PFC. 
 At this time, limited work has explored the interaction between acute 
ethanol and dopaminergic metabolic mechanisms in the PFC. While early studies 
demonstrated increased tissue concentrations of dopamine metabolites in the 
striatum and PFC of animals that received acute systemic ethanol administration, 
it is unclear if these elevations are a direct result of ethanol-induced increases in 
extracellular dopamine or if these effects vary depending on the ethanol dose 
(Fadda, Argiolas, Melis, Serra, & Gessa, 1980; Milio & Hadfield, 1992; Reggiani, 
Barbaccia, Spano, & Trabucchi, 1980). Further research is necessary to 
determine if ethanol directly affects the activity of enzymes involved in dopamine 
metabolism, specifically within the PFC, as these enzymes may be potential 
therapeutic targets in alcohol use disorders. 
 
CONCLUSION 
In conclusion, a dissociation exists in the temporal profiles of extracellular 
concentrations of dopamine and tissue concentrations of ethanol, which may be 
attributable to ethanol’s mechanism of action. Within the first 25-30 minutes 
following acute i.v. ethanol administration the time course of this dissociation 
demonstrates regional variability. Such variability may be due to ethanol’s 
pharmacological interactions with a heterogeneous population of midbrain 
 66 
dopamine neurons, regional differences in dopamine clearance mechanisms, 
and/or acute modulation of dopamine clearance mechanisms by ethanol. Further 
investigation is necessary to determine if ethanol exerts such effects on 
dopamine activity, the precise cellular and molecular mechanisms by which 
ethanol enhances mesocorticolimbic dopamine activity, and if the ethanol-
induced transient rise and decline in extracellular dopamine contributes to the 





Regional analysis of the pharmacological effects of acute 
ethanol on extracellular striatal dopamine activity 
 
The work presented in this chapter will be published in December 2016 in 
Alcoholism: Clinical and Experimental Research by Vena, Mangieri, and 
Gonzales. This publication has been reprinted with permissions from John Wiley 
& Sons (License #: 3994840327842). Ashley Vena contributed to data collection 
and analyses, and prepared and submitted the final manuscript. 
 
ABSTRACT 
The objective of the present study was to characterize the acute 
pharmacological effects of ethanol on extracellular dopamine in the dorsomedial 
and dorsolateral striata. This is the first study to quantify and directly compare the 
effects of acute ethanol on dopamine in these subregions. Therefore, we also 
tested the nucleus accumbens as a positive control. We hypothesized that while 
ethanol may increase extracellular dopamine in the dorsomedial striatum and 
dorsolateral striatum, the magnitude of this increase and the temporal profiles of 
extracellular dopamine concentrations would differ among the dorsomedial 
striatum, dorsolateral striatum, and nucleus accumbens. We performed in vivo 
microdialysis in adult, male Long Evans rats as they received a single 
(experiment 1) or repeated (experiment 2) doses of ethanol. The results of our 
positive control study validate earlier work by our lab demonstrating that acute 
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intravenous ethanol immediately and robustly increases extracellular dopamine 
in the nucleus accumbens (Howard et al., 2008). In contrast, a single 1 g/kg dose 
of intravenous ethanol did not significantly affect extracellular dopamine in the 
dorsomedial striatum or the dorsolateral striatum. However, following a 
cumulative ethanol dosing protocol we observed a ramping up of tonic dopamine 
activity in both the dorsomedial striatum and dorsolateral striatum over the 
course of the experiment, but this effect was more robust in the dorsomedial 
striatum. These results suggest that distinct mechanisms underlie the stimulating 
effects of acute ethanol on extracellular dopamine in striatal subregions. 
Additionally, our findings suggest a role for the dorsomedial striatum and minimal 
to no role for the dorsolateral striatum in mediating the intoxicating effects of 
acute moderate to high doses of ethanol. 
 
INTRODUCTION 
Several studies have demonstrated that the mesolimbic and nigrostriatal 
dopaminergic systems are sensitive to the pharmacological effects of acute 
ethanol.  In vitro electrophysiological studies by Brodie et al. (1999,1990) 
demonstrated that ethanol dose-dependently increases the firing rate of 
dopamine cell bodies in the ventral tegmental area. Mereu et al. (1984) reported 
that in paralyzed rats, intravenous administration of low to moderate doses of 
ethanol (0.5-2.5 g/kg) increased the firing rate of dopamine cell bodies in the 
substantia nigra, while high doses (4.0 g/kg and higher) suppressed firing rates.  
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In vivo neurochemical studies sampling from striatal regions innervated by 
ventral tegmental area dopamine neurons confirm an effect of acute ethanol on 
mesolimbic dopamine activity, suggesting a dose-dependent, biphasic effect of 
ethanol on extracellular dopamine activity, Microdialysis and voltammetry studies 
indicate that low to moderate doses of systemic ethanol (0.5-2.5 g/kg) increase 
extracellular dopamine in the nucleus accumbens (Robinson et al. 2009; Howard 
et al. 2008; Yim et al. 2000a; Imperato & Di Chiara 1986). Higher doses of 
ethanol (5 g/kg), however, appear to depress extracellular dopamine activity in 
the nucleus accumbens (Imperato & Di Chiara, 1986). 
Relative to the mesolimbic dopamine system, in vivo microdialysis studies 
exploring the effects of acute ethanol on nigrostriatal dopamine activity are less 
consistent. Imperato & Di Chiara (1986) demonstrated that low doses of systemic 
ethanol (0.25-0.5 g/kg; i.p.) had no significant effect on dorsal striatal dopamine 
activity, while moderate to high doses (1.0-5.0 g/kg; i.p.) increased extracellular 
dopamine relative to baseline. In contrast, Blanchard et al. (1993) reported 
enhanced extracellular dopamine following low doses of ethanol (i.p.) and no 
effect or decreases following moderate to high doses of ethanol (i.p.). Despite 
these inconsistent findings, it appears that substantia nigra dopamine neurons 
are generally less sensitive to acute ethanol as any increases from baseline are 
less robust in the dorsal striatum relative to the nucleus accumbens. 
A potential limitation of these earlier studies is that the dorsal striatal 
subregions were not tested separately. The dorsomedial and dorsolateral striata 
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have been shown to be distinct functionally and in the origins of their dopamine 
afferents (Joel & Weiner 2000; Yin et al. 2008; Voorn et al. 2004). The 
dorsomedial striatum is critical for learning the action-outcome associations that 
underlie goal-directed behaviors, while the dorsolateral striatum is critical for 
learning the stimulus-response associations that underlie habit formation (Yin et 
al. 2008). Dopamine afferents to the dorsomedial striatum originate in the 
retrorubral area, substantia nigra pars compacta and the ventral tegmental area 
(Joel & Weiner, 2000; Voorn et al., 2004). In contrast, the dorsolateral striatum 
only receives dopaminergic projections from the substantia nigra and retrorubral 
area (Voorn et al. 2004; Joel & Weiner 2000). Recent work has demonstrated 
heterogeneity in the sensitivity of midbrain dopamine neurons to drugs of abuse, 
including ethanol (Lammel et al., 2011; Mrejeru, Martí-Prats, Avegno, Harrison, & 
Sulzer, 2015). Therefore, it is possible that midbrain dopamine projections to the 
dorsomedial striatum and dorsolateral striatum may differ in their sensitivity to 
ethanol, which may be assessed by measuring extracellular dopamine 
concentrations in these target subregions. 
 In this study we sought to characterize and directly compare the acute 
pharmacological effects of ethanol on extracellular dopamine in both the 
dorsomedial striatum and dorsolateral striatum using microdialysis in awake, 
freely moving animals. Intravenous administration of either a single dose (1 g/kg) 
or a cumulative dosing procedure was used to minimize the effects of stress and 
handling on extracellular dopamine activity, as well as to avoid the potentially 
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confounding effects of behavior, expectation, and motivation on dopamine that 
may be evident in a self-administration design. Our results indicate that 
dopamine in these subregions is differentially affected by ethanol.  
METHODS 
Animals 
A total of fifty-three adult Long Evans rats were used in these 
experiments. Twenty-six rats (from Charles River, Raleigh, NC), weighing 300-
430 grams on dialysis day, were used for the acute ethanol experiments. Twenty-
seven rats (from Harlan, Indianapolis, IN), weighing 310-450 grams on dialysis 
day, were used for the cumulative dose-response experiments. Rats were 
housed in a temperature (25° C) and light (12 hours on/12 hours off) controlled 
room and had access to chow and tap water ad libitum. Upon arrival, the rats 
were dually-housed for the first week, during which they were handled and 
weighed daily. All procedures were carried out in compliance with the National 
Institutes of Health Guide for the Care and Use of Laboratory Animals and were 
approved by the Institutional Animal Care and Use Committee of the University of 
Texas at Austin. 
 
Surgery 
Cannulation and jugular catheterization surgeries were carried out 
according to the procedures described in Duvauchelle (1998) and Howard et al. 
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(2008). Intravenous catheters were constructed from silastic tubing (0.30 mm ID, 
0.64 mm OD, Fisher Scientific, Hampton, NH), a metal cannula (22 gauge, 
Plastics One, Roanoke, VA), and silicone adhesive. Rats were anesthetized with 
isoflurane and an incision was made above the skull. Upon securing the catheter 
in the jugular vein, it was pulled subcutaneously to the top of the skull.  A 
microdialysis guide cannula (21 gauge, Plastics One, Roanoke, VA) was 
implanted into the skull directly above the nucleus accumbens (AP +2.0, ML 
+1.1, DV -3.4), dorsomedial striatum (AP +1.2, ML +1.8, DV -1.0), or the 
dorsolateral striatum (AP 0.0, ML +3.7, DV -1.0) while the animal was in a 
stereotaxic frame. The guide cannula, catheter cannula, and a tether bolt were 
held in place on the skull with dental cement. A Timentin (13.4 mg/kg, Animal 
Health International) and heparinized saline solution was used as a catheter lock 
solution to maintain patency. Catheters were flushed with 0.2 mL of heparinized 
saline at least once a week before dialysis experiments commenced. Following 
surgeries, rats were individually housed and given at least 6 days of recovery 
prior to experiments. 
 
Drugs 
 A 10 % (w/v) solution of ethanol (1 g/kg, 10 ml/kg) in saline was made 




Approximately 12-18 hours prior to the microdialysis experiment, rats were 
lightly anesthetized with isoflurane to implant the microdialysis probe through the 
guide cannula and to secure the animal to the tethering apparatus. The probes 
(1.5 mm active membrane length, 270 µm OD, 13,000 MWCO) were constructed 
in the laboratory according to the procedures described by Pettit & Justice 
(1991). Probes were continuously perfused with artificial cerebrospinal fluid 
(ACSF; 149 mM NaCl, 2.8 mM KCl, 1.2 mM CaCl2, 1.2 mM MgCl2, 0.2 mM 
ascorbic acid, and 5.4 mM D-glucose) overnight at 0.2 µL/min. The flow rates 
were increased to 2.0 µL/min at least 2 hours prior to dialysate sample collection 
and remained at 2.0 µL/min for the duration of the experiment. 
Animals were awake and freely moving during the microdialysis 
experiments. In all experiments, the sample collection interval was 5 minutes and 
four baseline samples were collected per animal prior to any infusions. Baseline 
dopamine concentrations were required to have a relative standard deviation 
<0.16 for data inclusion. To confirm that the dopamine in the dialysate samples 
was due to calcium-dependent exocytotic release, probes were perfused with 
calcium-free ACSF for approximately 2 hours at the conclusion of all experiments 
and additional samples were collected. All dialysate samples were immediately 
frozen on dry ice upon collection. 
 
Experiment 1: Acute intravenous 1 g/kg ethanol 
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Following collection of the baseline samples, animals received a manual 
bolus of saline. Samples were collected for 45 minutes following the infusion. 
Animals then received a manual bolus of a 1 g/kg dose of ethanol (10% w/v, in 
saline), and post-infusion samples were collected for 25 minutes (Table 1).  
 
Experiment 2: Cumulative intravenous ethanol 
For the cumulative dosing study, animals received 4 infusions of ethanol 
(10% w/v, in saline) or saline. Infusions were administered 20 minutes apart via a 
syringe pump (CMA 400, Japan) at a flow rate of 1 mL/min. All animals received 
a saline infusion at least 1 hour prior to sample collection to habituate them to the 
sound of the pump. Ethanol infusions were administered in the following order: 
0.5, 0.5, 0.75, and 0.75 g/kg (Table 1). This produced cumulative doses of 0.5, 




Table 1: Timeline of microdialysis experiments 
  
Experiment 2 
Sample Experimental phase 
1-4 Baseline samples 
5 Ethanol (0.5 g/kg) or saline infusion 
6-8 Post infusion 1 
9 Ethanol (0.5 g/kg) or saline infusion 
10-12 Post infusion 2 
13 Ethanol (0.75 g/kg) or saline infusion 
14-16 Post infusion 3 
17 Ethanol (0.75 g/kg) or saline infusion 
18-20 Post infusion 4 
Experiment 1 
Sample Experimental phase 
1-4 Baseline samples 
5 Saline infusion 
6-9 Post-saline infusion 
10-13 Baseline samples 
14 Ethanol infusion (1 
g/kg) 




After the dialysis experiments, rats were overdosed with sodium 
pentobarbital (150 mg/kg, i.v.) and probes were carefully unimplanted. Their 
brains were harvested and stored in vials containing 10% formalin for at least 24 
hours. The brain tissue was coronally sectioned (120 µm thick), stained with 
cresyl violet, and examined under a microscope to confirm probe placement. The 
probe tracks were mapped using the Paxinos & Watson (2007) atlas. 
 
HPLC Analysis 
Dialysate dopamine concentrations were quantified via reversed-phase 
high performance liquid chromatography with electrochemical detection. The 
HPLC systems consisted of a Luna 50 x 1.0 mm column (C18, 3 µm particle size; 
Phenomenex, Torrance, CA), 2 mm glassy carbon working electrode 
electrochemical detector (SenCell; Antec Leyden) at potential +450 mV, an 8125 
manual injector (Rheodyne, Cotati, CA), and an INTRO controller (Antec 
Leyden).  Mobile phase was continuously pumped through the systems via either 
a syringe pump (ISCO 65D, Telodyne) or an LC110S pump (Antec Leyden). The 
mobile phase consisted of 0.500 g octanesulfonic acid, 0.050 g decanesulfonic 
acid, 0.128 g ethylenediaminetetraacetic acid, and 11.08 g NaH2PO4 dissolved in 
1 liter of deionized water, and methanol as the organic solvent (8-10% v/v). The 
mobile phase was adjusted to pH 5.6 prior to adding the methanol. The sample 
 77 
injection volume was 5 microliters. External standards (0.3125 to 7.5 nM) were 
used to quantify the dopamine concentrations. EZChrom Elite software (Agilent, 
Wilmington, DE) was used to record and analyze all chromatograms. Only 
dopamine peaks with a signal to noise ratio >6 were included in the analyses. 
 
GC Analysis 
For animals that received ethanol infusions, dialysate ethanol 
concentrations were quantified via gas chromatography (GC) with flame 
ionization detection. Prior to freezing the dialysate samples, 2 µL aliquots were 
transferred to 2 mL glass chromatography vials and sealed with a septum. A 
Varian CP 3800 (Agilent Technologies) or Scion 436 gas chromatograph (Bruker, 
Netherlands) and a Varian 8200 headspace autosampler was used to analyze 
the concentrations of ethanol in the samples. The stationary phase was an HP 
Innowax capillary column (30 m × 0.53 mm × 1.0 µm film thickness). For the 
acute, single-dose studies, helium was used as the carrier gas, but prior to the 
cumulative dosing studies a hydrogen generator (Model 20H-MD, Parker 
Hannifin, England) was installed to use hydrogen as the carrier. Resulting 
ethanol peaks were recorded using either Varian Star Chromatography 
Workstation or CompassCDS (Bruker, Netherlands) software, and calibration 




Repeated measures analyses of variance (ANOVA) were performed on 
both the dialysate dopamine concentrations and the dialysate dopamine values 
normalized to baseline. Repeated measures ANOVAs were also performed on 
the dialysate ethanol concentrations. Two animals from experiment 1 (1 each 
from the nucleus accumbens and dorsolateral striatum groups) were missing 1-2 
dialysate ethanol values due to technical issues with the GC. In order to have the 
animals included in statistical analyses, the mean of the surrounding values was 
used in place of the missing value. For the overall repeated measures ANOVA 
on the dialysate ethanol data, the degrees of freedom were appropriately 
adjusted to account for these missing values. 
In experiment 1, we analyzed the effects of the saline and ethanol 
infusions separately, using 2-way mixed-model, repeated measures ANOVAs. 
Separate ANOVAs were performed on the first 9 time points (4 baseline and 5 
post-saline infusion) and the second 9 time points (4 baseline and 5 post-ethanol 
infusion). The four samples prior to each infusion were used to determine basal 
dopamine concentrations for each animal. In each ANOVA, the between subjects 
factor was brain region (3 levels: nucleus accumbens, dorsomedial striatum, 
dorsolateral striatum), and the within subjects factor was time.  
In experiment 2, we performed a three-way, mixed model, repeated 
measures ANOVA. The 2 between-subjects factors were brain region (2 levels: 
dorsomedial striatum, dorsolateral striatum) and drug (2 levels: saline, ethanol) 
and the within-subjects factor was time (20 time points). Additionally, because 
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our a priori hypothesis was that cumulative infusions of ethanol would 
differentially affect extracellular dopamine within the dorsomedial and 
dorsolateral striata relative to cumulative saline infusions, we also explored the 
time by drug interaction within each brain region. Samples 1-4 were used to 
determine basal dopamine concentrations for each animal. Sample 10 from an 
animal in the dorsomedial striatum-saline group was contaminated and thus 
removed from the dataset. The missing value was replaced with the mean of the 
surrounding samples and the degrees of freedom were appropriately adjusted. 
We performed simple effects analyses (with Bonferroni corrections) when 
appropriate to follow up on any significant interaction effects identified in the 
overall ANOVAs (Kirk, 1982).  Data were analyzed using SPSS software (IBM).  
Significance was assigned if p < 0.05; NS = not significant. 
Table 2: Basal dialysate dopamine concentrations and number of animals 
included in analyses for each region 
  




Infusion* Saline Group 
Ethanol 
Group 
Region n [DA] (nM) n [DA] (nM) n [DA] (nM) n [DA] (nM) 
DMS 9 1.8 ± 0.1 7 1.8 ± 0.1 5 1.5 ± 0.3 8 2.0 ± 0.2 
DLS 7 1.3 ± 0.2 6 1.3 ± 0.2 7 1.7 ± 0.2 7 2.3 ± 0.3 
Nac 5 1.3 ± 0.3 8 0.9 ± 0.1 n/a n/a 
Basal dopamine concentrations for each brain region (mean ± SEM). In 
experiment 1, separate baseline samples were collected prior to both the saline 
and ethanol infusions. In experiment 2, basal dopamine concentrations were 
determined from the first 4 dialysate samples. The asterisk (*) indicates 
significance difference in basal values across brain regions (p<0.05). 
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RESULTS 
Basal dopamine concentrations 
Basal dopamine concentrations for each brain region are reported in Table 
1. In experiment 1, the saline and ethanol baseline values for each animal were 
analyzed separately. Therefore, it was possible for an animal’s saline data to be 
excluded (due to instability of the baseline values) despite the ethanol data 
meeting all inclusion criteria, and vice versa. Due to significant differences in 
baseline dopamine concentrations among the 3 brain regions prior to the ethanol 
infusion (F2,18=12.05, p<0.01), we did the statistical analyses on the percent 
basal data for experiment 1. For experiment 2, because there were no significant 




Figure 7: Dialysate dopamine in the DMS, DLS, and NAc (percent of baseline) 
 
Dialysate dopamine in the DMS, DLS, and NAc represented as a percent of 
basal levels following intravenous administration of (a) saline (0.9% NaCl) and 
(b) ethanol (1 g/kg). Figure (c) shows the temporal profiles of dialysate ethanol 
concentrations in the DMS, DLS, and NAc. Symbols represent the mean. Error 
bars are SEM, but not all are shown for clarity. Asterisk (*) indicates significant 
difference from baseline (p<0.05; nucleus accumbens only), and the caret (^) 
indicates significant differences among the three brain regions at that time point 









































































Single dose 1 g/kg 
Control infusions of saline had no significant effect on dopamine activity in 
any subregion (Fig 7a; F8,144=1.89, NS). In contrast, the ethanol infusion 
stimulated dopamine release in some but not all striatal subregions (subregion x 
time interaction: F16,144=2.06, p<0.05). In the nucleus accumbens, extracellular 
dopamine was significantly elevated above baseline following the ethanol 
infusion (n=8; Fig 7b; simple effect of time: F8,144=7.98, p<0.01). Post hoc 
analyses showed that ethanol-induced stimulation of dopamine peaked at 40% 
above baseline within the first 5 minutes following the infusion (F4,144=11.16, 
p<0.01). Furthermore, dopamine remained elevated in the nucleus accumbens 
15-25 minutes following the infusion (F4,144=3.54-5.14, p<0.01 for each time 
point). In the dorsomedial striatum, the same dose of ethanol stimulated 
dopamine to 16% above baseline, but this effect was not statistically significant 
(n=7; Fig 7b; simple effect of time: F8,144=1.49, NS). In the dorsolateral striatum, 
there was clearly no effect of ethanol on extracellular dopamine (n=6; Fig 7b; 
simple effect of time: F8,144=0.22, NS).  
Simple effect analysis indicated that the dopamine response in the sample 
immediately following the ethanol infusion differed among the three brain regions 
(F2,138=11.5, p<0.001). Post hoc tests found that the response in the nucleus 
accumbens was significantly greater than that in the dorsomedial striatum 
(F1,138=8.84, p<0.01) and dorsolateral striatum (F1,138=22.04, p<0.01). However, 
extracellular dopamine concentrations in the sample immediately following the 
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ethanol infusion were not significantly different between the dorsomedial and 
dorsolateral striatum (F1,138=3.21, NS). Additional simple effects and post hoc 
analyses revealed only significant differences between the nucleus accumbens 
and the dorsolateral striatum (F1,138=9.44, p<0.01) at the 80-minute time point (15 
minutes following the ethanol infusion). Lastly, the dialysate ethanol time courses 




Figure 8: Temporal profiles of dialysate dopamine (nM) and ethanol 
concentrations (mM)  
 
 
Temporal profiles of dialysate dopamine (nM) and ethanol concentrations (mM) 
for DMS (a and b, respectively) and DLS (c and d, respectively) following 
cumulative intravenous infusions. Separate groups of rats received either ethanol 
doses (0.5, 0.5, 0.75, and 0.75 g/kg; filled symbols) or control saline infusions 
(open symbols). Symbols represent the mean. Error bars are SEM, but not all are 
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Cumulative dose-response  
The objective of Experiment 2 was to use a cumulative-dosing design to 
test whether a large ethanol dose range had differential effects on extracellular 
dopamine in the dorsomedial striatum and dorsolateral striatum. There were 4 
groups: dorsomedial striatum-ethanol, dorsomedial striatum-saline, dorsolateral 
striatum-ethanol, and dorsolateral striatum-saline. Within each group, the within-
subjects factor was time. Infusions occurred at the 20, 40, 60, and 80-minute 
time points. 
The overall ANOVA conducted on the raw (untransformed; Figs 8a and 
8c) nanomolar dopamine concentrations indicated significant main effects of time 
(within-subjects; F19,436=3.02, p<0.001) and drug (between-subjects; F1,23=8.28, 
p<0.01) on extracellular dopamine. While the three-way interaction between time, 
drug, and brain region was not significant (F19,436=0.94, NS), there were 
significant interactions of time by drug (F19,436=5.08, p<0.001) and of time by 
brain region (F19,436=2.08, p<0.01). Post-hoc analyses following up on the 
interaction of time and drug indicated a significant simple effect of time only for 
the ethanol groups (F19,436=8.43, p<0.001; collapsed across dorsomedial striatum 
and dorsolateral striatum). Cumulative saline infusions had no significant effect 
on extracellular dopamine concentrations (F19,436=1.04, NS; collapsed across 
dorsolateral striatum and dorsomedial striatum). Additional post hocs examining 
drug effects indicated significant differences between the saline and ethanol 
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groups at time points 55-90 minutes (F1,28=5.40, p<0.01; collapsed across 
dorsomedial striatum and dorsolateral striatum).  
Following up on the time by brain region interaction, post hoc analyses 
indicated a significant simple effect of time on extracellular dopamine only in the 
dorsomedial striatum (F19,436=5.40, p<0.001; collapsed across saline and ethanol 
groups). However, subsequent post hoc analyses comparing baseline vs 
individual time points were not statistically significant (Fig 8a). The effect of time 
was not significant for the dorsolateral striatum (F19,436=1.38, NS; collapsed 
across saline and ethanol groups). Additionally, because our a priori hypothesis 
was that ethanol would differentially affect dopamine concentrations in the 
dorsomedial and dorsolateral striatum, we also analyzed drug effects within each 
subregion. A significant time by drug interaction was observed in both the 
dorsomedial (F19,436=3.26, p<0.001) and dorsolateral (F19,436=2.71, p<0.001) 
striatum. However, subsequent post hoc analyses comparing ethanol time points 
vs. baseline or ethanol vs. saline at individual time points were not statistically 
significant for either subregion. 
Separate analyses were performed on the normalized data (Figure 9). 
Similar to the results from the analyses on the raw data, the overall ANOVA 
indicated significant main effects of time (within-subjects; F19,436=2.93, p<0.001) 
and drug (between-subjects; F1,23=10.84, p<0.01), as well as a significant 
interaction of time by drug (F19,436=10.58, p<0.001).  The three-way interaction 
between time, drug, and brain region was not significant (F19,436=0.90, NS), but 
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the two way interaction between time and brain region trended towards 
significance (F19,436=1.46, p=0.097).  Post hoc analyses following up on the 
overall time by drug interaction indicated a significant simple effect for the 
ethanol groups only (F19,436=8.57, p<0.001; collapsed across dorsomedial and 
dorsolateral striatum). Cumulative saline infusions had no significant effect on 
extracellular dopamine (F19,436=1.09, NS; collapsed across dorsomedial and 
dorsolateral striatum). 
Although the interaction between time and brain region did not meet the 
criteria for statistical significance in our analyses of the normalized dopamine 
data, our a priori hypothesis was that ethanol would exert differential effects on 
dopamine based on subregion. Therefore, we analyzed drug and time effects 
within each brain region. A significant time by drug interaction was observed in 
both the dorsomedial striatum (Fig 9a; F19,436=3.77, p<0.001) and dorsolateral 
striatum (Fig 9b; F19,436=2.39, p<0.001). Additionally, the simple effect of time 
was significant in both the dorsomedial striatum (F19,436=8.17, p<0.001) and 
dorsolateral striatum (F19,436=2.38, p<0.001), only for the ethanol groups and not 
the saline groups. However, subsequent post hoc analyses comparing ethanol 
time points vs. baseline or ethanol vs. saline at individual time points were 
statistically significant only for the dorsomedial striatum (Fig 9a).  
Between the dorsomedial striatum and the dorsolateral striatum, there 
were no significant differences in the temporal profiles of the dialysate ethanol 
concentrations (Figs 8b and 8d, respectively; F1,13=0.92, NS). Dialysate ethanol 
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concentrations increased with each ethanol infusion, peaking at 8.5 ± 0.3 mM in 




Figure 9: Dose-response effect of cumulative infusions of ethanol and saline on 
dialysate dopamine in the dorsomedial striatum and the dorsolateral 
striatum (percent of baseline) 
 
 
From Experiment 2, the dose-response effect of cumulative infusions of ethanol 
and saline on dialysate dopamine in (a) the dorsomedial striatum and (b) the 
dorsolateral striatum, represented as a percent of baseline. Asterisks (*) indicate 
statistical significance (p<0.05) relative to baseline and relative to carets (^) 
indicate statistical significance (p<0.05) between the ethanol and saline groups at 
specific time points. Symbols represent the mean. Error bars are SEM, but not all 
are shown for clarity.  
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Histologies and calcium-dependency 
 Histological analyses were performed to confirm probe placements, and 
for inclusion in the final dataset, probes were required to have at least 50% of the 
active area in the region of interest (Figure 10). Additionally, all animals had at 
least 50% calcium dependent dopamine release (range: 55-89% calcium 
dependency).  
 





Histologies to show probe placements for (a) experiment 1 and (b) experiment 2. 



























The current study is the first to compare the effects of acute systemic 
ethanol on dorsomedial and dorsolateral striatal dopamine activity. In experiment 
1, we showed that striatal subregions significantly differ in their extracellular 
dopamine responses to a single dose of intravenous ethanol (1 g/kg), with the 
nucleus accumbens demonstrating an immediate response to the drug 
administration that was more robust than either the dorsomedial or dorsolateral 
striatum. In experiment 2, our findings indicate an overall dose-dependent effect 
of non-contingent, systemic ethanol on dorsal striatal dopamine, and this 
stimulation was driven by a stronger effect in the dorsomedial striatum (Figure 3). 
While we observed slightly higher basal dopamine concentrations in the ethanol 
groups relative to the saline groups in experiment 2, this difference was not 
statistically significant. However, in order to directly compare drug effects, we 
reconciled the differences in basal dopamine by transforming the raw data to 
percent of baseline (Figure 9). 
 The present work is the first to demonstrate that the direct 
pharmacological effect of acute ethanol on extracellular dopamine differs across 
dorsal striatal subregions. Additionally, the present work supports the previously 
reported difference between the ventral and dorsal striatum in the dopamine 
response to acute ethanol (Imperato & Di Chiara, 1986; Melendez et al., 2003). 
The use of intravenous ethanol administration minimizes the impact of handling 
stress, motivation, and behavior on striatal dopamine activity. Therefore, the 
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subregional differences we observed reflect the direct pharmacological effects of 
ethanol.  Here we report that administration of a single dose of ethanol (1 g/kg) 
produces an immediate and robust increase in extracellular dopamine content to 
about 140-150% of basal levels in the nucleus accumbens, which is consistent 
with previous work (Howard et al. 2008; Melendez et al. 2003; Yim & Gonzales 
2000b; Imperato & Di Chiara 1986). Furthermore, the temporal profiles of 
extracellular dopamine in the dorsomedial striatum and dorsolateral striatum 
starkly contrast that of the nucleus accumbens following a bolus of ethanol. In the 
nucleus accumbens, a 1 g/kg infusion of ethanol produces an immediate 
transient increase in dopamine.  Conversely, in the dorsomedial striatum we 
observe a gradual, but non-significant increase in dopaminergic tone, and little or 
no effect of ethanol in the dorsolateral striatum. 
 Previous in vivo microdialysis studies in rats have also demonstrated a 
blunted dopamine response in the dorsal striatum relative to the ventral striatum 
following acute systemic ethanol administration (Imperato & Di Chiara, 1986; 
Melendez et al., 2003). Melendez and colleagues (2003) demonstrated that 
following a single dose of ethanol (2.25 g/kg, i.p.), dopamine peaks at 198% and 
156% of baseline levels in the nucleus accumbens and dorsal striatum, 
respectively. Additionally, Imperato and DiChiara (1986) reported that low doses 
of ethanol (0.25 and 0.5 g/kg, i.p.), which stimulated accumbal dopamine activity 
to 135-180% of basal levels, failed to stimulate dopamine activity in the dorsal 
striatum. Higher doses of ethanol (2.5 and 5.0 g/kg, i.p.) also had a greater effect 
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on extracellular dopamine content in the nucleus accumbens relative to the 
dorsal striatum.  
The work presented here is consistent with these earlier studies; however, 
we further delineate the effect of cumulative ethanol doses on dopamine in dorsal 
striatal subregions. With higher doses of ethanol (in the range of 1.75-2.5 g/kg), 
we observe enhanced dopaminergic tone in the dorsomedial striatum that 
stabilizes at 130% of basal dopamine concentrations and endures as brain 
ethanol levels decline. In contrast, we observed little to no effect of ethanol on 
dopamine in the dorsolateral striatum at any dose. The overall conclusion from 
these experiments is that dopamine neurons projecting to the dorsomedial 
striatum and dorsolateral striatum show differential sensitivity to a systemic 
ethanol challenge. However, a caveat is that the difference in the response to 
acute ethanol between these subregions did not reach statistical significance in 
all of our analyses, suggesting that the overall difference between these two 
regions is not very robust. 
The current data add to the body of literature suggesting that midbrain 
dopamine circuits differ in their sensitivity to the stimulant effects of ethanol 
(Gessa, Muntoni, Collu, Vargiu, & Mereu, 1985; Melendez et al., 2003; Vena & 
Gonzales, 2014).  Gessa et al. (1985) were the first to report that ethanol 
stimulated ventral tegmental area dopamine neuron firing rate in vivo with higher 
potency relative to substantia nigra dopamine neurons in awake, paralyzed rats.  
These investigators showed that the ethanol dose-response curve was shifted to 
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the right for electrodes placed in the substantia nigra compared to the ventral 
tegmental area.  Microdialysis studies by Melendez et al. (2003) also provide 
evidence for a higher ethanol sensitivity of ventral tegmental area dopamine 
neurons compared with those in the substantia nigra in awake, behaving rats.  
They showed that an injection of ethanol (2.25 g/kg, i.p.) in naïve rats produced a 
significant dopamine response in the ventral pallidum, which receives 
dopaminergic input primarily from the ventral tegmental area.  In contrast, no 
dopamine response to ethanol was observed in the globus pallidus, which 
receives dopaminergic input primarily from the substantia nigra (H. Fuchs & 
Hauber, 2004; Lindvall & Björklund, 1979; Prensa & Parent, 2001).  The 
differential sensitivity of ventral tegmental area and substantia nigra dopamine 
neurons to ethanol likely contributes to the differences we report here in the 
magnitude and temporal profile of the dopamine response to acute ethanol 
among the dorsomedial striatum, dorsolateral striatum, and nucleus accumbens.  
In rats, dopaminergic projections to the dorsomedial striatum and dorsolateral 
striatum arise primarily from distinct groups of neurons within the substantia 
nigra, but the dorsomedial striatum also receives some innervation by dopamine 
neurons with cell bodies located in the ventral tegmental area (Gerfen, 
Herkenham, & Thibault, 1987; Joel & Weiner, 2000).  This ventral tegmental area 
innervation of the dorsomedial striatum may explain, in part, our finding of a 
dose-dependent stimulation of dopamine release by ethanol in the dorsomedial 
striatum, but not in the dorsolateral striatum. Interestingly, differences in the 
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magnitudes and temporal profiles of the dopamine responses between the 
dorsomedial and dorsolateral striatum have also been reported following 
electrically stimulated dopamine activity. Following stimulation of the medial 
forebrain bundle, the dopamine response in the dorsomedial striatum is larger 
than that in the dorsolateral striatum (Taylor et al., 2015), which is similar to what 
we observe following acute ethanol administration. 
The mechanisms that underlie the apparent increased sensitivity of the 
ventral tegmental area dopamine neurons to ethanol relative to the substantia 
nigra are unknown.  Numerous possibilities could contribute to this differential 
vulnerability to ethanol, and a complete exploration of these possibilities is 
beyond the scope of the present report.  However, the literature provides some 
clues that would need further experimentation to verify.  For example, recent 
work has demonstrated functional diversity between substantia nigra and ventral 
tegmental area dopamine neurons in motivated behaviors, which may be due to 
regulation by contrasting sources of excitatory input (Masayuki Matsumoto & 
Hikosaka, 2009; Watabe-Uchida, Zhu, Ogawa, Vamanrao, & Uchida, 2012). 
Substantia nigra dopamine neurons primarily receive input from somatosensory 
and motor cortices in addition to the subthalamic nucleus.  On the other hand, 
ventral tegmental area dopamine neurons receive projections from the lateral 
hypothalamus. These projections from the lateral hypothalamus are rich in 
neuropeptides, which induce burst firing in ventral tegmental area neurons 
(Korotkova, Ponomarenko, Brown, & Haas, 2004; Watabe-Uchida et al., 2012). It 
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is possible that ethanol may be modulating activity at or upstream from these 
excitatory synapses in the ventral tegmental area while having minimal effects at 
afferents to the substantia nigra.  However, additional distinctions exist between 
ventral tegmental area and substantia nigra dopamine neurons including receptor 
expression patterns and mechanisms of terminal regulation in projection regions 
(Cass & Gerhardt, 1995; Cass et al., 1993; Korotkova et al., 2004; Roeper, 
2013). Further work is clearly needed to determine if the differences ethanol 
sensitivity between the dorsomedial striatum and dorsolateral striatum we 
observed in the present study could be due to ethanol’s direct effects on 
dopamine cell bodies, afferents regulating midbrain dopamine activity, effects at 
the level of the dopamine terminals in the striatal subregions, or some 
combination of these factors.   
In conclusion, our microdialysis experiments indicate differential 
pharmacological effects of acute ethanol on extracellular dopamine in the 
dorsomedial striatum, dorsolateral striatum, and nucleus accumbens. 
Specifically, the temporal profiles and magnitudes of the dopamine response to 
an intravenous bolus of ethanol significantly differed across these regions. 
Therefore, our results indicate distinctions in the regulation of extracellular 
neurochemical activity among the dorsomedial striatum, dorsolateral striatum, 
and nucleus accumbens, which may contribute to their proposed functional 
distinctions. Furthermore, the doses used in the present studies induced varying 
degrees of ataxia and sedation, suggesting that they are acutely intoxicating 
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(Majchrowicz, 1975). Therefore, our findings suggest a role for the dorsomedial 





Medial Prefrontal Cortical Dopamine Responses During Operant 
Self-Administration of Sweetened Ethanol 
 
The work presented in this chapter was published in 2016 in Alcoholism: Clinical 
and Experimental Research by Doherty*, Schier*, Vena*, Dilly and Gonzales 
(*denotes equal contributions). This publication is reprinted with permissions from 
John Wiley & Sons (License #: 3994840195169). Parts of this work have also 
been published in a dissertation by Dr. Schier. Ashley Vena conducted the 
independent replication project, edited the manuscript, and prepared the 
manuscript for final publication. 
 
ABSTRACT   
Medial prefrontal cortex (mPFC) dysfunction is present in heavy alcohol 
consumers.  Dopamine signaling in mPFC is associated with executive 
functioning and affects drinking behavior; however, direct measurement of 
extracellular mPFC dopamine during appetitive and consummatory ethanol self-
administration behavior has not been reported. We used in vivo microdialysis in 
freely-behaving, adult, male, Long Evans rats to determine extracellular 
dopamine concentration in the mPFC during operant self-administration of an 
ethanol-plus-sucrose or sucrose solution.  The model separated 
appetitive/seeking from consummatory phases of the operant session.  
Dopamine was also monitored in an untrained handling control group, and 
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dialysate ethanol was measured in the ethanol-drinking group. Home cage 
baseline dopamine was lower in rats that experienced a week of drinking 
sweetened ethanol compared to sucrose-drinking and handling controls.  
Transfer into the operant chamber and waiting to drink, and cues/initiation of 
consumption stimulated a relatively higher change in dopamine over baseline in 
the sweetened ethanol group compared with sucrose and handling controls.  
However, all groups show a dopamine response during transfer into the operant 
chamber, and the sucrose group had a relatively higher change in dopamine over 
baseline during initiation of consumption compared to handling controls.  The 
time courses of dopamine and ethanol in the mPFC differ in the ethanol-
consuming rats. Differences in extracellular mPFC dopamine between ethanol 
drinkers compared to control groups suggest that mPFC dopamine is involved in 
the mechanism of operant self-administration of sweetened ethanol and sucrose.  
Furthermore, the increase in dopamine during consumption is consistent with a 
role of mPFC dopamine in reward prediction. 
 
INTRODUCTION 
Medial prefrontal cortex (mPFC) dysfunction, which is frequently noted in 
heavy alcohol consumers, is associated with increased impulsivity and 
perseveration, as well as deficits in executive functions (e.g. working memory, 
decision-making, attention, goal-directed behavior; Bechara & Damasio, 2002; 
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Bechara & Van Der Linden, 2005; Chanraud et al., 2007; Goldstein et al., 2004; 
Sullivan et al., 1993).  Similarly, acute ethanol can also disrupt working memory 
(Ralevski et al., 2012).  When exposed to drug-related cues, detoxified alcoholics 
showed significantly greater mPFC activation compared to controls (Heinz et al., 
2004).  These findings suggest that ethanol use may be associated with 
enhanced sensitivity to drug-related cues and decreased behavioral control due 
to compromised prefrontal cortical function.  
The mechanisms by which ethanol alters mPFC function are not clear, 
although recent work has suggested that ethanol-induced changes in 
dopaminergic activity in the mPFC may contribute (Z.-M. Ding, Ingraham, Rodd, 
& McBride, 2015; Trantham-Davidson et al., 2014; Tu et al., 2007).  Altered 
dopaminergic signaling has been shown to affect reinstatement of drug-seeking 
behaviors (Kehagia, Murray, & Robbins, 2010; McFarland, Davidge, Lapish, & 
Kalivas, 2004; Sinha, 2013), however, the relationship between mPFC dopamine 
and ethanol self-administration behavior is still unclear.  Recent studies show 
that ethanol increases extracellular dopamine in the mPFC in naïve rats after 
intravenous administration (Schier et al., 2013), or a single microinjection of 
ethanol directly into the ventral tegmental area (VTA; Ding et al., 2011), although 
earlier work suggested that ethanol administration had no effect (Bassareo et al., 
1996; Engleman, Ingraham, McBride, Lumeng, & Murphy, 2006; Hegarty & 
Vogel, 1993).  Furthermore, modulation of dopamine receptor signaling in the 
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mPFC has been shown to change ethanol self-administration behaviors (Ding et 
al., 2015; Hodge et al., 1996; Samson & Chappell, 2003), but due to the 
experimental designs used it is unclear if mPFC dopamine was important for 
drug-seeking or consummatory behaviors.  
Previous work indicated that ethanol-associated stimuli can increase 
extracellular dopamine in the nucleus accumbens (NAC) during operant 
sweetened ethanol self-administration (Carrillo & Gonzales, 2011; Doyon, 
Anders, Ramachandra, Czachowski, & Gonzales, 2005; Elaina C Howard, 
Schier, Wetzel, & Gonzales, 2009a), and therefore, we hypothesized that 
extracellular dopamine would also increase in the mPFC when an experienced, 
non-dependent, rat is exposed to drinking-associated stimuli.  To test this, we 
used microdialysis to monitor extracellular dopamine within the mPFC during an 
operant self-administration session, in which rats drank a 10% sucrose plus 10% 
ethanol solution (10S10E), a 10% sucrose-only solution (10S; to control for 
sucrose in the ethanol solution), or no solution (Handling; to control for 
experimenter handling and experience within the operant chamber).  Additionally, 
our operant self-administration sessions separated anticipatory/seeking and 
consummatory behavioral phases.  Thus, we monitored mPFC dopamine 
concentrations affected by contextual cues during transfer into the drinking 
environment (operant chamber) before exposure to stimuli experienced during 
the drink period (taste, smell, and consumption).   
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MATERIALS AND METHODS 
Materials 
Drinking solutions (10S: 10% sucrose (w/v) or 10S10E: 10% ethanol (v/v) 
in 10S) were made from 95% ethanol (AAPER Alcohol and Chemical Co., 
Shelbyville, KY), ultra-pure sucrose (MP Biomedicals, LLC, Solon, OH) and 
distilled water.  Carprofen (Pfizer, New York, NY) and gentamicin (APP 
Pharmaceuticals, Schaumburg, IL) were used during surgery.   
 
Animals 
Final statistical analyses used 27 male, young adult, Long Evans rats from 
Charles River Laboratories (Portage, MI or Raleigh, NC, USA; 200-225 g upon 
arrival).  An additional 16 male Long Evans rats were used for an independent 
replication study (see Supplementary Materials). Animals were maintained on a 
12-hour light/dark schedule, at 23 ± 2 ºC, with ad libitum food and water (except 
where noted); rats were weighed each day.  All animal procedures complied with 
the NIH Guide for the Care and Use of Laboratory Animals and were approved 





After a week of habituation to the facility and experimenters, rats were 
anesthetized with isoflurane (5% induction, 2.5% maintenance), and using 
stereotaxic equipment a 21-gauge guide cannula was surgically placed (Plastics 
One, Roanoke, VA) above the left mPFC (mm relative to bregma and skull 
surface: +3.0 AP, +0.6 ML, -2.0 DV (Paxinos & Watson, 2007).  Three skull 
screws and dental cement secured the cannula and a tether bolt to the skull.  We 
administered carprofen (5 mg/kg, subcutaneously) to minimize post-surgical 
malaise, placed a dummy cannula into the cannula to prevent blockage, and 
monitored weight and health over a seven-day recovery period prior to beginning 
operant training.     
 
Self-Administration Training and Protocols 
Groups 
Rats were initially trained to lever press for access to the 10S solution, 
and then two groups were formed, one that consumed increasing concentrations 
of ethanol (2-10% ethanol (v/v) in 10S; Table 3), and a group that continued to 
drink 10S.  The Handling control group was exposed to all the same procedures 
as the 10S10E and 10S groups (physical handling, water deprivation during lever 
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press training, time in the operant chamber, tethering, and dialysis), but they 
were not exposed to drinking solutions or operant training.                
Lever-press training and operant protocol 
A week after surgery, animals were habituated to operant chambers (Med 
Associates, Inc., Vermont, USA) and then trained to lever press for a 10S 
solution (10S10E and 10S groups only).  Water deprivation (maximum 22 
hours/day) was used to expedite lever-press training.  Animals typically learned 
to lever press within three training sessions (one session/day), after which they 
regained ad libitum access to water for the remainder of the experiment.  
Chambers were as previously described by Howard et al. (2009).  Briefly, 
chambers had a retractable lever, sipper tube bottle, house light, cue light and 
lickometer circuit.  Chambers were contained in sound-attenuating boxes.  
Operant programs were run and data were collected using Med Associates 
software.  
Once trained to lever press, animals began an eight-session testing 
schedule during which a pre-lever-press wait period was lengthened from 0-28 
min, and the response requirement was increased from 2-4 (Table 3).  Following 
completion of the response requirement, the sipper tube containing the drinking 
solution entered the chamber for 21 minutes, during which animals had ad libitum 
access to the drinking solution. No further responding was required. For the 
10S10E group, ethanol started at a 2% (v/v) concentration in 10% (w/v) sucrose, 
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and gradually increased to 10% ethanol in 10% sucrose (10S10E) (Table 3).  
This procedure is modified from the Samson (1986) sucrose fading procedure; 
however, we did not fade sucrose out of the solution because we wanted to 
maximize ethanol consumption. Sessions were run once a day, four to six days 
per week.  Animals received a total of three to four, but never more than two 
sequential days off from training once the eight-session protocol began.  The 
handling control group completed the same procedures, except drinking solutions 
were not available, and the lever was present but pressing had no 
consequences.  Solution consumption was measured by the volume of solution 
before and after the drinking session (to the nearest 0.25 ml, accounting for 
spillage), and pattern of consumption was monitored using the lickometer. 
Following the sixth operant session, a spring was attached to the tether 
bolt on the animal’s head and connected to a swivel suspended above the rat by 
a counter-balance lever arm. Rats were tethered in their home cages (placed 
next to their operant chamber) and during the seventh operant session to 
facilitate habituation to the apparatus and environment. The tethering apparatus 
did not interfere with the rats’ abilities to move freely about their home cage or to 




After the seventh operant session, rats were briefly anesthetized with 
isoflurane to implant the lab-constructed microdialysis probe (3.25 mm active 
area, 13,000 MW cutoff, constructed similar to Pettit and Justice, 1991).  Probes 
were perfused with artificial cerebral spinal fluid (ACSF: 149 mM NaCl, 2.8 mM 
KCl, 1.2 mM CaCl2, 1.2 mM MgCl2, 0.2 mM ascorbic acid, and 5.4 mM D-
glucose), at a 0.2 µl/min flow rate overnight, and then to a 1.0 µl/min flow rate at 
least two hours prior to dialysis sampling.  For the 10S10E group, two samples 
before the lever extended into the chamber and all samples after were evaluated 
for ethanol concentration (described below).  The dialysis samples were 
immediately frozen on dry ice and stored at -80 ºC until dopamine analysis.   
 Table 3: 8-session protocol parameters 
 
10S10E refers to the 10% sucrose + 10% ethanol solution the ethanol-
consuming rats drank the day of dialysis.  Sucrose-consuming rats drank only the 
10% sucrose solution (10S), and the handling group did not receive a drinking 
solution and are not required to lever press. *Data are the mean g/kg ± SEM. 
 

















1 2 2 0% n/a 2.94 ± 0.31 
2 5 2 2% 0.43 ± 0.05 2.99 ± 0.30 
3 8 2 2% 0.57 ± 0.06 2.88 ± 0.36 
4 13 2 5% 1.06 ± 0.10 2.78 ± 0.55 
5 18 4 5% 1.07 ± 0.17 3.44 ± 0.31 
6 23 4 10% 1.12 ± 0.18 3.63 ± 0.34 
7 (Tethered) 28 4 10% 1.28 ± 0.12 3.56 ± 0.28 
8 (Dialysis) 28 4 10% 1.65 ± 0.14 3.27 ± 0.38 
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Experimental Timeline 
Microdialysis samples were manually collected every seven minutes 
before and during the eighth operant session (Figure 11).  Four baseline samples 
were taken in the home cage.  During the last minute of the fourth baseline 
sample, the rat was transferred into the operant chamber.  The operant program 
began with turning on the house light and sound-attenuating fan, and the sample 
collection vial was changed to the first wait period sample.  Four wait period 
samples were taken.  The time it took the rat to meet the response requirement 
of four lever presses was collapsed into the last wait period sample.  The 
wait/lever-press sample was changed to the first drink sample as the drinking 
bottle entered the chamber.  Three samples were taken during the drink period, 
after which the bottle retracted and the house light turned off.  Then three 
samples were taken during the post-drink period.  The rat was then returned to 
its home cage, and the ACSF was changed to calcium-free ACSF.  




Figure 11: Time course of the operant self-administration session 
 
On the eighth day of operant testing, consecutive seven-minute dialysis samples 
were taken during all behavioral phases.  Figure adapted from Schier et al., 
2013. 
Dopamine Analysis 
We evaluated the dopamine concentration in all samples using reverse-
phase high performance liquid chromatography with electrochemical detection.  
All samples were run with accompanying external standards (0.03125 to 1.0 nM 
dopamine).  Samples and standards were run using a 8125 manual injector 
(Rheodyne, Cotati, CA), a Luna 50 x 1.0 mm (C18, 3-µm particle size; 
Phenomenex, Torrance CA) or Haisil 100 50 x 0.5 mm column (C18, 3-µm 
particle size; Higgins Analytical Inc., Mountain View, CA), and a 2 mm glassy 
carbon working electrode (SenCell or VT03 with ISAAC reference electrode, 
Antec Leyden, Netherlands) at potential + 345 or + 395 mV.  Mobile phase 
aqueous solution consisted of approximately 2.1 mM octanesulfonic acid, 0.04 - 
0.3 mM decanesulfonic acid (adjusted to optimize chromatography), 0.34 mM 
ethylenedianimetetraacetic acid, 71 mM sodium phosphate monobasic dihydrate, 
Transfer into operant 
            chamber 
Lever extends 













50 min 30 min 30 min 30 min
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and 60 mM potassium chloride, adjusted to 5.60 pH with 1 M sodium hydroxide.  
Prior to use, 150 mL/L of methanol was added and the mobile phase solution 
was sparged with helium.  Mobile phase flow rates ranged from 0.1 to 0.12 
ml/min for 50 x 1.0 mm columns, and 0.025 – 0.032 ml/min for 50 x 0.5 mm 
columns.  Four to 5.5 µl of dialysate was mixed with 1 to 3 µl of ascorbate 
oxidase (EC 1.10.3.3; 102.3 U/mg) prior to injecting 5 µl of the mixture into the 
system.  The amount of ascorbate oxidase was adjusted to optimize dopamine 
detection.  EZChrome Elite software (Agilent Technologies, Wilmington, DE) was 
used for chromatogram acquisition and peak integration.  The dopamine signal 
was required to be at least 3 times greater than the background noise.  See 
Supplementary Materials for details regarding the dopamine analyses for the 
independent replication study.          
 
Ethanol Analysis 
Samples were analyzed for ethanol concentration on the day they were 
collected (Schier, Mangieri, Dilly, & Gonzales, 2012).  Briefly, 1 µl aliquots of 
dialysate or external standards (0.3125 to 20 mM ethanol) were sealed in 2 ml 
glass vials, heated in an autosampler tray (50-65 ºC), and analyzed for ethanol 




Within three days of dialysis, animals were overdosed with sodium 
pentobarbital (150 mg/kg, intraperitoneal) and perfused through the heart with 
saline and 10% formalin in saline prior to brain extraction.  Brains were post-fixed 
with 10% formalin in saline, coronally sectioned (100 µm thick), and stained with 
cresyl violet for verification of the microdialysis probe placement (Paxinos et al., 
1999).   
 
Exclusion Criteria 
For inclusion of rats in data analysis, dopamine concentrations in home 
cage baseline samples were required to have a relative standard deviation < 
0.25.  We also required a 40% decrease in dopamine concentration in calcium-
free ACSF samples compared to basal ACSF samples to verify that dopamine 
release was exocytotic.  Rats were required to acquire the lever-press behavior 
within six training sessions, complete the lever press requirement on the day of 
dialysis, and the 10S10E group was required to consume at least 0.8 g/kg on the 
day of dialysis.  Finally, rats were excluded if technical errors resulted in loss of 
critical dopamine samples (before and after transfer into the operant chamber, or 




Raw dopamine concentrations (nM) were analyzed using repeated 
measures analysis of variance (ANOVA) with group (10S10E, 10S, and handling) 
as between subjects factor, and time (14 time points: 4 home cage baseline, 4 
wait period, 6 drink and post-drink) as within subjects repeated factor.  Post hoc 
analyses (using pooled error and Bonferroni corrections) separated the 
experiment into three phases: home cage baseline, wait period, and drink/post-
drink.  Specifically, when significant interactions between main effects were 
observed for the overall experiment, simple effects analyses were done to 
determine the source of the significant interaction.  Since significant group 
differences occurred in raw dopamine concentrations during the home cage 
baseline (see results; Figure 2), we also analyzed dopamine expressed as a 
percentage of home cage baseline levels.  Behavioral data were analyzed using 
independent samples t-tests; except licks separated into seven minute bins were 
analyzed with repeated measures ANOVA with group (10S10E and 10S) as 
between subjects factor, and bin as within subjects repeated factor.  Data were 
analyzed using SPSS software (IBM).  Significance was assigned if p < 0.05; ns= 




Consumption during operant self-administration sessions 
 Ethanol and sucrose consumption data for the eight operant sessions are 
represented in Table 3. In the group consuming sweetened ethanol, rats 
increased their ethanol intake over the eight sessions and consumed at least 1 





Figure 12: Dialysate dopamine concentrations in mPFC during home cage 
baseline, wait, drink and post-drink periods for the sucrose and 
handling controls along with rats trained to drink 10S10E.  
 
For clarity only group comparisons are shown on the figure as follows.  * 
indicates a significant difference between the 10S10E group compared with 
either the 10S or Handling groups during the baseline and wait periods.   # 
indicates that drink and post-drink period dopamine concentrations were 
significantly different in 10S compared with either the 10S10E or Handling 
groups.  Not indicated in the figure are significant increases in dopamine at the 
first sample during the wait period compared with the remaining samples.  
Similarly, there was a significant increase in dopamine during the first drink 
sample compared with the remaining drink and post-drink samples.  Overall 
significant main effects of time and a group by time interaction occurred.  Data 
represented as mean ± SEM for most points, but selected error bars are omitted 



























Overall analysis of raw dopamine concentrations and home cage baseline 
In general, dopamine concentrations in both the 10S10E and 10S groups 
peaked once during the first wait period time point, and again during the first 
drink period time point.  In contrast, dopamine in the Handling group only peaked 
during the first wait period time point and remained at baseline levels during the 
drink and post-drink periods.  Comparison of overall raw dopamine 
concentrations across the entire experiment (Figure 12) resulted in significant 
main effects of time (F13,306=11.9, p<0.001), and a group by time interaction 
(F26,306=3.0, p<0.001).  Post hoc analyses of the significant group by time 
interaction separated the experiment into the three phases: home cage baseline, 
wait period, and drink/post-drink.   
Significant group differences occurred in raw dopamine concentrations 
during the home cage baseline (Figure 12; F2,33=12.1, p<0.001).  Following-up on 
the main effect of group, an ANOVA revealed that the 10S10E group exhibited 
significantly lower baseline dopamine concentrations compared to both the 10S 
(F1,33=20.9, p<0.05) and Handling groups (F1,32=14.8, p<0.05), while no 
difference occurred between 10S and Handling groups. A separate experiment 
utilizing the same experimental protocol also found that 10S10E animals show 
significantly lower baseline dopamine concentrations in the PFC compared to 
10S controls (t14= 1.76, p<0.05; Fig S1) 
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Raw dopamine concentrations and lever-press behavior during the wait period  
After collecting the home cage baseline samples, the rats were transferred 
into the operant chamber and the program was started.  During the wait period 
(Figure 12), dopamine concentrations significantly differed between groups 
(F2,33=6.3, p<0.01) and changed over time (F3,306=12.5, p<0.001), but there was 
not a group by time interaction (ns).  Post hoc analyses on the main effect of 
group during the wait period showed that dopamine in the 10S10E group 
significantly differed from both the 10S (F1,33=10.1, p<0.05) and Handling groups 
(F1,33=8.6, p<0.05).  Dopamine concentrations were similar between 10S and 
Handling groups during the wait period.  Analysis of the change in dopamine 
during the wait period collapsed across all groups showed that dopamine 
concentrations peaked during the first wait period time point, and then decreased 
back towards baseline levels (first sample differed from samples 2-4, p<0.05).   
At the end of the wait period, the lever was presented to all groups.  
10S10E and 10S groups were required to press the lever four times for access to 
the drinking solution.  The 10S10E group began lever pressing significantly 
sooner than the 10S group after lever presentation (t16= -2.3, p<0.05), yet both 
groups showed similar lever-press rates (t16= 1.1, ns), and similar time to 
complete the lever press requirement (t16= -0.1, ns) (Table 4).  The time taken to 
complete the lever presses was accounted for in the final wait period dialysis 









* represents significant difference in behavioral parameter between ethanol plus 
sucrose solution-consuming (10S10E) and sucrose solution-consuming (10S) 
groups.  Data represented as mean ± SEM.  
 
Drinking behavior and raw dopamine concentrations during the drink and post-
drink periods 
Once the response requirement was completed, the lever retracted and 
the bottle entered the chamber, at which time the dialysis sample was changed 
and the drink period began.  The 10S10E and 10S groups showed similar latency 
to drink, rate of licking during the first drinking bout, and total number of drinking 
bouts (Table 4; bout defined as a minimum of 25 licks without a two-minute 
break; t16= 1.5, -1.6, -0.7, respectively, ns).  The 10S10E group drank 
significantly less solution, had significantly fewer licks overall and during the first 
Table 4: Behavioral parameters 
 
Parameter 10S10E Group 10S Group 
Time to complete presses (sec) 24 ± 16 25 ± 3.2 
Latency to press (sec) 7.0 ± 3.8* 18.3 ± 3.2 
Latency to drink (sec) 6.1 ± 2.2 2.8 ± 0.2 
Length of first bout (min) 4.9 ± 0.3* 8.4 ± 1.1 
Licks in first bout 1239 ± 80* 2478 ± 310 
First bout lick rate (licks/min) 259 ± 21 305 ± 20 
Solution consumed (ml) 8.8 ± 0.7* 13.8 ± 0.9 
Total licks 1503 ± 100* 2704 ± 265 
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bout, and had a significantly shorter first bout compared to the 10S group (Table 
4; t16= -4.7, -4.2, -3.9, -3.1, respectively, p < 0.01).  When licks were binned per 
seven minutes, the 10S10E group had significantly fewer licks during the first two 
bins compared to the 10S group, but both groups had similar licks during the 
third bin (Figure 13; group by time interaction F2,32=12.4, p < 0.001; bin 1: 
F1,32=45.4, p<0.05; bin 2: F1,32=13.0, p<0.01; bin 3: F1,32=0.1, ns).  On dialysis 
day, the 10S10E group consumed 1.7 ± 0.1 g/kg ethanol during the drink period 
(Table 3). 
During the drink and post-drink periods (Figure 12), dopamine 
concentrations significantly differed between groups (F2,33=6.9, p<0.01) and 
changed over time (F5,306=9.4, p<0.001).  Following-up on the main effect of 
group, a post hoc ANOVA revealed that dopamine in the 10S10E group 
significantly differed from the 10S group (F1,33=11.4, p<0.05), but not the 
Handling group (ns).  Dopamine concentrations were also significantly different 
between 10S and Handling groups (F1,33=9.2, p<0.05).  Because there was not a 
significant group by time interaction in the overall ANOVA conducted on the drink 
and post-drink periods, the groups were collapsed to analyze the change in 
dopamine over time during the experimental periods. These analyses revealed 
that dopamine concentrations peaked during the first drink period time point, and 
then decreased back towards baseline levels (first drink sample differed from 
drink sample 3 and post-drink samples 1-3, p<0.05).   
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Figure 13: Licks in seven-minute bins.   
 
 
Asterisks (*) represent significant difference in licks between 10S10E (n = 9; 10% 
sucrose + 10% ethanol) and 10S (n = 9; 10% sucrose) groups.  Data represented 



















Figure 14: mPFC dopamine relative to home cage baseline during home cage 





The data shown in fig. 2 were transformed to percent of home cage baseline.  
For clarity only group comparisons are shown on the figure as follows.  * 
indicates a significant difference between the 10S10E group compared with 
either the 10S or Handling groups during the wait period.   # indicates that drink 
and post-drink period dopamine responses above baseline were significantly 
different in each group compared with the other two groups.  Overall significant 
main effects of time, group, and a group by time interaction occurred.  Data 
represented as mean ± SEM for most points, but selected error bars are omitted 
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Dopamine concentration as a percentage of home cage baseline levels 
Due to significant group differences in raw dopamine concentrations 
during the home cage baseline (results above; Figure 12), we also analyzed 
dopamine expressed as a percentage of home cage baseline levels (% BL; 
Figure 14).  In general, analysis of raw and % BL dopamine resulted in similar 
conclusions, therefore with % BL analysis we mainly describe differences 
compared to that obtained with raw dopamine concentrations.  For example, 
analysis of all ten time points within the operant chamber (wait period, drink, and 
post-drink) revealed a significant main effect of group (F2,24=7.7, p<0.01) in 
addition to significant time and group by time effects seen with the raw 
concentration analysis.  Simple effects analyses between groups showed that 
each group significantly differs from one another (10S10E vs. 10S F1,63=44.7, 
p<0.001, 10S10E vs. Handling F1,63=85.0, p<0.001, 10S vs. Handling F1,63=6.4, 
p<0.05).   
Following up on these simple effects analyses, we identified where 
significant group differences occurred within each experimental phase. During 
the wait period, the % BL analysis revealed similar results compared to raw 
dopamine concentrations.  During the drink and post-drink periods, the % BL 
analysis also revealed similar results compared to raw dopamine concentrations, 
with significant main effects of group and time.  However, an ANOVA on the %BL 
data also revealed a significant main effect of group, with significant differences 
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between 10S10E and Handling groups (F1,30=81.2, p<0.05), and a significant 
group by time interaction (F10,115=3.0, p<0.01).  Subsequent simple effects 
analysis of the group by time interaction showed that dopamine concentrations in 
the 10S10E group differed from the 10S group during the first drink time point 
(F1,30=7.7, p<0.05), and differed from the Handling group during all three drink 
and the first post-drink time points (p<0.05).  Dopamine concentrations in the 10S 
group only differed from the Handling group during the first drink time point 
(F1,30=8.5, p<0.05).  
 
Figure 15: Dopamine and ethanol concentrations in mPFC during the drink and 
post-drink periods in the 10S10E group.   
 
 
Left y-axis shows the dialysate ethanol concentrations (circles).  Right y-axis 
shows the percent change in mPFC dopamine concentration during the drink and 
post-drink periods relative to home cage baseline  (squares, same data shown in 
Fig. 3).  The bottle retracted from the chamber after the third sample.  Data 
































Dialysate ethanol concentrations during and after the drink period 
At the initiation of drinking, dialysate ethanol was lowest and then 
increased throughout the drink and post-drink period to peak at 5.2 ± 0.8 mM 
ethanol (Figure 15).  Dialysate ethanol concentrations are not corrected with an 
in vivo extraction fraction, and are therefore lower than true tissue ethanol 
concentrations.   
 
Histology, body weight, and calcium-dependent dopamine concentration  
Histologies showed that the percent of probe active area within the 
infralimbic and prelimbic regions was not significantly different between groups 
(Figure 16; F2,24=2.1, ns).  Probe active area was required to be at least 50% in 
the infralimbic and prelimbic regions of the mPFC.  10S10E, 10S, and Handling 
groups were 76 ± 3%, 66 ± 5%, and 65 ± 5% within these regions, respectively.  
Body weights on the day of dialysis were not significantly different between 
groups (F2,24=2.7, ns; range 337-477 grams).  Calcium-dependent dopamine 
release was confirmed by a minimum 40% dialysate dopamine concentration 
decrease when calcium-free ACSF was perfused through the probe.  10S10E, 
10S, and Handling groups showed an average of 67 ± 3%, 57 ± 4%, and 61 ± 
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5% decrease in dopamine in calcium-free ACSF samples compared to 
concentrations at the conclusion of the operant session, respectively.      
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Figure 16: Microdialysis probe placements within the medial prefrontal cortex.   
 
 
Coronal slices 2.7, 3.2, and 3.7 mm from bregma showing microdialysis probe 
placements for all experimental groups.  Lines represent 3.25 mm active dialysis 
area.  10S10E = 10% sucrose + 10% ethanol, 10S = 10% sucrose.  Histology 







This is the first report of changes in mPFC extracellular dopamine during 
operant self-administration of sweetened ethanol.  Dopamine concentrations 
during the home cage baseline were lower in the mPFC of rats that had 
experienced about a week of drinking sweetened ethanol vs. sucrose-drinking 
and handling controls.  Upon transfer into the operant chamber, dopamine 
increased to a greater degree relative to baseline in the mPFC of the sweetened 
ethanol group compared with sucrose and handling controls; however, all groups 
showed a dopamine response during the transfer.  At the start of the drink period, 
extracellular dopamine increased in the PFC in both the 10S10E and 10S 
groups, the magnitude of this effect relative to baseline was greater in the 
10S10E group. Overall, we used a behaviorally relevant operant model and show 
differences in mPFC dopamine concentrations that are unique to rats drinking 
sweetened ethanol. 
Compared to animals in the control groups, rats that had self-administered a 
sweetened ethanol solution for about a week demonstrated significantly lower 
basal dopamine concentrations in the mPFC. The reliability of this effect is 
demonstrated by our own independent replication (Supplementary materials).  
No baseline mPFC dopamine differences occurred between sucrose-
experienced and handling control groups, which highlights the specificity of 
ethanol experience on mPFC baseline dopamine levels.  We speculate that this 
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limited voluntary ethanol drinking experience may be sufficient to induce synaptic 
adaptions that alter the regulation of basal extracellular dopamine concentrations 
in the mPFC, and raises the possibility that lower mPFC dopamine concentration 
contributes to ethanol-related seeking or drinking behaviors. In the present 
studies, rats consumed on average 1-1.3 g/kg in the four sessions prior to the 
microdialysis session. At these doses, it is unlikely that basal dopamine levels 
were influenced by the aversive, lingering effects of alcohol intoxication during 
the microdialysis sessions. Previous work has demonstrated that with high doses 
of acute ethanol (3 or 4 g/kg), rats show conditioned place aversion 10 hours 
post-ethanol administration, but this behavior is not observed with lower doses (2 
g/kg; Morse, Schulteis, Holloway, & Koob, 2000). Furthermore, we did not 
observe a relationship between ethanol intake on the day prior to microdialysis 
and basal mPFC dopamine concentrations (data not shown). This supports our 
argument that the observed reduction in basal mPFC dopamine concentrations in 
the ethanol-experienced animals is related to repeated self-administration of 
intoxicating doses of ethanol and not to the lingering effects of the dose 
consumed the day prior to microdialysis. 
Consistent with the suggestion of ethanol-specific effects on basal PFC 
dopamine, is the report of lower basal dopamine concentrations in mPFC of 
naïve alcohol-preferring “P” rats compared to the outbred Wistar strain 
(Engleman et al., 2006).  However, not all alcohol-preferring strains of rats 
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demonstrate reduced basal dopamine activity in the mPFC relative to controls. 
For example, Leggio et al. (2003) demonstrated higher basal dopamine content 
in the mPFC of Sardinian alcohol-preferring (sP) rats compared to Wistar control 
rats. Furthermore, we did not observe baseline dopamine differences in the 
nucleus accumbens (NAC) between ethanol-experienced rats and controls using 
similar procedures (Doyon et al., 2005; Howard et al., 2009).  This clear contrast 
between mPFC and NAC suggests that low tonic basal dopamine concentrations 
selectively in the mPFC might be important for operant self-administration of 
ethanol.   
Differences between ethanol and sucrose drinking groups, and handling 
controls were noted in the dopamine response during transfer from the home 
cage into the operant chamber.  Rats in all three groups exhibited peak increases 
in mPFC dopamine when transferred into the operant chamber, and the largest 
increase in dopamine relative to baseline occurred in the 10S10E group.  In 
contrast, we did not observe a difference between sucrose and handling groups.  
Across all groups, we attribute some of the dopamine increase to the physical 
handling of the rat and environment change.  Physical handling increases 
extracellular dopamine in the mPFC, as does transfer into a novel environment 
(Feenstra, Botterblom, & Mastenbroek, 2000; Feenstra & Botterblom, 1996; 
Feenstra, Botterblom, & van Uum, 1998).  While the operant chamber 
environment was not novel, it was an environment change.  In both ethanol and 
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sucrose groups, transfer into the operant chamber exposed the rats to reward-
associated contextual cues that could have contributed to the observed 
stimulation of mPFC dopamine. The present data along with previous studies of 
the NAC (Doyon et al., 2005; Howard et al., 2009), suggest that both regions 
respond to ethanol-associated contextual stimuli with significant increases in 
extracellular dopamine relative to baseline compared to sucrose controls.  
Therefore, dopamine may be acting in the mPFC and NAC to stimulate ethanol-
seeking behavior in response to ethanol-associated stimuli.  
Our data clearly show that dopamine activity is enhanced in the mPFC during 
operant self-administration of sweetened ethanol or sucrose alone.  Since both 
solutions are rewarding and can act as reinforcers, the current work provides 
novel data to support the reward prediction role of mPFC dopamine, as has been 
found for the NAC (Carrillo & Gonzales, 2011; Day, Roitman, Wightman, & 
Carelli, 2007; Doyon et al., 2003b, 2005; Doyon, Howard, Shippenberg, & 
Gonzales, 2006; Howard, Schier, Wetzel, & Gonzales, 2009b; Stuber et al., 
2008).  The original reward prediction theory arose, in part, from experimental 
findings of single unit recording of presumed dopamine cell activity in the 
midbrain (Schultz, 1997).  However, single unit recording in the midbrain does 
not allow conclusions about where dopamine release occurs in response to cues 
that predict reward.  Recent work measuring changes in dopamine release in the 
NAC has added strong support for the role of dopamine as a reward prediction 
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signal (Brown, McCutcheon, Cone, Ragozzino, & Roitman, 2011; Day et al., 
2007; Hart, Clark, & Phillips, 2015; Stuber et al., 2008; Wassum, Ostlund, & 
Maidment, 2012).  The current work using microdialysis of dopamine in the 
mPFC is also consistent with the idea that dopamine release may also act as a 
reward prediction signal similar to that in the NAC, at least in a qualitative 
manner.  This was possible through the use of microdialysis followed by 
chromatographic separation of dopamine from other biogenic amines found in 
the mPFC. The time course of the dopamine signals in our microdialysis work is 
much longer (7 min) than observed with single unit recording or fast scan cyclic 
voltammetry methods in which the reward signals are observed within 10 
seconds 
We present our dopamine microdialysis data in two forms: raw dialysate 
concentration and percent of home cage baseline.  In general, the results and 
interpretations are similar for both analyses across the different phases of the 
experiment.  However, there are minor, but critical differences that should be 
noted.  Specifically, the net increase in concentration of dopamine is similar in 
the ethanol and sucrose groups during the initiation of drinking when analyzed as 
raw concentration data, but the ethanol group shows a significantly greater 
increase as a percent of baseline.  This is due to lower baseline concentrations in 
the ethanol group.  The biological significance of either way of looking at this 
dopamine response is not clear, and both could be important.  It has been 
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suggested that dopamine signaling in the mPFC has an optimal level and 
increases or decreases from this level contribute to cognitive deficits (Cools & 
D’Esposito, 2011; Floresco & Magyar, 2006). However, without assessing the 
functional consequences of reduced basal dopamine concentrations in the mPFC 
of our animals, we cannot make assumptions about the implications of our 
findings on cognition.   
In conclusion, we present novel data using a behaviorally relevant model that 
within the mPFC the amount of extracellular dopamine is significantly different in 
rats that drink sweetened ethanol, compared to sucrose and handling controls.  
Rats trained to drink sweetened ethanol not only demonstrated reduced basal 
mPFC dopamine concentrations, but also exhibited a different dopamine 
response in anticipation of the drinking event and once consumption was 
initiated.  Compared to previous reports on the NAC, our results also highlight 
important regional differences in the dopamine response to ethanol or ethanol-
associated cues that are specific to the mPFC.  Thus, our current data provides a 
critical foundation for future studies that may help identify mechanisms behind 
compromised prefrontal cortical executive function that are frequently observed 




This section details the procedures and results of an independent study to 
assess the reliability of the observation of reduced basal PFC dopamine in 
ethanol experienced rats relative to control rats. The overall procedures were 
similar to those described in the manuscript so only key differences are 
highlighted below.  
 
Materials and Methods 
Materials 
 Drinking solutions were prepared as described in the manuscript, with the 
exception that tap water was used instead of deionized water.  
 
Animals 
 Sixteen male, young adult Long Evans rats from Charles River 
Laboratories (Raleigh, NC, USA; 220-240 g upon arrival). All animal procedures 
complied with the NIH Guide for the Care and Use of Laboratory Animals and 
were approved by the Institutional Animal Care and Use Committee of the 
University of Texas at Austin.  Stereotaxic surgeries were performed as 
described in the manuscript to implant a cannula directly above the mPFC (+3.0 
AP; +0.5 ML; -1.1 DV). 
 
Self-Administration Training and Protocols 
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 For the replication project, operant self-administration training was 
conducted as described in the manuscript. However, a handling group was not 
necessary for this project and therefore animals were assigned to either the 
ethanol (10S10E) or sucrose group (10S). 
 
Microdialysis 
 The microdialysis experiment followed the same procedures as described 
in the manuscript, with a few exceptions discussed below. During the final 
microdialysis session, only basal samples were collected.  
 Following the seventh operant session, rats were briefly anesthetized with 
isoflurane and a lab-constructed microdialysis probe (Pettit and Justice, 1991) 
was implanted through the guide cannula and into the mPFC. As described 
above, probes were perfused with ACSF overnight at a flow rate of 0.2 µl/min. 
Immediately following probe implantation and for the duration of microdialysis 
sampling, animals remained in their home cage next to their respective operant 
chamber. The next morning, the flow rate was increased to 1.0 µl/min at least 2 
hours prior to the start of microdialysis. 
Microdialysis samples were manually collected every six minutes and 
were immediately frozen on dry ice. After a minimum of 4 samples was collected, 
the ACSF was changed to calcium-free ACSF. Calcium-free ACSF was perfused 





 Dopamine content in each sample was quantified via reverse-phase high 
performance liquid chromatography (HPLC) with electrochemical detection.  All 
samples were run with accompanying external standards (0.015 to 1.25 nM 
dopamine).  Samples and standards were run using an 8125 manual injector 
(Rheodyne, Cotati, CA), a Luna 50 x 1.0 mm (C18, 3-µm particle size; 
Phenomenex, Torrance CA), and a 2 mm glassy carbon working electrode 
(SenCell, Antec Leyden, Netherlands) at potential + 450 mV relative to a Ag/AgCl 
reference electrode.  Mobile phase was pumped through the HPLC system at a 
flow rate of 0.2 mL/min using an ISCO 65D syringe pump. The mobile phase 
consisted of 0.500 g octanesulfonic acid, 0.050 g decanesulfonic acid, 0.128 g 
ethylenediaminetetraacetic acid, and 11.08 g NaH2PO4 dissolved in 1 liter of 
deionized water, adjusted to 5.60 pH with 1 M sodium hydroxide.  Methanol (6-
8% v/v) was added to the mobile phase solution as the organic solvent and the 
solution was sparged with helium. EZChrome Elite software (Agilent 
Technologies, Wilmington, DE) was used for chromatogram acquisition and peak 
integration.  For three animals, the chromatography software was unable to 
determine peak heights of the dopamine signal for one or more of the samples. 
Therefore, peak area was used to determine the dopamine concentrations of all 
samples collected for these animals. The dopamine signal was required to be at 




 Within three days of dialysis, animals were overdosed with sodium 
pentobarbital (150 mg/kg, intraperitoneal) prior to brain extraction.  Brains were 
post-fixed with 10% formalin in saline, coronally sectioned (120 µm thick), and 
stained with cresyl violet for verification of the microdialysis probe placement 
(Paxinos et al., 1999).   
 
Exclusion Criteria 
 For inclusion of rats in data analysis, dopamine concentrations in home 
cage baseline samples were required to have a relative standard deviation < 
0.25.  We also required a 40% decrease in dopamine concentration in calcium-
free ACSF samples compared to basal ACSF samples to verify that dopamine 
release was exocytotic.  Rats were required to acquire the lever-press behavior 
within two training sessions and the 10S10E group was required to consume at 
least 0.24 g/kg in session 5, 0.43 in session 6, and 0.58 g/kg in session 7. These 
minimum values for consumption were determined from the ethanol consumption 
data for the animals included in the original experiment. 
 
Statistical Analysis 
 Raw dopamine concentrations (nM) were analyzed via a one-sided 
student’s t-test to determine differences in basal PFC dopamine content between 
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the 10S10E and 10S groups. Data were analyzed using SPSS software (IBM).  
Significance was assigned if p < 0.05; ns= not significant.   
 
Results 
Consumption during operant self-administration sessions 
 Ethanol and sucrose consumption data for the seven operant sessions are 
represented in Table 5. In the group consuming sweetened ethanol, rats 
increased their ethanol intake over the eight sessions and consumed at least 1 
g/kg during the four sessions prior to microdialysis. The consumption data for the 
10S10E and 10S groups resembled those of the original experiment. 
Table 5: Ethanol and sucrose consumption per session 
Training 
Day 









1 0% n/a 2.80 ± 0.65 
2 2% 0.27 ± 0.06 2.52 ± 0.31 
3 2% 0.47 ± 0.06 3.03 ± 0.43 
4 5% 1.06 ± 0.12 3.17 ± 0.45 
5 5% 1.05 ± 0.18 2.89 ± 0.47 
6 10% 1.43 ± 0.33 3.13 ± 0.60 
7 (Tethered) 10% 1.18 ± 0.25 3.00 ± 0.50 
* indicates mean ± SEM. 
 
Analysis of raw basal PFC dopamine concentrations 
 As observed in the original experiment, animals with about a week of 
sweetened ethanol experience demonstrated significantly lower basal dopamine 
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concentrations in the PFC relative to sucrose-only controls (t14= 1.76, p<0.05; Fig 
17).  
 
Histologies and calcium-dependent dopamine concentration  
 Histologies indicated that at least 50% of the probe active area for each 
animal was in the infralimbic and prelimbic regions (Figure 18).  Calcium-
dependent dopamine release was confirmed by a minimum 40% dialysate 
dopamine concentration decrease when calcium-free ACSF was perfused 
through the probe.  10S10E and 10S groups showed an average of 63 ± 5% and 
57 ± 4% decrease in dopamine in calcium-free ACSF samples compared to 
concentrations at the conclusion of the operant session, respectively.  
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Figure 17.  Basal dopamine concentrations in the medial PFC of rats trained to 
consume 10S or 10S10E. 
 
Animals with prior ethanol self-administration experience (10S10E) demonstrate 
significantly lower basal dopamine concentrations than control rats with only 10S 






Figure 18: Microdialysis probe placements within the medial prefrontal cortex.   
 
Coronal slices 2.7, 3.2, and 3.7 mm from bregma showing placements of 
the active area (3.0 mm) of the microdialysis probes for each experimental 
group.  Ethanol indicates the group that consumed 10% sucrose + 10% 
ethanol.  Sucrose indicates the group that consumed sucrose only.  It 
should be noted that for one animal in the 10S group, the brain extraction 
occurred about 72 hours following probe removal. To ensure that a probe 
track would be visible, the probe was reinserted immediately prior to 
euthanasia. The animal ended up with 2 separate probe tracks, but based 
on the extent of the tissue damage, we made an assumption as to which 




Quantification of extracellular noradrenergic activity in the 
mPFC in rats following acute intravenous administration or self-
administration of ethanol 
 
The work presented in this chapter has not been previously published. 
 
ABSTRACT 
In the present study, we sought to characterize the pharmacological 
effects of ethanol on extracellular norepinephrine concentrations in the medial 
prefrontal cortex. To this end, we utilized two different routes of administration to 
quantify ethanol’s actions. Following an acute intravenous infusion of ethanol, we 
observed a 77% increase from baseline in dialysate norepinephrine. A control 
saline infusion did not stimulate extracellular norepinephrine, and in fact we 
observed a slight decline relative to baseline. In a separate experiment, we 
performed in vivo microdialysis in rats during an operant self-administration 
session. Prior to microdialysis, animals had experienced about one week of self-
administration of a sweetened ethanol solution or a sucrose solution. To control 
for the effects of animal handling, a separate group of animals were placed in the 
operant chambers but did not receive any drinking solutions. We observed a 
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reduction in basal norepinephrine concentrations in the ethanol-experienced 
animals relative to control groups. Although there were no significant differences 
in extracellular norepinephrine activity among the three groups during the 
operant session, we did observe a transient spike in norepinephrine during the 
transfer from the home cage to the operant chamber. We conclude that ethanol 
exerts direct pharmacological actions on central noradrenergic neurons, though 
the mechanism is unclear. Furthermore, limited voluntary ethanol consumption 




Cognitive deficits, such as impairments in working memory, response 
inhibition, and attention, are well documented in human alcoholics (Bates, 
Bowden, & Barry, 2002; Potenza, Sofuoglu, Carroll, & Rounsaville, 2011; Stavro, 
Pelletier, & Potvin, 2013). Such deficits may result from or be exacerbated by 
drug-induced adaptations in catecholamine signaling in the prefrontal cortex, as 
suggested by preclinical studies. For example, we recently demonstrated 
reduced basal dopamine concentrations in the medial prefrontal cortex (mPFC) 
of rats with about one week of ethanol self-administration experience relative to 
control animals (Doherty, Schier, Vena, Dilly, & Gonzales, 2016).  Although the 
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functional implications of the reduced mPFC dopamine concentrations were not 
explored, other work has demonstrated that localized antagonism of dopamine 
D1-receptors or depletion of dopamine within the prefrontal cortex produces 
some cognitive deficits (Brozoski, Brown, Rosvold, & Goldman, 1979; Bubser & 
Schmidt, 1990; Sawaguchi & Goldman-Rakic, 1994). An abundance of literature 
suggests that cognition is dependent on optimal concentrations of both dopamine 
and norepinephrine in the prefrontal cortex (Arnsten & Pliszka, 2011; Arnsten, 
Wang, & Paspalas, 2012; Aston-Jones et al., 1999; Vijayraghavan et al., 2007), 
and that both neuromodulators may work in concert in the prefrontal cortex to 
regulate cognition (Sara, 2009; Xing et al., 2016). Pharmacological and lesion 
studies directly implicate noradrenergic signaling in the mPFC in aspects of 
cognition, such as sustained attention and attentional set-shifting behaviors 
(Lapiz & Morilak, 2006; McGaughy, Ross, & Eichenbaum, 2008). Furthermore, 
drugs such as methylphenidate and atomoxetine are believed to exert their 
cognitive-enhancing effects by increasing catecholaminergic signaling in the 
prefrontal cortex (Arnsten & Li, 2005). 
The prefrontal cortex receives dopaminergic innervation from the ventral 
tegmental area and noradrenergic innervation from the locus coeruleus. Within 
the prefrontal cortex of adult rats, norepinephrine concentrations have been 
shown to be about 4-5 times higher than dopamine concentrations (Boyce & 
Finlay, 2009; Slopsema, van der Gugten, & de Bruin, 1982), though another 
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study has reported that basal dopamine concentrations are slightly higher that 
norepinephrine concentrations (Pan & Lai, 1995). There is significant overlap in 
the mechanisms regulating extracellular dopamine and norepinephrine. For 
example, both neuromodulators are cleared from the synapse primarily via the 
norepinephrine transporter (NET), which has similar affinity (Km ~1 micromolar) 
for both dopamine and norepinephrine (Bymaster et al., 2002; Giros et al., 1994; 
Morón et al., 2002; Tanda et al., 1997; Valentini, Frau, & Di Chiara, 2004). The 
relative absence of tyrosine hydroxylase from noradrenergic terminals in the 
mPFC suggests that norepinephrine in this region may be synthesized by 
dopamine β-hydroxylase from dopamine taken up by NET (Miner, Schroeter, 
Blakely, & Sesack, 2003). Furthermore, a recent body of literature indicates that 
noradrenergic terminals in the prefrontal cortex co-release dopamine and 
norepinephrine (Devoto, Flore, Pani, & Gessa, 2001; Devoto, Flore, Pira, Diana, 
& Gessa, 2002; Devoto, Flore, Saba, Fà, & Gessa, 2005). 
Ethanol has also been shown to acutely affect performance on cognitive-
behavioral tasks in humans and rodents (Popke et al., 2000; Ralevski et al., 
2012). Though the underlying mechanisms are unknown, it is possible that 
ethanol may be altering catecholaminergic activity in the mPFC. We have 
previously quantified the effects of passive and self-administered ethanol on 
extracellular dopamine in the mPFC (Doherty et al., 2016; Schier et al., 2013), 
however, few studies have examined the pharmacological effects of ethanol on 
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norepinephrine in the mPFC. Ventura and colleagues (2006) demonstrated that 
selective norepinephrine depletion in the mPFC impairs conditioned place 
preference for ethanol in mice. An earlier in vivo microdialysis study 
demonstrated dose-dependent effects of acute ethanol on norepinephrine in the 
mPFC. A low dose (0.2 g/kg) of ethanol significantly increased norepinephrine, 
while a high dose (2.0 g/kg) initially increased norepinephrine before significantly 
declining below baseline (Rossetti, Longu, Mercuro, Hmaidan, & Gessa, 1992). 
However, because the sampling time in this study was 30 minutes, any transient 
effects of ethanol on norepinephrine may have been missed. Indeed, in vivo 
recordings of locus coeruleus neurons demonstrated that although the during a 
slow intravenous infusion of ethanol showed an initial transient spike followed by 
a robust decrease in firing rates (Verbanck et al., 1990). Therefore, the first aim 
of the present work was to quantify the effect of a moderate dose of acute 
ethanol (1 g/kg) on norepinephrine in the mPFC via in vivo microdialysis with 
enhanced temporal resolution. Secondly, we sought to quantify extracellular 
norepinephrine activity in the mPFC during operant self-administration of a 
sweetened ethanol solution or a sucrose solution. Microdialysis was also 
performed in a second control group of animals that received access to the 
operant chambers but did not consume any drinking solutions. Additionally, we 
used the same experimental design as previously used in our dopamine 
experiments to determine if about one week of ethanol self-administration would 
also be sufficient to alter basal cortical noradrenergic signaling. Given the 
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overlapping mechanisms regulating extracellular concentrations of both 
dopamine and norepinephrine, we hypothesized that altered basal 
norepinephrine activity in the mPFC of ethanol exposed animals following seven 




Final statistical analyses used 27 male adult, Long Evans rats from Envigo 
Laboratories (Indianapolis, IN, USA; 270-285 g upon arrival). Animals were 
maintained on a 12-hour light/dark schedule, at 23 ± 2 ºC, with ad libitum food 
and water (except where noted); rats were weighed each day. All animal 
procedures complied with the NIH Guide for the Care and Use of Laboratory 
Animals and were approved by the Institutional Animal Care and Use Committee 
of the University of Texas at Austin. 
 
Materials 
 The intravenous ethanol solution was a 10 % (w/v) solution of ethanol (1 
g/kg, 10 ml/kg) in saline was made from 95 % ethanol (Aaper Alcohol and 
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Chemical Co., Shelbyville, KY). Drinking solutions (10S: 10% sucrose (w/v) or 
10S10E: 10% ethanol (v/v) in 10S) were made from 95% ethanol (AAPER 
Alcohol and Chemical Co., Shelbyville, KY), ultra-pure sucrose (Fisher Scientific, 
Pittshburgh, PA) and tap water.  Carprofen (Pfizer, New York, NY) and 
gentamicin (APP Pharmaceuticals, Schaumburg, IL) were used during surgery.   
 
Surgery 
Cannulation and jugular catheterization surgeries were carried out according 
to the procedures described in Duvauchelle (1998) and Howard et al. (2008). 
Intravenous catheters were constructed from silastic tubing (0.30 mm ID, 0.64 
mm OD, Fisher Scientific, Hampton, NH), a metal cannula (22 gauge, Plastics 
One, Roanoke, VA), and silicone adhesive. Rats were anesthetized with 
isoflurane and an incision was made above the skull. Upon securing the catheter 
in the jugular vein, it was pulled subcutaneously to the top of the skull.  A 
microdialysis guide cannula (21 gauge, Plastics One, Roanoke, VA) was 
implanted into the skull directly above the medial prefrontal cortex (AP +3.0, ML 
+0.57, DV -1.1) while the animal was in a stereotaxic frame. The guide cannula, 
catheter cannula, and a tether bolt were held in place on the skull with dental 
cement. Catheters were flushed with 0.2 mL of heparinized saline at least once a 
week before dialysis experiments commenced. For the self-administration 
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experiments, rats were not catheterized and only underwent intracranial 
cannulation surgery. Following surgeries, rats were individually housed and given 
at least 6 days of recovery prior to experiments.  
 
Microdialysis 
Approximately 12-18 hours prior to the microdialysis experiment, rats were 
lightly anesthetized with isoflurane to implant the microdialysis probe through the 
guide cannula and to secure the animal to the tethering apparatus. The probes (3 
mm active membrane length, 270 µm OD, 13,000 MWCO) were constructed in 
the laboratory according to the procedures described by Pettit & Justice (1991). 
Probes were continuously perfused with artificial cerebrospinal fluid (ACSF; 149 
mM NaCl, 2.8 mM KCl, 1.2 mM CaCl2, 1.2 mM MgCl2, and 5.4 mM D-glucose) 
overnight at 0.2 µL/min. The flow rates were increased to 1.0 µL/min at least 2 
hours prior to dialysate sample collection and remained at 1.0 µL/min for the 
duration of the experiment. 
Animals were awake and freely moving during the microdialysis experiments. 
In all experiments, the sample collection interval was 10 minutes and three 
baseline samples were collected per animal in the home cage prior to any 
experimental manipulations. Baseline norepinephrine concentrations were 
required to have a relative standard deviation <0.30 for data inclusion. To confirm 
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that the norepinephrine in the dialysate samples was due to calcium-dependent 
exocytotic release, probes were perfused with calcium-free ACSF for 
approximately 2 hours at the conclusion of all experiments and additional 
samples were collected. All dialysate samples were immediately frozen on dry 
ice upon collection. 
 
Self-Administration Training and Protocols 
Groups 
Rats were initially trained to lever press for access to a 10% sucrose (10S) 
solution, and then two groups were formed, one that consumed 10% ethanol in 
10% sucrose (10S10E) and a group that continued to drink 10S.  The Handling 
control group was exposed to all the same procedures as the 10S10E and 10S 
groups (physical handling, water deprivation during lever press training, time in 
the operant chamber, tethering, and dialysis), but they were not exposed to 
drinking solutions or operant training.                
 
Lever-press training and operant protocol 
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At least 6 days after surgery, animals were habituated to operant 
chambers (Med Associates, Inc., Vermont, USA) and then trained to lever press 
for a 10S solution (10S10E and 10S groups only).  Water deprivation (maximum 
22 hours/day) was used to expedite lever-press training.  Animals typically 
learned to lever press within 1-2 training sessions (one session/day), after which 
they regained ad libitum access to water for the remainder of the experiment.  
Operant chambers were as previously described by Howard et al. (2009).  
Briefly, chambers had a retractable lever, sipper tube bottle, house light, cue light 
and lickometer circuit, and were contained in sound-attenuating boxes with the 
doors removed to accommodate microdialysis sample collection. Med Associates 
software was used to run the operant programs.  
Once trained to lever press, animals began an eight-session training 
schedule during which a pre-lever-press wait period was lengthened from 0-30 
min, and the response requirement was increased from 2-4. Following 
completion of the response requirement, the sipper tube containing the drinking 
solution entered the chamber for 30 minutes, during which animals had ad libitum 
access to the drinking solution. No further responding was required. Sessions 
were run once a day, four to six days per week.  Animals received a total of three 
to four, but never more than two sequential days off from training once the eight-
session protocol began. All sessions were run between the hours of 9:00 am – 
12:00 pm, during the animal’s light cycle. The room light was turned off during all 
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sessions to minimize distractions. The handling control group completed the 
same procedures, except drinking solutions were not available, and the lever was 
present but pressing had no consequences. Drinking bottles were weighed 
before and after the drinking session to quantify solution consumption, and 
pattern of consumption was monitored using the lickometer. Any spillage or 
evaporation was accounted for in the final consumption calculations. 
 Following the sixth operant session, a spring was attached to the tether 
bolt on the animal’s head and connected to a swivel suspended above the rat by 
a counter-balance lever arm. Rats were tethered in their home cages (placed 
next to their operant chamber) overnight and during the seventh operant session 
to facilitate habituation to the apparatus. The tethering apparatus did not interfere 
with the rats’ abilities to move freely about their home cage or to lever press in 
the operant chamber. Following completion of the seventh operant session, 
animals underwent the microdialysis procedure as described above. 
 
Microdialysis Timeline 
 Microdialysis samples were manually collected every 10 minutes before 
and during the eighth operant session (Figure 19).  Three baseline samples were 
taken in the home cage.  During the last minute of the fourth sample, the rat was 
transferred into the operant chamber.  The operant program began with turning 
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on the house light and sound-attenuating fan, and the sample collection vial was 
changed to the first wait period sample.  Three wait period samples were taken.  
The time it took the rat to meet the response requirement of four lever presses 
was collapsed into the last wait period sample.  The wait/lever-press sample was 
changed to the first drink sample as the sipper tube entered the chamber.  Three 
samples were taken during the drink period, after which the bottle retracted and 
the house light turned off.  Then three samples were taken during the post-drink 
period.  The rat was then returned to its home cage, and the ACSF was changed 
to calcium-free ACSF. For the 10S10E group, two microliter aliquots were 
removed from the sample before the lever extended into the chamber and all 
subsequent samples to determine dialysate ethanol content. Animals receiving 
10S10E were required to consume at least 0.8 g/kg during the microdialysis 
operant session for inclusion in the final analyses. 
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Figure 19: Experimental timeline for operant self-administration session on the 8th 
day of testing. 
 
Microdialysis was performed during the final operant session, and consisted of 4 
phases during which dialysate samples were collected every 10 minutes. Figure 




 Dialysate norepinephrine concentrations were quantified via reversed-
phase high performance liquid chromatography (HPLC) with electrochemical 
detection. The HPLC system consisted of a Waters Acquity UPLC column (either 
HSS T3 1.0 x 50 mm or BEH, 1.0 x 100 mm; C18, 1.7 µm particle size; Waters 
Corporation, Milford, MA), 2 mm glassy carbon working electrode 
electrochemical detector (SenCell; Antec Leyden) at potential +450 mV, an 8125 
manual injector (Rheodyne, Cotati, CA), and a Decade ELITE controller (Antec 
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Leyden).  Mobile phase was continuously pumped through the system via an 
LC110S pump (Antec Leyden). The mobile phase consisted of 0.500 g 
octanesulfonic acid, 0.150 g decanesulfonic acid, 0.128 g 
ethylenediaminetetraacetic acid, and 11.08 g NaH2PO4 dissolved in 1 liter of 
deionized water, and methanol as the organic solvent (4-10% v/v). The mobile 
phase was adjusted to pH 5.6 prior to adding the methanol. The sample injection 
volume was 5 microliters. External standards (0.16 to 2.5 nM) were used to 
quantify the norepinephrine concentrations. EZChrom Elite software (Agilent, 
Wilmington, DE) was used to record and analyze all chromatograms. Only 




 For animals that received ethanol infusions, dialysate ethanol 
concentrations were quantified via gas chromatography (GC) with flame 
ionization detection (Robinson, Lara, Brunner, & Gonzales, 2000). Prior to 
freezing the dialysate samples, 2 µL aliquots were transferred to 2 mL glass 
chromatography vials and sealed with a septum. The GC system consisted of a 
Scion 436 gas chromatograph (Bruker, Netherlands), a Varian 8200 headspace 
autosampler, and hydrogen (via a hydrogen generator; Model 20H-MD, Parker 
 153 
Hannifin, England) as the carrier gas. The stationary phase was an HP Innowax 
capillary column (30 m × 0.53 mm × 1.0 µm film thickness). Resulting ethanol 
peaks were recorded using CompassCDS (Bruker, Netherlands) software, and 
calibration was achieved using external standards (0.3125 to 40 mM). For one 
animal in the operant self-administration experiment, some samples were lost 
due to a technical malfunction. 
 
Histological Analysis 
 Within three days of dialysis, animals were overdosed with sodium 
pentobarbital (150 mg/kg, intraperitoneal).  Brains were extracted and placed in 
jars containing 10% formalin in saline. At least 48 hours later, brains were 
coronally sectioned (120 µm thick), and stained with cresyl violet for verification 
of the microdialysis probe placement (Paxinos et al., 2007).   
 
Statistical Analyses 
Normalized norepinephrine concentrations (represented as a percent of 
baseline) were analyzed using repeated measures analysis of variance (ANOVA) 
in both the acute and self-administration experiments. Post hoc analyses (using 
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pooled error and Bonferroni corrections, as appropriate) followed up on any 
significant findings from the overall ANOVA. 
The acute intravenous experiments followed a within subjects design with 
animals receiving both a saline and an ethanol infusion. The within subjects 
factor was time, and separate ANOVAs were performed on the saline and 
ethanol data. 
In the operant self-administration experiments, treatment was the 
between-subjects factor (three levels: 10S10E, 10S, and handling) and time (13 
time points: 3 home cage baseline, 4 wait period, 6 drink and post-drink) as 
within subjects repeated factor. Specifically, when significant interactions 
between main effects were observed in the omnibus ANOVA, simple effects 
analyses were done to determine the source of the significant interaction. 
 
RESULTS 
Acute systemic ethanol (1 g/kg) stimulates extracellular norepinephrine in the 
medial prefrontal cortex 
 The mean dialysate norepinephrine concentration in the basal samples 
prior to the saline infusion was 0.32 ± 0.04 nM. Prior to the ethanol infusion, the 
mean dialysate norepinephrine concentration was 0.24 ± 0.01 nM. 
 155 
 Separate repeated measures ANOVAs were performed on the pre- and 
post-saline infusion samples and the pre- and post-ethanol samples. Analyzing 
the normalized data, the overall ANOVA on the baseline and post-saline infusion 
samples revealed a simple effect of time (Figure 20a, left panel; F9,54=2.73, 
p=0.01). Post hoc analysis indicated significance only at the 60-minute time point 
(F4,54=3.71, p<0.01; 20 minutes following the saline infusion). The overall ANOVA 
on the pre- and post-ethanol infusion samples also revealed a simple effect of 
time (Figure 20a, right panel; F8,48=12.80, p<0.01). The ethanol infusion 
significantly increased extracellular norepinephrine to 77% above baseline in the 
dialysate sample immediately following the ethanol infusion. Post hoc analysis 
indicated significance at the 130-minute (F3,48=25.05, p<0.01) and the 140-
minute (F3,48=6.98, p<0.01) time points. 
 The dialysate ethanol concentrations from all samples subsequent to the 
infusion are depicted in Figure 20b. Dialysate ethanol concentrations peaked at 
11.3 ± 0.8 mM immediately following the infusion and steadily declined 






Figure 20: Extracellular norepinephrine (normalized to baseline) in the mPFC 
following intravenous administration of saline and 1 g/kg ethanol. 
 
(a) Extracellular norepinephrine (normalized to baseline) in the medial prefrontal 
cortex following intravenous administration of saline (left panel) and 1 g/kg 
ethanol (right panel). (b) Dialysate ethanol concentrations following intravenous 
administration of 1 g/kg ethanol. The arrows indicate the time of the infusions. 





Ethanol consumption during operant self-administration sessions 
 The ethanol consumption data for the 10S10E group is shown in Table 6. 
Over the four sessions prior to microdialysis, animals consumed on average 1.4 
± 0.2 g/kg. During the microdialysis session, animals consumed 1.6 ± 0.2 g/kg. 
 
Basal norepinephrine concentrations in the medial prefrontal cortex following 
limited voluntary ethanol consumption 
 Microdialysis was performed in three different groups of animals following 
about one week of operant self-administration. The baseline dialysate 
norepinephrine concentrations for the handling and 10S control groups were 0.50 
± 0.04 nM and 0.57 ± 0.04 nM, respectively (Figure 21). The baseline dialysate 
norepinephrine concentrations for the 10S10E group were 0.33 ± 0.04 nM, 




Table 6: Ethanol consumption during operant self-administration sessions 
Session Ethanol  consumption (g/kg) 
1 N/A 
2 0.30 ± 0.03 
3 1.08 ± 0.21 
4 1.75 ± 0.30 
5 1.27 ± 0.17 
6 1.46 ± 0.17 
7 1.26 ± 0.18 
8 (Microdialysis) 1.58 ± 0.17 






Dialysate norepinephrine during operant self-administration 
 The operant microdialysis session consisted of 3 phases: home cage 
baseline, transfer and wait period, and drink/post-drink period. Although an 
overall ANOVA on the normalized data revealed a significant effect of time 
(Figure 22; F12,168=8.78, p<0.01), there was no time by treatment interaction 
(F24,168=0.81, NS) and no main effect of treatment (F2,14=0.18, NS).  
 Post hoc analyses indicated that the main effect of time was driven by a 
significant increase in extracellular norepinephrine at the time of transfer from the 
home cage into the operant chamber, which occurred in all 3 groups. Significant 
increases from baseline were observed at the 40-minute (F3,168=30.45, p<0.001; 
collapsed across treatment groups) and 50-minute (F3,168=9.07, p<0.001; 
collapsed across treatment groups) time points. 
 
Dialysate ethanol concentrations during final operant session 
 For the animals in the 10S10E group, dialysate ethanol concentrations 
were determined via gas chromatography (Figure 23). Dialysate ethanol 
concentrations rose over the course of the drink/post-drink period, peaking at 6.1 
± 1.4 mM at 40 minutes following the start of the drink period. 
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Figure 21 Basal norepinephrine concentrations in the medial prefrontal cortex 
following limited voluntary operant self-administration.  
 
 
Animals received a sweetened ethanol solution (10S10E), a sucrose solution 
(10S), or nothing (Handle) over seven operant sessions prior to microdialysis. 
Basal samples were collected over 30 minutes while the animals remained in 
their home cages. Data points represent mean ± SEM; significant group 
differences indicated by the asterisk (*). The n per group is indicated by the 




























Figure 22: Dialysate norepinephrine (normalized to baseline) during the 8th 
operant self-administration session.  
 
During the final operant session, basal samples were collected prior to any 
manipulations. The animals were physically transferred (indicated by the arrow) 
to the operant chambers, initiating the onset of the 30-minute wait period. Upon 
completion of the response requirement, animals received 30 minutes of access 
to a sweetened ethanol solution (10S10E), a sucrose solution (10S), or no 


























Figure 23: Dialysate ethanol concentrations during final operant session.  
 




























 The current work demonstrates that intravenous administration of an 
intoxicating dose of ethanol acutely stimulates extracellular norepinephrine in the 
medial prefrontal cortex (mPFC) of naïve animals. While we observed a decline 
in extracellular norepinephrine following the saline infusion, this may have been 
due to the behavioral state of the animals. Typically, animals fall asleep or lay 
down after about 30 minutes into the acute microdialysis experiment, and 
norepinephrine levels are known to decrease during low arousal states (España, 
Schmeichel, & Berridge, 2016; Feenstra, 2000).  
Additionally, this is the first study to quantify norepinephrine activity in the 
mPFC during an operant self-administration session. We monitored extracellular 
norepinephrine activity in animals that had consumed a sweetened ethanol 
solution (10S10E), a 10% sucrose solution (10S), or nothing (handling) in the 
operant chamber for about one week prior to the microdialysis experiment. In all 
three groups, we observed a significant increase in extracellular cortical 
norepinephrine relative to baseline at the time of transfer into the operant 
chamber. Although this is consistent with other reports of stimulated 
norepinephrine concentrations in the mPFC during physical handling (Feenstra, 
Botterblom, & Mastenbroek, 2000; Ihalainen, Riekkinen Jr, & Feenstra, 1999; 
Kawahara, Kawahara, & Westerink, 2000; Marsteller et al., 2002), we cannot rule 
out the influence of appetitive stimuli on cortical norepinephrine activity. A 
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potential confound of these earlier studies is that the handling period lasted 10-
16 minutes, which may be stressful. In contrast, when the handling period is 
transient, such as during the transfer from one cage to another, there is no 
apparent effect on extracellular cortical norepinephrine (Rossetti & Carboni, 
2005). Additionally, conditioned appetitive and aversive stimuli have been shown 
to stimulate extracellular norepinephrine in the mPFC (Mingote, de Bruin, & 
Feenstra, 2004; Ventura, Latagliata, Morrone, La Mela, & Puglisi-Allegra, 2008). 
Therefore, it is possible that the noradrenergic response observed during the 
transfer period may be attributed to the conditioned stimuli associated with the 
operant chambers, but further experiments are necessary to confirm this 
hypothesis. 
Although we did not observe differences in norepinephrine activity among 
the three groups of animals, we did observe significant differences in tonic 
norepinephrine, with the 10S10E group showing reduced basal levels relative to 
the 10S and handling groups. Interestingly, we have previously reported a 
reduction in dopaminergic tone in the mPFC of ethanol-experienced animals 
relative to control animals under the same experimental conditions (Doherty et 
al., 2016). Together, our work is the first to demonstrate altered 
catecholaminergic signaling in the mPFC following limited voluntary ethanol self-
administration. Our observations are consistent with an early study that 
measured tissue concentrations of dopamine and norepinephrine in two strains 
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of mice following 7-10 days of a forced liquid ethanol diet. Both strains of mice 
demonstrated a reduction in basal levels of both catecholamines in the cortex 
(Shafik, Aiken, & McArdle, 1991). Additionally, another study in rats found 
reduced tissue concentrations of norepinephrine in the mPFC in rats given two 
weeks of a liquid ethanol diet, relative to pair-fed controls (Carlson & Drew 
Stevens, 2006). However, in these studies, it is unclear if extracellular 
concentrations were specifically reduced. Our interpretation of these findings is 
limited as minimal work exists investigating ethanol’s interactions with the 
mechanisms regulating extracellular concentrations of cortical catecholamines. 
Therefore, at this time, we can only speculate as to the mechanisms underlying 
our reports of reduced catecholaminergic tone in animals with limited voluntary 
ethanol consumption experience relative to ethanol-naïve controls.  
The literature contains an abundance of work exploring the effects of 
stress on catecholaminergic regulation in the prefrontal cortex that may have 
some relevance to the current work. Ethanol itself has been shown to activate the 
endogenous stress system (Lee & Rivier, 1997; Soon Lee, Selvage, Hansen, & 
Rivier, 2004; Rivier, 1996). Similar to ethanol, acute stress also stimulates 
extracellular dopamine and norepinephrine in the mPFC (Finlay, Zigmond, & 
Abercrombie, 1995; Nakane et al., 1994). Additionally, following chronic 
exposure to a severe stressor for 4 weeks, rats showed a reduction in basal 
dopamine concentrations in the mPFC relative to unstressed control rats 
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(Mizoguchi et al., 2000). A separate study demonstrated an increase in 
membrane-bound NET in the mPFC following 2 weeks of chronic cold stress 
(Miner et al., 2006), which theoretically would increase dopamine and 
norepinephrine clearance. However, the same stress paradigm produced no 
significant differences in basal norepinephrine concentrations between stress 
and unstressed animals (Gresch, Sved, Zigmond, & Finlay, 1994; Jedema, Sved, 
Zigmond, & Finlay, 1999). While it is unknown if chronic ethanol administration 
alters prefrontal catecholamine signaling via the same mechanism as chronic 
stress, our reports of reduced basal catecholamines could be explained by an 
enhancement of NET activity.  
Alternatively, ethanol may be interacting with catecholamine metabolic 
enzymes, another mechanism of clearance in the prefrontal cortex. Following 
administration of a high dose of ethanol (3.5 g/kg, i.p.), dopamine metabolite 
concentrations were significantly elevated in the PFC of mice, relative to controls. 
Increased concentrations of a norepinephrine metabolite were also observed, but 
this effect was not statistically significant (Milio & Hadfield, 1992). In humans, 
elevated concentrations of a norepinephrine metabolite have been observed in 
the CSF of alcoholics and healthy controls following acute administration of an 
intoxicating dose of ethanol (Borg, Kvande, Sedvall, & Goldman, 1981). 
However, in these studies, it is unclear if the increased concentrations of 
catecholamine metabolites is the result of ethanol-induced alterations in the 
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function of metabolic enzymes, or if they are simply the result of stimulated 
dopamine and norepinephrine concentrations following acute ethanol 
administration. Lastly, ethanol may be inducing adaptations in the mechanisms 
regulating catecholamine synthesis and release, such as autoreceptor feedback 
control mechanisms. Further investigation is required to explore these 
hypotheses. 
Several studies have examined the effect of pharmacologically targeting 
the noradrenergic system on alcohol self-administration in humans and rodents. 
In general, these studies report that drugs that have a net effect of activating the 
noradrenergic system, appear to enhance alcohol seeking and consumption. In 
contrast, drugs that reduce noradrenergic signaling appear to reduce alcohol 
seeking and consumption. For example, systemic prazosin, an a1-receptor 
antagonist, reduced ethanol-seeking behavior in non-dependent animals, but 
only at the highest tested dose (Walker, Rasmussen, Raskind, & Koob, 2008). 
Prazosin also reduced ethanol consumption and seeking behavior in alcohol-
preferring P rats (Verplaetse, Rasmussen, Froehlich, & Czachowski, 2012). 
Human alcohol dependent patients treated with prazosin also reported fewer 
drinking days and fewer drinks per week than those receiving placebo (Simpson 
et al., 2009). Similar effects have also been observed with another a1-receptor 
antagonist, doxazosin (Kenna et al., 2016; O’Neil, Beckwith, Kincaid, & 
Rasmussen, 2013), and with clonidine (Rasmussen, Alexander, Malone, 
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Federoff, & Froehlich, 2014) and guanfacine (Riga, Schmitz, et al., 2014), both of 
which reduce noradrenergic signaling by agonizing a2-receptors. Together, these 
studies appear difficult to reconcile with our observation of reduced 
noradrenergic tone in the mPFC following about one week of alcohol self-
administration. However, it is necessary to consider the clinical or preclinical 
populations in which these noradrenergic agents were tested. 
In the current study, the 10S10E animals were unlikely to experience 
significant tolerance and withdrawal due to the limited self-administration 
experience. In contrast, the clinical studies in which a1 antagonism reduced 
drinking were conducted in alcohol-dependent individuals. Furthermore, in the 
studies conducted by Rasmussen et al (2014) and Riga et al (2014), animals had 
prolonged (at least 9 weeks) ethanol self-administration experience prior to being 
treated with clonidine and guanfacine, respectively. The central noradrenergic 
system may be differentially regulated in the early stages of alcohol use and 
following prolonged alcohol use. With chronic and prolonged alcohol use, 
withdrawal symptoms emerge that are associated with activation of the 
sympathetic nervous system, in which norepinephrine is a key mediator. For 
example, a hyperexcitability endophenotype has been observed in alcohol-
dependent males (Krystal et al., 1997), alcoholics undergoing acute withdrawal 
(Begleiter & Porjesz, 1999), alcohol-preferring P and HAD rats (Chester, Blose, & 
Froehlich, 2004), and ethanol-experienced mice undergoing acute withdrawal 
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(Kovács, Soroncz, & Tegyei, 2002). This endophenotype is associated with 
greater sensitivity to the stimulatory effects experienced during the ascending 
limb of the blood alcohol curve (Begleiter & Porjesz 1999) and enhanced 
noradrenergic activation (Kovács et al., 2002). Studies in humans and animals 
report either normal or reduced peripheral noradrenergic signaling in dependent 
subjects not experiencing withdrawal symptoms relative to controls. However, 
with the onset of ethanol withdrawal, there is an abrupt upregulation of the 
peripheral noradrenergic system (Fitzgerald, 2013; Kovács et al., 2002; Mäki et 
al., 1990; Patkar et al., 2003; Smith, Brent, Henry, & Foy, 1990). Furthermore, 
plasma norepinephrine concentrations are positively correlated with withdrawal 
scores (Kovács et al., 2002; Smith et al., 1990). Therefore, following voluntary 
alcohol self-administration in non-dependent subjects, there may be an initial 
reduction in noradrenergic activity, but following repeated withdrawal experiences 
there may be an upregulation of noradrenergic signaling, as suggested by 
elevations in norepinephrine metabolites in the CSF and plasma of alcoholics 
undergoing withdrawal (Linnoila, Mefford, Nutt, & Adinoff, 1987; Nutt, Glue, 
Molyneux, & Clark, 1988). Additionally, plasma concentrations of a 
norepinephrine metabolites correlated with a history of alcohol withdrawal-
induced hospitalizations and the number of years of experiencing withdrawal 
symptoms (Linnoila et al, 1987). These findings and others provide evidence for 
a sensitized sympathetic nervous system following multiple alcohol withdrawal 
episodes, potentially mediated by an upregulated noradrenergic system. 
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However, there is remarkably limited work monitoring central norepinephrine 
concentrations during alcohol withdrawal. 
Lastly, reduced norepinephrine signaling could have effects on cortical 
glial activity. Several recent studies have suggested that locus coeruleus 
norepinephrine neurons exert neuromodulatory effects on astrocytes that may 
promote widespread coordination of neural-glial networks (Fuxe, Agnati, Marcoli, 
& Borroto-Escuela, 2015). For example, in an aroused behavioral state or 
following stimulation of locus coeruleus neurons, enhancement of astrocytic Ca2+ 
signaling throughout the cortex has been reported (Bekar, He, & Nedergaard, 
2008; Ding et al., 2013; Paukert et al., 2014). Additionally, alpha-1 and beta-
1/beta-2 adrenergic receptors have been identified on cortical astrocytes, and 
norepinephrine (as well as α1 and β1/ β2 agonists) activates astrocytes via these 
receptors (Ding et al., 2013; Fuxe et al., 2015; Laureys et al., 2010). Activation of 
astrocytic adrenergic receptors has been shown to be neuroprotective and 
facilitates anti-inflammatory signaling. For example, application of norepinephrine 
to rat cortical slices or cell cultures increased levels of brain-derived neurotrophic 
factor (BDNF) and MCP-1 in astrocytes, which function as neuroprotective 
factors when released by astrocytes (Jurič, Lončar, & Čarman-Kržan, 2008; 
Laureys et al., 2010; Madrigal, Leza, Polak, Kalinin, & Feinstein, 2009). 
Furthermore, activation of astrocytic β2 adrenergic receptors blocks the synthesis 
of nuclear factor kappa B (Nf-κB) derived pro-inflammatory signaling molecules, 
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such as TNF-α and IL-β, and upregulates the anti-inflammatory pathway 
mediated by peroxisome proliferator-activated receptor gamma (PPAR-ϒ) (Fuxe 
et al., 2015; Laureys et al., 2010). Therefore, a possible consequence of reduced 
prefrontal cortical norepinephrine signaling may be altered regulation of 
astrocyte-mediated immune activity, potentially resulting in increased pro-
inflammatory signaling. However, because norepinephrine has a lower affinity for 
α1 and, more so, for β adrenergic receptors, it is unclear if the reduction in basal 
norepinephrine concentrations observed in the current study is significant enough 
to influence astrocytic activity. 
In summary, we have quantified the direct pharmacological effects of 
acute ethanol on extracellular norepinephrine activity in the mPFC. Furthermore, 
the current work provides evidence of ethanol-induced alterations in basal 
noradrenergic signaling in the mPFC, a region known to exert top-down 
behavioral control. Previous work found similar effects on basal dopamine 
concentrations in the mPFC using the same self-administration paradigm. These 
observations may be the result of ethanol’s complex mechanism of action; 
ethanol may be interacting with catecholaminergic synthesis, release, and/or 
clearance mechanisms to produce alterations in basal cortical concentrations. 
Functionally, a deficit in tonic catecholamine signaling in the mPFC could impair 
cognitive and executive processes similar to the impairments observed in ADHD 
and PTSD, such as poor inhibitory control, deficits in behavioral flexibility, and 
reductions in working memory (Arnsten & Li, 2005; Arnsten & Pliszka, 2011; 
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George et al., 2015; Swick, Honzel, Larsen, & Ashley, 2013). The functional 
consequences of reduced catecholamine signaling in the mPFC were not 
explored in the current work, however, so additional studies are necessary to 
determine if the observed reduction in basal catecholamine concentrations are 
sufficient to alter behavior.  
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Chapter 6: 
Concluding remarks and future directions 
 
SUMMARY OF FINDINGS 
 The work presented within this dissertation provides critical information on 
the differential actions of ethanol on catecholamine activity in the medial 
prefrontal cortex and striatal subregions. Defining ethanol’s precise mechanism 
of action has been highly elusive for several reasons. As discussed in Chapter 2, 
ethanol’s chemical properties enable it to interact with various substrates 
involved in highly diverse physiological functions. Even ethanol’s actions on 
midbrain dopamine circuits are highly heterogeneous, and alone do not explain 
precisely how ethanol acts to contribute to the development of alcohol use 
disorders. This is evident in Chapter 3, where we quantitate the differential 
pharmacological effects of acute intravenous ethanol on extracellular dopamine 
in the nucleus accumbens, dorsomedial striatum, and dorsolateral striatum. Our 
findings indicate a potential, albeit limited role of dorsomedial striatal dopamine in 
the acute reinforcing effects of ethanol, and this may contribute to the 
development of ethanol seeking behaviors by facilitating the learning of action-
outcome contingencies (Yin et al., 2008). 
 While these initial studies used intravenous administration to quantify 
ethanol’s acute pharmacological effects on extracellular dopamine, a self-
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administration model possesses enhanced face validity for human alcohol use. 
Our analyses of the dopamine-ethanol “response ratios” in Chapter 2 suggests 
that ethanol exerts particularly unique effects on the regulation of extracellular 
dopamine in the medial prefrontal cortex (mPFC). Consistent with this, we are 
the first group to report reductions in basal dopamine in the mPFC in non-
dependent animals with limited ethanol self-administration experience, relative to 
controls (Chapter 4).  
 Because ethanol’s effects on neurobiology, neurochemistry, and behavior 
extend beyond its interactions with a heterogeneous population of midbrain 
dopamine neurons, we also examined the effects of ethanol on cortical 
noradrenergic activity. In Chapter 5, we demonstrate that acute intravenous 
ethanol robustly stimulates extracellular norepinephrine in the mPFC. Similar to 
what we have reported with dopamine, we also observed a dissociation in the 
temporal profiles of dialysate ethanol and norepinephrine following acute 
administration. After about one week of self-administration of a sweetened 
ethanol solution, however, systemic ethanol does not alter norepinephrine activity 
in the mPFC. Whether this observation indicates tolerance to the stimulatory 
effects of ethanol or is due to differences in the route of administration remains to 
be investigated. Intriguingly, the same study also reported a reduction in basal 
norepinephrine concentrations in the mPFC of animals consuming sweetened 
ethanol for about one week, relative to sucrose and handling controls. Together, 
the findings of Chapters 4 and 5 demonstrate that even with voluntary, goal-
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directed ethanol consumption, there are alterations in the mechanisms regulating 
extracellular catecholamine activity in the mPFC. 
 
IMPLICATIONS AND FUTURE DIRECTIONS 
 The findings presented here incrementally contribute to our understanding 
of the mechanisms by which ethanol targets central catecholamine signaling. 
These studies also invite several opportunities for future investigation. For 
example, as discussed in Chapter 2, the temporal dissociation in dialysate 
dopamine and ethanol concentrations following acute ethanol administration may 
have functional relevance, which remains to be tested. Acute functional tolerance 
to the stimulatory or sedative effects of ethanol represents a rapid 
neuroadaptation that occurs on the time scale of minutes and is dose-dependent. 
Ponomarev and colleagues determined that acute functional tolerance in mice 
approaches its maximum for a given dose within 10-20 minutes following an 
injection of ethanol (Ponomarev & Crabbe, 2004). Although it is important to 
consider differences in ethanol metabolism between species, this time frame may 
match the onset of the temporal dissociation between dialysate dopamine and 
ethanol concentrations in the nucleus accumbens that we have observed in rats. 
However, microdialysis studies lack the temporal resolution to confirm this. 
Future studies using techniques with enhanced temporal resolution to monitor 
midbrain dopamine neuron activity can assess whether specific aspects of acute 
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functional tolerance are associated with rapid adaptations in the sensitivity of 
mesolimbic dopamine neurons to acute ethanol. 
Additionally, voluntary ethanol self-administration appears to alter the 
mechanisms regulating extracellular catecholamine concentrations specifically in 
the mPFC, but the mechanisms are unknown. Quantitative microdialysis can be 
employed to confirm the observed ethanol-induced reduction in basal 
catecholamine concentrations in the mPFC. Additionally, quantitative 
microdialysis could help determine if ethanol is modulating release or clearance 
mechanisms to produce this effect. While several studies have examined 
ethanol’s interactions with the mechanisms regulating extracellular dopamine, 
little is known about the effects of ethanol on the mechanisms regulating 
extracellular norepinephrine. 
 Additionally, the question remains whether the observed ethanol-induced 
reduction in basal catecholamine concentrations in the mPFC is functionally 
relevant. As discussed in Chapter 1, proper mPFC function relies on optimal 
concentrations of dopamine and norepinephrine, and the mPFC is highly 
sensitive to neurochemical changes (Robbins & Arnsten, 2009). Therefore, it is 
reasonable to hypothesize that the observed reduction in basal catecholamine 
concentrations in the mPFC of ethanol-experienced animals is sufficient to 
induce behavioral deficits. Reduced catecholamine activity in the mPFC is 
associated with impairments in inhibitory control, behavioral flexibility, working 
memory and attentional selection (Dalley, Theobald, Eagle, Passetti, & Robbins, 
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2002; Robbins & Arnsten, 2009; Rossetti & Carboni, 2005). Such impairments 
have been associated with increased alcohol consumption (Bogg, Fukunaga, 
Finn, & Brown, 2012) and are prominent in human alcoholics (Noël et al., 2001; 
Xavier Noël et al., 2005). Indeed, reduced dopamine transmission in the mPFC 
has been reported in human alcoholics (Narendran et al., 2014) and in rats 
exposed to a chronic intermittent ethanol protocol, which also displayed deficits 
in behavioral flexibility (Trantham-Davidson et al., 2014). Additionally, recent 
human imaging studies have demonstrated regional reductions in white and grey 
matter in the mPFC in individuals with mild (Asensio et al., 2016) and severe 
(Wang et al., 2016) alcohol use disorders, and these structural abnormalities 
were associated with increased impulsivity. Together, our work in conjunction 
with existing work indicates that ethanol-induced reductions in basal 
catecholamine concentrations in the mPFC may facilitate the development of 
impaired control over alcohol use. However, additional work is necessary to 
determine if the reduction in extracellular catecholamines that we observed is 
sufficient to produce deficits in behavioral flexibility or impulse control. 
 Lastly, this work is consistent with earlier studies implicating mPFC 
dopamine in alcohol self-administration (Hodge et al., 1996; Samson & Chappell, 
2001), but it also provides novel data indicating a potential role of mPFC 
norepinephrine in maintaining alcohol self-administration. However, additional 
studies are necessary to determine if the observed ethanol-induced alterations in 
catecholamine signaling in the mPFC can be reversed with abstinence, and it if 
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has any bearing on the activity of mPFC neuronal projection targets, such as 
striatal subregions, ventral tegmental area, and the locus coeruleus. 
Furthermore, the findings presented here provide clear evidence for ethanol’s 
acute actions on the central noradrenergic system. While many previous studies 
have focused on norepinephrine’s role in alcohol withdrawal, we have 
demonstrated adaptations in cortical norepinephrine signaling following only 
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